CN114507149A - Diamine compound, polymer, alignment agent, alignment film, and liquid crystal display element - Google Patents
Diamine compound, polymer, alignment agent, alignment film, and liquid crystal display element Download PDFInfo
- Publication number
- CN114507149A CN114507149A CN202011282222.9A CN202011282222A CN114507149A CN 114507149 A CN114507149 A CN 114507149A CN 202011282222 A CN202011282222 A CN 202011282222A CN 114507149 A CN114507149 A CN 114507149A
- Authority
- CN
- China
- Prior art keywords
- liquid crystal
- formula
- diamine compound
- polymer
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/32—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings and esterified hydroxy groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/76—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings and etherified hydroxy groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/78—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C217/80—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
- C07C217/82—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring
- C07C217/90—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring the oxygen atom of at least one of the etherified hydroxy groups being further bound to a carbon atom of a six-membered aromatic ring, e.g. amino-diphenylethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/34—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having amino groups and esterified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
- C08G73/12—Unsaturated polyimide precursors
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/52—Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
- C09K19/54—Additives having no specific mesophase characterised by their chemical composition
- C09K19/542—Macromolecular compounds
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/52—Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
- C09K19/54—Additives having no specific mesophase characterised by their chemical composition
- C09K19/56—Aligning agents
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour
- G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
- G02F1/133—Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
- G02F1/1333—Constructional arrangements; Manufacturing methods
- G02F1/1337—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
- G02F1/133711—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Materials Engineering (AREA)
- Engineering & Computer Science (AREA)
- Nonlinear Science (AREA)
- General Health & Medical Sciences (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Mathematical Physics (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Liquid Crystal (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Abstract
Description
技术领域technical field
本发明涉及一种二胺化合物、聚合物、液晶配向剂、液晶配向膜以及液晶显示元件, 尤其涉及一种可以制作出电场记忆效应与耐环境性佳的液晶显示元件的二胺化合物、聚合 物、液晶配向剂、液晶配向膜以及液晶显示元件。The present invention relates to a diamine compound, a polymer, a liquid crystal alignment agent, a liquid crystal alignment film and a liquid crystal display element, in particular to a diamine compound and a polymer that can produce a liquid crystal display element with good electric field memory effect and environmental resistance , liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element.
背景技术Background technique
一直以来,作为液晶显示元件的工作方式,已知有使用具有正介电异方向性的液晶分 子的扭转向列(Twisted Nematic,TN)型或超扭转向列(Super Twisted Nematic,STN)型、 垂直配向(Vertical Alignment,VA)型、共面切换(In Plane Switching,IPS)型、边缘场 切换(Fringe Field Switching,FFS)型、光学补偿弯曲(Optically CompensatedBend,OCB) 型等各种液晶显示元件,而为了进行各液晶分子的配向控制,主要使用由有机膜所形成的 液晶配向膜(专利文献1~4)。Conventionally, a twisted nematic (TN) type or a super twisted nematic (STN) type using liquid crystal molecules having positive dielectric anisotropy has been known as an operation method of a liquid crystal display element. Various liquid crystal display elements such as Vertical Alignment (VA) type, In Plane Switching (IPS) type, Fringe Field Switching (FFS) type, Optically Compensated Bend (OCB) type, etc. However, in order to control the alignment of each liquid crystal molecule, a liquid crystal alignment film formed of an organic film is mainly used (Patent Documents 1 to 4).
由于上述TN型、STN型等液晶配向膜的液晶分子高速响应,以及上述VA型等液晶配向膜在液晶驱动时的倾斜方向一定,因此它们各自都需要具有预倾角特性。作为赋予预倾角特性的方法,在前者的情况下,通常为摩擦法,而在后者的情况下,通常为摩擦法,或 在基板表面设置突起物的方法等。摩擦法步骤中所产生的灰尘或静电有时会导致显示不良或电路损坏的问题,另一方面,在基板表面设置突起物的方法有时会损害所得液晶显示元件的亮度等,因此这些方法都存在问题。Since the liquid crystal alignment films of the TN type and STN type have a high-speed response of liquid crystal molecules, and the liquid crystal alignment films of the VA type and other liquid crystal alignment films have a certain tilt direction during liquid crystal driving, they each need to have a pretilt angle characteristic. As a method of imparting the pretilt angle characteristic, in the case of the former, a rubbing method is usually used, and in the case of the latter, a rubbing method or a method of providing protrusions on the surface of the substrate is usually used. Dust or static electricity generated in the rubbing process may cause problems such as poor display or circuit damage. On the other hand, the method of providing protrusions on the surface of the substrate may impair the brightness of the resulting liquid crystal display element. Therefore, these methods have problems. .
由此,作为替代这些方法的预倾角赋予方法,已经提出了从相对于膜法线倾斜的方向 对感光性薄膜照射紫外线的所谓光配向法(专利文献5)。然而,以专利文献5所记载的液 晶配向剂而制作的液晶显示元件,其存在液晶显示元件的电场记忆效应与耐环境性不佳的 问题,而不利于应用。Therefore, as a pretilt angle imparting method instead of these methods, a so-called photo-alignment method in which ultraviolet rays are irradiated to a photosensitive thin film from a direction inclined with respect to the film normal has been proposed (Patent Document 5). However, the liquid crystal display element produced with the liquid crystal aligning agent described in Patent Document 5 has the problems of poor electric field memory effect and environmental resistance of the liquid crystal display element, which is not suitable for application.
另一方面,作为对由含有聚酰胺酸等的液晶配向剂所形成的涂膜赋予液晶配向能力的 方法,近年来,提出有利用光异构化或光二聚化、光分解等光配向法作为代替摩擦法的技 术。光配向法是如下的方法:通过对形成在基板上的感放射线性的有机薄膜照射偏光或非 偏光的放射线来对膜赋予异向性,由此控制液晶分子的配向。根据此方法,与先前的摩擦 法相比,可抑制步骤内的灰尘或静电的产生,因此可抑制由灰尘等所引起的显示不良的产 生或良率的下降。另外,也具有可对形成在基板上的有机薄膜均匀地赋予液晶配向能力等 优点。On the other hand, as a method of imparting liquid crystal alignment ability to a coating film formed of a liquid crystal aligning agent containing polyamic acid or the like, in recent years, photo-alignment methods such as photoisomerization, photodimerization, and photolysis have been proposed. A technique that replaces the friction method. The photo-alignment method is a method of controlling the alignment of liquid crystal molecules by irradiating a radiation-sensitive organic thin film formed on a substrate with polarized or non-polarized radiation to impart anisotropy to the film. According to this method, the generation of dust and static electricity in the step can be suppressed compared with the conventional rubbing method, so that the occurrence of display defects and the decrease in yield due to dust and the like can be suppressed. In addition, there is also an advantage that liquid crystal alignment ability can be uniformly imparted to the organic thin film formed on the substrate.
具体而言,光配向法的技术文献如专利文献6。专利文献6提出一种具有共轭烯酮(conjugated enone)的重复单元及具有酰亚胺构造的液晶配向剂。然而,以专利文献6所记载的液晶配向剂而制作的液晶显示元件,也存在液晶显示元件的电场记忆效应与耐环境性不佳的问题。Specifically, there are technical documents on the photo-alignment method such as Patent Document 6. Patent Document 6 proposes a liquid crystal aligning agent having a repeating unit of a conjugated enone and an imide structure. However, the liquid crystal display element produced by using the liquid crystal aligning agent described in Patent Document 6 also has problems that the electric field memory effect and environmental resistance of the liquid crystal display element are not good.
[先前技术文献][Prior Art Literature]
[专利文献][Patent Literature]
[专利文献1]日本特开昭56-91277号公报[Patent Document 1] Japanese Patent Laid-Open No. 56-91277
[专利文献2]日本特开平1-120528号公报[Patent Document 2] Japanese Patent Application Laid-Open No. 1-120528
[专利文献3]日本特开平11-258605号公报[Patent Document 3] Japanese Patent Application Laid-Open No. 11-258605
[专利文献4]日本特开2002-250924号公报[Patent Document 4] Japanese Patent Laid-Open No. 2002-250924
[专利文献5]日本特开2004-83810号公报[Patent Document 5] Japanese Patent Laid-Open No. 2004-83810
[专利文献6]日本特开2005-037654号公报[Patent Document 6] Japanese Patent Laid-Open No. 2005-037654
因此,如何改善液晶显示元件的电场记忆效应与耐环境性不佳的问题,以达到目前业 界的要求,实为目前此领域技术人员亟欲解决的问题。Therefore, how to improve the problems of the electric field memory effect and the poor environmental resistance of the liquid crystal display element in order to meet the requirements of the current industry is an urgent problem to be solved by those skilled in the art at present.
发明内容SUMMARY OF THE INVENTION
有鉴于此,本发明提供一种二胺化合物,其可以形成聚合物,聚合物可以制作出用于 液晶显示元件的液晶配向剂及液晶配向膜,其能够改善上述液晶显示元件的电场记忆效应 与耐环境性不佳的问题。In view of this, the present invention provides a diamine compound, which can form a polymer, and the polymer can make a liquid crystal alignment agent and a liquid crystal alignment film for a liquid crystal display element, which can improve the electric field memory effect and the liquid crystal display element of the above-mentioned liquid crystal display element. The problem of poor environmental resistance.
本发明提供一种二胺化合物,其为由式(I)表示的二胺化合物(b1-1)。The present invention provides a diamine compound, which is a diamine compound (b1-1) represented by formula (I).
式(I)中,In formula (I),
X1及X2各自独立表示单键、-O-、 其中R14表示氢或碳数为1至4的烷基;X 1 and X 2 each independently represent a single bond, -O-, wherein R 14 represents hydrogen or an alkyl group having a carbon number of 1 to 4;
x表示0或1;x represents 0 or 1;
y表示0至4的整数;y represents an integer from 0 to 4;
R1表示亚甲基或碳数为2至4的亚烷基;R 1 represents a methylene group or an alkylene group having a carbon number of 2 to 4;
R3各自独立表示碳数为1至6的烷基、碳数为1至6的烷氧基、卤素原子或氰基;R 3 each independently represents an alkyl group having 1 to 6 carbon atoms, an alkoxy group having 1 to 6 carbon atoms, a halogen atom or a cyano group;
R2表示由式(I-A)表示的有机基团或碳数为17至40的具有类固醇骨架的一价有机基团;R 2 represents an organic group represented by formula (IA) or a monovalent organic group having a steroid skeleton having a carbon number of 17 to 40;
式(I-A)中,In formula (I-A),
R4表示氟或甲基;R 4 represents fluorine or methyl;
R5、R6及R7各自独立表示单键、-O-、 亚甲基或碳数为2至3的亚烷基;R 5 , R 6 and R 7 each independently represent a single bond, -O-, Methylene or alkylene having 2 to 3 carbons;
R8表示其中R10及R11各自独立表示氟或甲基,*表示键结位置;R 8 means wherein R 10 and R 11 each independently represent fluorine or methyl, and * represents the bonding position;
R9表示氢、氟、碳数为1至12的烷基、碳数为1至12的氟烷基、碳数为1至12的烷氧基、 经氟取代的碳数为1至12的烷氧基、-OCH2F、-OCHF2、-OCF3;R 9 represents hydrogen, fluorine, alkyl having 1 to 12 carbons, fluoroalkyl having 1 to 12 carbons, alkoxy having 1 to 12 carbons, fluorine-substituted alkoxy having 1 to 12 carbons Alkoxy, -OCH 2 F, -OCHF 2 , -OCF 3 ;
a表示0至2的整数;a represents an integer from 0 to 2;
b、c及d各自独立表示0至4的整数;b, c and d each independently represent an integer from 0 to 4;
e、f及g各自独立表示0至3的整数;e, f and g each independently represent an integer from 0 to 3;
i及j各自独立表示0至2的整数;i and j each independently represent an integer from 0 to 2;
*表示键结位置;* indicates the bond position;
当R4、R5、R6、R7、R8、R10或R11为多个时,各自独立表示相同或不同的基团。When R 4 , R 5 , R 6 , R 7 , R 8 , R 10 or R 11 are plural, each independently represents the same or different groups.
在本发明的一实施例中,上述由式(I)表示的二胺化合物(b1-1)中,当x为0时,X1为 -O-、 其中R14表示氢或碳 数为1至4的烷基;当x为1时,X1为单键。In an embodiment of the present invention, in the above-mentioned diamine compound (b1-1) represented by formula (I), when x is 0, X 1 is -O-, wherein R 14 represents hydrogen or an alkyl group having a carbon number of 1 to 4; when x is 1, X 1 is a single bond.
在本发明的一实施例中,上述由式(I)表示的二胺化合物(b1-1)中,当x为0时,X1为 -O-、 In an embodiment of the present invention, in the above-mentioned diamine compound (b1-1) represented by formula (I), when x is 0, X 1 is -O-,
在本发明的一实施例中,上述由式(I)表示的二胺化合物(b1-1)中,R5、R6及R7各自独 立表示单键、-O-、亚甲基或碳数为2至3的亚 烷基。In one embodiment of the present invention, in the above-mentioned diamine compound (b1-1) represented by formula (I), R 5 , R 6 and R 7 each independently represent a single bond, -O-, A methylene group or an alkylene group having 2 to 3 carbon atoms.
在本发明的一实施例中,上述由式(I)表示的二胺化合物(b1-1)中,当e+f+g<3时,f 与g不同时为0;当f≧1时,b≧1;当g≧1时,c+d≧1。In one embodiment of the present invention, in the above-mentioned diamine compound (b1-1) represented by formula (I), when e+f+g<3, f and g are different, it is 0; when f≧1 , b≧1; when g≧1, c+d≧1.
本发明提供一种聚合物(A-1)是由第一混合物进行反应而制得,且第一混合物包含四羧 酸二酐化合物(a1)及二胺化合物(b1)。二胺化合物(b1)包括如上述的由式(I)表示的二胺化合 物(b1-1)。The present invention provides a polymer (A-1) prepared by reacting a first mixture, and the first mixture comprises a tetracarboxylic dianhydride compound (a1) and a diamine compound (b1). The diamine compound (b1) includes the diamine compound (b1-1) represented by the formula (I) as described above.
在本发明的一实施例中,上述二胺化合物(b1)还包括由式(II)表示的二胺化合物(b1-2)。In an embodiment of the present invention, the above-mentioned diamine compound (b1) further includes a diamine compound (b1-2) represented by formula (II).
式(II)中,In formula (II),
R15及R17各自独立表示-O-、-S-、 R 15 and R 17 each independently represent -O-, -S-,
R16表示碳数为2至10的亚烷基;R 16 represents an alkylene group having a carbon number of 2 to 10;
R18表示单键、亚甲基或亚乙基;R 18 represents a single bond, methylene or ethylene;
Y1表示碳数为17至40的具有类固醇骨架的一价有机基团。Y 1 represents a monovalent organic group having a carbon number of 17 to 40 having a steroid skeleton.
在本发明的一实施例中,上述二胺化合物(b1)还包括由式(III)表示的二胺化合物(b1-3)。In an embodiment of the present invention, the above-mentioned diamine compound (b1) further includes a diamine compound (b1-3) represented by formula (III).
式(III)中,In formula (III),
Y2各自独立表示-O-、-NH-、 -CH2O-、 Y 2 each independently represents -O-, -NH-, -CH 2 O-,
Y3各自独立表示单键、碳数为1至20的二价脂肪族烃基、二价脂环族烃基或二价芳香族 烃基;Y 3 each independently represents a single bond, a divalent aliphatic hydrocarbon group with a carbon number of 1 to 20, a divalent alicyclic hydrocarbon group or a divalent aromatic hydrocarbon group;
Y4各自独立表示单键、-O-、-NH-、 其中m表示 1至5的整数;Y 4 each independently represents a single bond, -O-, -NH-, where m represents an integer from 1 to 5;
Y5各自独立表示含氮的芳香族杂环基;Y 5 each independently represents a nitrogen-containing aromatic heterocyclic group;
k表示1至4的整数。k represents an integer of 1 to 4.
在本发明的一实施例中,基于二胺化合物(b1)的使用量为100摩尔份,由式(I)表示的二 胺化合物(b1-1)的使用量为50摩尔份至100摩尔份。In an embodiment of the present invention, the amount of the diamine compound (b1-1) represented by the formula (I) is 50 to 100 parts by mole based on 100 parts by mole of the diamine compound (b1) .
在本发明的一实施例中,基于二胺化合物(b1)的使用量为100摩尔份,由式(II)表示的 二胺化合物(b1-2)的使用量为5摩尔份至30摩尔份。In an embodiment of the present invention, the amount of the diamine compound (b1-2) represented by the formula (II) is 5 to 30 parts by mole based on 100 parts by mole of the diamine compound (b1) .
在本发明的一实施例中,基于二胺化合物(b1)的使用量为100摩尔份,由式(III)表示的 二胺化合物(b1-3)的使用量为1摩尔份至20摩尔份。In one embodiment of the present invention, the amount of the diamine compound (b1-3) represented by the formula (III) is 1 to 20 parts by mole based on 100 parts by mole of the diamine compound (b1) .
本发明还提供一种液晶配向剂包括上述的聚合物(A-1)以及溶剂(B)。The present invention also provides a liquid crystal alignment agent comprising the above-mentioned polymer (A-1) and a solvent (B).
在本发明的一实施例中,上述的液晶配向剂还包括聚合物(A-2)。聚合物(A-2)是由第二 混合物进行反应而制得。第二混合物包含四羧酸二酐化合物(a2)及二胺化合物(b2)。In an embodiment of the present invention, the above-mentioned liquid crystal alignment agent further includes a polymer (A-2). The polymer (A-2) is obtained by reacting the second mixture. The second mixture contains the tetracarboxylic dianhydride compound (a2) and the diamine compound (b2).
在本发明的一实施例中,基于聚合物(A-1)的使用量为100重量份,溶剂(B)的使用量为 1000重量份至3500重量份。In an embodiment of the present invention, based on the polymer (A-1) in an amount of 100 parts by weight, the solvent (B) in an amount of 1000 to 3500 parts by weight.
在本发明的一实施例中,基于聚合物(A-1)与聚合物(A-2)的总使用量为100重量份,聚 合物(A-1)的使用量为30重量份至95重量份。In an embodiment of the present invention, based on the total usage amount of the polymer (A-1) and the polymer (A-2) being 100 parts by weight, the usage amount of the polymer (A-1) is 30 parts by weight to 95 parts by weight parts by weight.
在本发明的一实施例中,基于聚合物(A-1)与聚合物(A-2)的总使用量为100重量份,溶 剂(B)的使用量为1000重量份至3500重量份。In an embodiment of the present invention, based on the total usage amount of polymer (A-1) and polymer (A-2) is 100 parts by weight, the usage amount of solvent (B) is 1000 parts by weight to 3500 parts by weight.
本发明另提供一种液晶配向膜,其是由上述的液晶配向剂所形成。The present invention further provides a liquid crystal alignment film, which is formed from the above-mentioned liquid crystal alignment agent.
本发明还提供一种液晶显示元件,其包括上述的液晶配向膜。The present invention also provides a liquid crystal display element comprising the above-mentioned liquid crystal alignment film.
基于上述,本发明将具有特定结构的二胺化合物应用于形成聚合物、液晶配向剂以及 液晶显示元件时,使用所述液晶配向剂所制作的液晶显示元件可以具有良好的电场记忆效 应及耐环境性,进而适用于液晶配向膜以及液晶显示元件。Based on the above, when the present invention applies the diamine compound with a specific structure to form a polymer, a liquid crystal alignment agent and a liquid crystal display element, the liquid crystal display element produced by using the liquid crystal alignment agent can have good electric field memory effect and environmental resistance. It is suitable for liquid crystal alignment films and liquid crystal display elements.
为让本发明的上述特征和优点能更明显易懂,下文特举实施例,并配合附图作详细说 明如下。In order to make the above-mentioned features and advantages of the present invention more obvious and easy to understand, the following embodiments are given and described in detail in conjunction with the accompanying drawings as follows.
附图说明Description of drawings
图1是根据本发明一实施例的液晶显示元件的侧视图。FIG. 1 is a side view of a liquid crystal display element according to an embodiment of the present invention.
附图标记说明100:液晶显示元件DESCRIPTION OF REFERENCE NUMERALS 100: Liquid crystal display element
110:第一单元110: Unit 1
112:第一基板112: first substrate
114:第一导电膜114: first conductive film
116:第一液晶配向膜116: The first liquid crystal alignment film
120:第二单元120: Unit Two
122:第二基板122: Second substrate
124:第二导电膜124: Second conductive film
126:第二液晶配向膜126: Second liquid crystal alignment film
130:液晶单元130: Liquid crystal cell
具体实施方式Detailed ways
<二胺化合物><Diamine compound>
二胺化合物为由式(I)表示的二胺化合物(b1-1)。The diamine compound is a diamine compound (b1-1) represented by formula (I).
式(I)中,X1及X2各自独立表示单键、-O-、 其中R14表示氢或碳数为1至4的烷基。In formula (I), X 1 and X 2 each independently represent a single bond, -O-, wherein R 14 represents hydrogen or an alkyl group having 1 to 4 carbons.
式(I)中,x表示0或1。当x为0时,X1较佳为表示-O-、 更佳为-O-、 其中R14表示氢或碳数为1至4的烷基。当x为1时,X1较佳为表示单键。In formula (I), x represents 0 or 1. When x is 0, X 1 preferably represents -O-, More preferably -O-, wherein R 14 represents hydrogen or an alkyl group having 1 to 4 carbons. When x is 1, X 1 preferably represents a single bond.
式(I)中,y表示0至4的整数;较佳为表示0至3的整数;更佳为表示0至2的整数。In formula (I), y represents an integer of 0 to 4; preferably, an integer of 0 to 3; more preferably, an integer of 0 to 2.
式(I)中,R1表示亚甲基或碳数为2至4的亚烷基;较佳为表示亚甲基或碳数为2至3的亚烷基;更佳为表示亚甲基。In formula (I), R 1 represents a methylene group or an alkylene group with a carbon number of 2 to 4; preferably a methylene group or an alkylene group with a carbon number of 2 to 3; more preferably a methylene group .
式(I)中,R3表示碳数为1至6的烷基、碳数为1至6的烷氧基、卤素原子或氰基;较佳为表示碳数为1至4的烷基、碳数为1至4的烷氧基、氟原子或氰基。In formula (I), R 3 represents an alkyl group having 1 to 6 carbon atoms, an alkoxy group having 1 to 6 carbon atoms, a halogen atom or a cyano group; preferably an alkyl group having 1 to 4 carbon atoms, An alkoxy group having a carbon number of 1 to 4, a fluorine atom or a cyano group.
式(I)中,R2表示由式(I-A)表示的有机基团或碳数为17至40的具有类固醇骨架的一价 有机基团。In the formula (I), R 2 represents an organic group represented by the formula (IA) or a monovalent organic group having a steroid skeleton having a carbon number of 17 to 40.
式(I-A)中,R4表示氟或甲基。In formula (IA), R 4 represents fluorine or methyl.
式(I-A)中,R5、R6及R7各自独立表示单键、-O-、 亚甲基或碳数为2至3的亚烷基;较佳为各 自独立表示单键、-O-、亚甲基或碳数为2 至3的亚烷基。In formula (IA), R 5 , R 6 and R 7 each independently represent a single bond, -O-, Methylene group or alkylene group having 2 to 3 carbon atoms; preferably each independently represents a single bond, -O-, A methylene group or an alkylene group having 2 to 3 carbon atoms.
式(I-A)中,R8表示其中R10及R11各自独立表示氟或甲基;*表示键结位置。i及j各自独立表示0至2的整数。In formula (IA), R 8 represents wherein R 10 and R 11 each independently represent fluorine or methyl; * represents a bonding position. i and j each independently represent an integer of 0 to 2.
式(I-A)中,a表示0至2的整数;b、c及d各自独立表示0至4的整数,较佳为各自 独立表示0至2的整数;e、f及g各自独立表示0至3的整数,较佳为各自独立表示0至2 的整数。当e+f+g<3时,f与g不可同时为0。当f≧1时,b≧1。当g≧1时,c+d≧1。In formula (I-A), a represents an integer from 0 to 2; b, c and d each independently represent an integer from 0 to 4, preferably each independently represents an integer from 0 to 2; e, f and g each independently represent 0 to 2 The integer of 3 is preferably an integer each independently representing 0 to 2. When e+f+g<3, f and g cannot be 0 at the same time. When f≧1, b≧1. When g≧1, c+d≧1.
式(I-A)中,*表示键结位置。In formula (I-A), * represents a bonding position.
式(I-A)中,当R4、R5、R6、R7、R8、R10或R11为多个时,各自独立表示相同或不同的 基团。In formula (IA), when R 4 , R 5 , R 6 , R 7 , R 8 , R 10 or R 11 are plural, each independently represents the same or different groups.
具体而言,在f及g不为0的情况下,当a表示2时,多个R4中的每一个可表示相同 或不同的基团;当b、c及d各自独立表示2至4的整数时,多个R5中的每一个可表示相同 或不同的基团,多个R6中的每一个可表示相同或不同的基团,多个R7中的每一个可表示相 同或不同的基团;当e表示2或3时,多个R8中的每一个可表示相同或不同的基团。另外, 当i表示2时,多个R10中的每一个可表示相同或不同的基团。当j表示2时,多个R11中 的每一个可表示相同或不同的基团。Specifically, in the case where f and g are not 0, when a represents 2, each of the plurality of R 4 may represent the same or different groups; when b, c and d each independently represent 2 to 4 In the case of integers, each of the plurality of R 5 may represent the same or different groups, each of the plurality of R 6 may represent the same or different groups, and each of the plurality of R 7 may represent the same or different groups; when e represents 2 or 3, each of the plurality of R 8 may represent the same or different groups. In addition, when i represents 2, each of a plurality of R 10 may represent the same or different groups. When j represents 2, each of the plurality of R 11 may represent the same or different groups.
式(I-A)中,R9表示氢、氟、碳数为1至12的烷基、碳数为1至12的氟烷基、碳数为 1至12的烷氧基、经氟取代的碳数为1至12的烷氧基、-OCH2F、-OCHF2、-OCF3。In formula (IA), R 9 represents hydrogen, fluorine, alkyl having 1 to 12 carbons, fluoroalkyl having 1 to 12 carbons, alkoxy having 1 to 12 carbons, carbon substituted by fluorine Alkoxy groups of 1 to 12, -OCH 2 F, -OCHF 2 , -OCF 3 .
由式(I-A)表示的有机基团的具体例包括式(I-A-1)至式(I-A-9)表示的有机基团中的至少 一者。Specific examples of the organic group represented by the formula (I-A) include at least one of the organic groups represented by the formula (I-A-1) to the formula (I-A-9).
式(I-A-1)至式(I-A-9)中,R9所表示的基团与式(I-A)中的R9所表示的基团相同,在此不 另行赘述。In the formula (IA-1) to the formula (IA-9), the group represented by R 9 is the same as the group represented by R 9 in the formula (IA), and will not be repeated here.
碳数为17至40的具有类固醇骨架的一价有机基团中的类固醇骨架是指环戊烷-全氢菲 (cyclopentano-perhydro phenanthrene)骨架或其所含的碳-碳键中的一个或多个改为双键的 骨架。具有此种类固醇骨架的一价有机基团可以列举例如下述式(I-B-a)、式(I-B-b)、式(I-B-c) 或式(I-B-d)表示的基团,其中*表示键结位置。The steroid skeleton in the monovalent organic group having a steroid skeleton having a carbon number of 17 to 40 refers to a cyclopentano-perhydro phenanthrene skeleton or one or more of the carbon-carbon bonds contained therein Change to double bond skeleton. Examples of the monovalent organic group having such a steroid skeleton include groups represented by the following formula (I-B-a), formula (I-B-b), formula (I-B-c) or formula (I-B-d), wherein * represents a bonding position.
式(I-B-a)、式(I-B-b)、式(I-B-c)及式(I-B-d)中,AI各自独立表示下述结构式中任一者表 示的基团,其中*表示键结位置。In formula (IBa), formula (IBb), formula (IBc) and formula (IBd), A I each independently represents a group represented by any one of the following structural formulas, wherein * represents a bonding position.
碳数为17至40的具有类固醇骨架的一价有机基团的具体例包括由式(I-B-1)、式(I-B-2)、 式(I-B-3)或式(I-B-4)表示的有机基团,其中*表示键结位置。Specific examples of the monovalent organic group having a steroid skeleton having a carbon number of 17 to 40 include those represented by formula (I-B-1), formula (I-B-2), formula (I-B-3) or formula (I-B-4) Organic groups, where * denotes the bonding position.
由式(I)表示的二胺化合物(b1-1)的具体例较佳为包括由式(I-1)至式(I-9)表示的化合物, 更佳为包括由式(I-1)至式(I-3)、式(I-6)、式(I-7)、式(I-9)表示的化合物。Specific examples of the diamine compound (b1-1) represented by formula (I) preferably include compounds represented by formula (I-1) to formula (I-9), more preferably include compounds represented by formula (I-1) ) to compounds represented by formula (I-3), formula (I-6), formula (I-7), and formula (I-9).
当下述液晶配向剂中的聚合物(A-1)未使用二胺化合物(b1-1)时,液晶配向剂所形成的液 晶配向膜及液晶显示元件有电场记忆效应与耐环境性不佳的问题。When the polymer (A-1) in the following liquid crystal alignment agent does not use the diamine compound (b1-1), the liquid crystal alignment film and the liquid crystal display element formed by the liquid crystal alignment agent have electric field memory effect and poor environmental resistance. question.
<液晶配向剂><Liquid crystal alignment agent>
本发明提供一种液晶配向剂,包括聚合物(A-1)以及溶剂(B)。在其他实施例中,液晶配 向剂可还包括聚合物(A-2)。此外,若需要,液晶配向剂也可还包括添加剂(C)。以下将详细 说明用于本发明的液晶配向剂的各个成分。The present invention provides a liquid crystal alignment agent, comprising a polymer (A-1) and a solvent (B). In other embodiments, the liquid crystal alignment agent may further include the polymer (A-2). In addition, the liquid crystal aligning agent may further include an additive (C) if necessary. The individual components of the liquid crystal aligning agent used in the present invention will be described in detail below.
聚合物(A-1)Polymer (A-1)
聚合物(A-1)包括聚酰胺酸聚合物、聚酰亚胺聚合物、聚酰亚胺系嵌段共聚合物或上述 聚合物的组合,其中聚酰亚胺系嵌段共聚合物包括聚酰胺酸嵌段共聚合物、聚酰亚胺嵌段 共聚合物、聚酰胺酸-聚酰亚胺嵌段共聚合物或上述共聚合物的组合。The polymer (A-1) includes a polyamic acid polymer, a polyimide polymer, a polyimide-based block copolymer or a combination of the above polymers, wherein the polyimide-based block copolymer includes A polyamic acid block copolymer, a polyimide block copolymer, a polyamic acid-polyimide block copolymer, or a combination of the foregoing copolymers.
聚合物(A-1)是由包含四羧酸二酐化合物(a1)及二胺化合物(b1)的第一混合物进行反应 而制得。以下将对四羧酸二酐化合物(a1)、二胺化合物(b1)及制备聚合物(A-1)的方法进行详 细的说明。The polymer (A-1) is obtained by reacting the first mixture containing the tetracarboxylic dianhydride compound (a1) and the diamine compound (b1). The tetracarboxylic dianhydride compound (a1), the diamine compound (b1) and the method for producing the polymer (A-1) will be described in detail below.
四羧酸二酐化合物(a1)Tetracarboxylic dianhydride compound (a1)
四羧酸二酐化合物(a1)包括脂肪族四羧酸二酐化合物、脂环族四羧酸二酐化合物、芳香 族四羧酸二酐化合物或如下述式(1-1)至式(1-6)表示的四羧酸二酐化合物等四羧酸二酐化合 物。The tetracarboxylic dianhydride compound (a1) includes an aliphatic tetracarboxylic dianhydride compound, an alicyclic tetracarboxylic dianhydride compound, an aromatic tetracarboxylic dianhydride compound or the following formulas (1-1) to (1) -6) Tetracarboxylic dianhydride compounds such as the tetracarboxylic dianhydride compounds represented.
脂肪族四羧酸二酐化合物的具体例包括乙烷四羧酸二酐或丁烷四羧酸二酐等脂肪族四 羧酸二酐。然而,本发明不限于此,脂肪族四羧酸二酐化合物可还包括其他合适的脂肪族 四羧酸二酐化合物。Specific examples of the aliphatic tetracarboxylic dianhydride compound include aliphatic tetracarboxylic dianhydrides such as ethanetetracarboxylic dianhydride and butane tetracarboxylic dianhydride. However, the present invention is not limited thereto, and the aliphatic tetracarboxylic dianhydride compound may further include other suitable aliphatic tetracarboxylic dianhydride compounds.
脂环族四羧酸二酐化合物的具体例包括1,2,3,4-环丁烷四羧酸二酐、1,2-二甲基-1,2,3,4- 环丁烷四羧酸二酐、1,3-二甲基-1,2,3,4-环丁烷四羧酸二酐、1,3-二氯-1,2,3,4-环丁烷四羧酸 二酐、1,2,3,4-四甲基-1,2,3,4-环丁烷四羧酸二酐、1,2,3,4-环戊烷四羧酸二酐、1,2,4,5-环己烷 四羧酸二酐、3,3’,4,4’-二环己基四羧酸二酐、顺-3,7-二丁基环庚基-1,5-二烯-1,2,5,6-四羧酸 二酐、2,3,5-三羧基环戊基醋酸二酐或二环[2.2.2]-辛-7-烯-2,3,5,6-四羧酸二酐等脂环族四羧酸 二酐化合物。然而,本发明不限于此,脂环族四羧酸二酐化合物可还包括其他合适的脂环 族四羧酸二酐化合物。Specific examples of the alicyclic tetracarboxylic dianhydride compound include 1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,2-dimethyl-1,2,3,4-cyclobutanetetra Carboxylic acid dianhydride, 1,3-dimethyl-1,2,3,4-cyclobutanetetracarboxylic acid dianhydride, 1,3-dichloro-1,2,3,4-cyclobutanetetracarboxylate Acid dianhydride, 1,2,3,4-tetramethyl-1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,2,3,4-cyclopentanetetracarboxylic dianhydride, 1,2,4,5-Cyclohexanetetracarboxylic dianhydride, 3,3',4,4'-dicyclohexyltetracarboxylic dianhydride, cis-3,7-dibutylcycloheptyl-1,5 - Diene-1,2,5,6-tetracarboxylic dianhydride, 2,3,5-tricarboxycyclopentylacetic dianhydride or bicyclo[2.2.2]-oct-7-ene-2,3 , 5,6-tetracarboxylic dianhydride and other alicyclic tetracarboxylic dianhydride compounds. However, the present invention is not limited thereto, and the alicyclic tetracarboxylic dianhydride compound may further include other suitable alicyclic tetracarboxylic dianhydride compounds.
芳香族四羧酸二酐化合物的具体例包括3,4-二羧基-1,2,3,4-四氢萘-1-琥珀酸二酐、苯均 四羧酸二酐、2,2’,3,3’-二苯甲酮四羧酸二酐、3,3’,4,4’-二苯甲酮四羧酸二酐、3,3’,4,4’-联苯 砜四羧酸二酐、1,4,5,8-萘四羧酸二酐、2,3,6,7-萘四羧酸二酐、3,3’-4,4’-二苯基乙烷四羧酸 二酐、3,3’,4,4’-二甲基二苯基硅烷四羧酸二酐、3,3’,4,4’-四苯基硅烷四羧酸二酐、1,2,3,4-呋 喃四羧酸二酐、2,3,3’,4’-二苯醚四羧酸二酐、3,3’,4,4’-二苯醚四羧酸二酐、4,4’-双(3,4-二羧 基苯氧基)二苯硫醚二酐、2,3,3’,4’-二苯硫醚四羧酸二酐、3,3’,4,4’-二苯硫醚四羧酸二酐、4,4’- 双(3,4-二羧基苯氧基)二苯砜二酐、4,4’-双(3,4-二羧基苯氧基)二苯丙烷二酐、3,3’,4,4’-全氟 异亚丙基二苯二酸二酐、2,2’,3,3’-二苯基四羧酸二酐、2,3,3’,4’-二苯基四羧酸二酐、3,3’,4,4’- 二苯基四羧酸二酐、双(苯二酸)苯膦氧化物二酐、对-亚苯基-双(三苯基苯二酸)二酐、间-亚 苯基-双(三苯基苯二酸)二酐、双(三苯基苯二酸)-4,4’-二苯基醚二酐、双(三苯基苯二酸)-4,4’- 二苯基甲烷二酐、乙二醇-双(脱水偏苯三酸酯)、丙二醇-双(脱水偏苯三酸酯)、1,4-丁二醇-双(脱水偏苯三酸酯)、1,6-己二醇-双(脱水偏苯三酸酯)、1,8-辛二醇-双(脱水偏苯三酸酯)、2,2- 双(4-羟苯基)丙烷-双(脱水偏苯三酸酯)、2,3,4,5-四氢呋喃四羧酸二酐、1,3,3a,4,5,9b-六氢 -5-(四氢-2,5-二侧氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮 (1,3,3a,4,5,9b-Hexahydro-5-(tetrahydro-2,5-dioxofuran-3-yl)naphtho[1,2-c]furan-1,3-dione)、 1,3,3a,4,5,9b-六氢-5-甲基-5-(四氢-2,5-二侧氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、 1,3,3a,4,5,9b-六氢-5-乙基-5-(四氢-2,5-二侧氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、 1,3,3a,4,5,9b-六氢-7-甲基-5-(四氢-2,5-二侧氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氢-7-乙基-5-(四氢-2,5-二侧氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、 1,3,3a,4,5,9b-六氢-8-甲基-5-(四氢-2,5-二侧氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、 1,3,3a,4,5,9b-六氢-8-乙基-5-(四氢-2,5-二侧氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、 1,3,3a,4,5,9b-六氢-5,8-二甲基-5-(四氢-2,5-二侧氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮或 5-(2,5-二侧氧基四氢呋喃基)-3-甲基-3-环己烯-1,2-二羧酸二酐等芳香族四羧酸二酐化合物。然而,本发明不限于此,芳香族四羧酸二酐化合物可还包括其他合适的芳香族四羧酸二酐化合物。Specific examples of the aromatic tetracarboxylic dianhydride compound include 3,4-dicarboxy-1,2,3,4-tetrahydronaphthalene-1-succinic dianhydride, pyromellitic dianhydride, 2,2' ,3,3'-benzophenone tetracarboxylic dianhydride, 3,3',4,4'-benzophenone tetracarboxylic dianhydride, 3,3',4,4'-biphenylsulfone tetra Carboxylic dianhydride, 1,4,5,8-naphthalenetetracarboxylic dianhydride, 2,3,6,7-naphthalenetetracarboxylic dianhydride, 3,3'-4,4'-diphenylethane Tetracarboxylic dianhydride, 3,3',4,4'-dimethyldiphenylsilane tetracarboxylic dianhydride, 3,3',4,4'-tetraphenylsilane tetracarboxylic dianhydride, 1 ,2,3,4-furan tetracarboxylic dianhydride, 2,3,3',4'-diphenyl ether tetracarboxylic dianhydride, 3,3',4,4'-diphenyl ether tetracarboxylic acid di Anhydride, 4,4'-bis(3,4-dicarboxyphenoxy)diphenyl sulfide dianhydride, 2,3,3',4'-diphenyl sulfide tetracarboxylic dianhydride, 3,3' ,4,4'-diphenyl sulfide tetracarboxylic dianhydride, 4,4'-bis(3,4-dicarboxyphenoxy)diphenylsulfone dianhydride, 4,4'-bis(3,4- Dicarboxyphenoxy) diphenylpropane dianhydride, 3,3',4,4'-perfluoroisopropylene diphthalic acid dianhydride, 2,2',3,3'-diphenyltetracarboxyl Acid dianhydride, 2,3,3',4'-diphenyltetracarboxylic dianhydride, 3,3',4,4'-diphenyltetracarboxylic dianhydride, bis(phthalic acid) phenylphosphine Oxide dianhydride, p-phenylene-bis(triphenylphthalic acid) dianhydride, m-phenylene-bis(triphenylphthalic acid) dianhydride, bis(triphenylphthalic acid) -4,4'-diphenylether dianhydride, bis(triphenylphthalic acid)-4,4'-diphenylmethane dianhydride, ethylene glycol-bis(anhydrotrimellitate), propylene glycol -Bis(anhydrotrimellitate), 1,4-Butanediol-bis(anhydrotrimellitate), 1,6-hexanediol-bis(anhydrotrimellitate), 1,8 -Octanediol-bis(anhydrotrimellitate), 2,2-bis(4-hydroxyphenyl)propane-bis(anhydrotrimellitate), 2,3,4,5-tetrahydrofuran tetracarboxylate Acid dianhydride, 1,3,3a,4,5,9b-hexahydro-5-(tetrahydro-2,5-dioxy-3-furyl)-naphtho[1,2-c]- Furan-1,3-dione (1,3,3a,4,5,9b-Hexahydro-5-(tetrahydro-2,5-dioxofuran-3-yl)naphtho[1,2-c]furan-1, 3-dione), 1,3,3a,4,5,9b-hexahydro-5-methyl-5-(tetrahydro-2,5-dioxy-3-furyl)-naphtho[1 ,2-c]-furan-1,3-dione, 1,3,3a,4,5,9b-hexahydro-5-ethyl-5-(tetrahydro-2,5-dioxy- 3-Furyl)-naphtho[1,2-c]-furan-1,3-dione, 1,3,3a,4,5,9b-hexahydro-7-methyl-5-(tetrakis Hydro-2,5-di-oxy-3-furyl)-naphtho[1,2-c]-furan-1,3-dione, 1,3,3a,4,5,9b-hexahydro -7-Ethyl-5-(tetrahydro-2,5-dioxy-3-furyl)-naphtho[1,2-c]-furan-1,3-dione, 1,3, 3a,4,5,9b-Hexahydro-8-methyl-5-(tetrahydro-2,5-dioxy-3-furyl)-naphtho[1,2-c]-furan-1 ,3-Dione, 1,3,3a,4,5,9b-hexahydro-8-ethyl-5-(tetrahydro-2,5-dioxy-3-furyl)-naphtho[ 1,2-c]-furan-1,3-dione, 1,3,3a,4,5,9b-hexahydro-5,8-dimethyl-5-(tetrahydro-2,5-dione pendant oxy-3-furyl)-naphtho[1,2-c]-furan-1,3-dione or 5-(2,5-dioxytetrahydrofuranyl)-3-methyl-3 -Aromatic tetracarboxylic dianhydride compounds such as cyclohexene-1,2-dicarboxylic dianhydride. However, the present invention is not limited thereto, and the aromatic tetracarboxylic dianhydride compound may further include other suitable aromatic tetracarboxylic dianhydride compounds.
由式(1-1)至式(1-6)表示的四羧酸二酐化合物如下所示。The tetracarboxylic dianhydride compounds represented by formula (1-1) to formula (1-6) are shown below.
式(1-5)中,A1表示含有芳香环的二价基团;r表示1或2;A2及A3各自独立表示氢或烷基。In formula (1-5), A 1 represents a divalent group containing an aromatic ring; r represents 1 or 2; and A 2 and A 3 each independently represent hydrogen or an alkyl group.
式(1-6)中,A4表示含有芳香环的二价基团;A5及A6可各自独立表示氢或烷基。In formula (1-6), A 4 represents a divalent group containing an aromatic ring; A 5 and A 6 may each independently represent hydrogen or an alkyl group.
由式(1-5)表示的四羧酸二酐化合物(a1)的具体例包括由式(1-5-1)至式(1-5-3)表示的四羧 酸二酐化合物。Specific examples of the tetracarboxylic dianhydride compound (a1) represented by the formula (1-5) include the tetracarboxylic dianhydride compounds represented by the formula (1-5-1) to the formula (1-5-3).
由式(1-6)表示的四羧酸二酐化合物(a1)的具体例包括由式(1-6-1)表示的四羧酸二酐化 合物。Specific examples of the tetracarboxylic dianhydride compound (a1) represented by the formula (1-6) include the tetracarboxylic dianhydride compound represented by the formula (1-6-1).
上述的四羧酸二酐化合物(a1)可以单独使用一种或者组合多种来使用。The above-mentioned tetracarboxylic dianhydride compound (a1) may be used alone or in combination of two or more.
四羧酸二酐化合物(a1)的具体例较佳为包括1,2,3,4-环丁烷四羧酸二酐(1,2,3,4-cyclobutane tetracarboxylic acid dianhydride)、1,2,3,4-环戊烷四羧酸二酐、2,3,5-三 羧基环戊基醋酸二酐(2,3,5-tricarboxycyclopentylacetic acid dianhydride)、1,2,4,5-环己烷四 羧酸二酐、3,4-二羧基-1,2,3,4-四氢萘-1-琥珀酸二酐、苯均四羧酸二酐(pyromellitic dianhydride)、3,3’,4,4’-二苯甲酮四羧酸二酐、3,3’,4,4’-联苯砜四羧酸二酐或其组合,更佳为 包括1,2,3,4-环丁烷四羧酸二酐、2,3,5-三羧基环戊基醋酸二酐、苯均四羧酸二酐或其组合。Specific examples of the tetracarboxylic dianhydride compound (a1) preferably include 1,2,3,4-cyclobutane tetracarboxylic acid dianhydride (1,2,3,4-cyclobutane tetracarboxylic acid dianhydride), 1,2 ,3,4-cyclopentanetetracarboxylic dianhydride, 2,3,5-tricarboxycyclopentylacetic acid dianhydride, 1,2,4,5-cyclohexane Alkanetetracarboxylic dianhydride, 3,4-dicarboxy-1,2,3,4-tetrahydronaphthalene-1-succinic dianhydride, pyromellitic dianhydride, 3,3', 4,4'-benzophenone tetracarboxylic dianhydride, 3,3',4,4'-biphenylsulfone tetracarboxylic dianhydride or combinations thereof, more preferably including 1,2,3,4-ring Butanetetracarboxylic dianhydride, 2,3,5-tricarboxycyclopentylacetic dianhydride, pyromellitic dianhydride, or a combination thereof.
二胺化合物(b1)Diamine compound (b1)
二胺化合物(b1)包括至少一种由式(I)表示的二胺化合物(b1-1)。另外,二胺化合物(b1) 可还包括由式(II)表示的二胺化合物(b1-2)及由式(III)表示的二胺化合物(b1-3)中的至少一种。 又,二胺化合物(b1)还可包括其他二胺化合物(b1-4)。以下,将对二胺化合物(b1-1)、二胺化 合物(b1-2)、二胺化合物(b1-3)及其他二胺化合物(b1-4)进行详细说明。The diamine compound (b1) includes at least one diamine compound (b1-1) represented by the formula (I). In addition, the diamine compound (b1) may further include at least one of the diamine compound (b1-2) represented by the formula (II) and the diamine compound (b1-3) represented by the formula (III). In addition, the diamine compound (b1) may include other diamine compounds (b1-4). Hereinafter, the diamine compound (b1-1), the diamine compound (b1-2), the diamine compound (b1-3) and the other diamine compounds (b1-4) will be described in detail.
二胺化合物(b1-1)Diamine compound (b1-1)
二胺化合物(b1-1)已于上述<二胺化合物>中说明,在此不另行赘述。当液晶配向剂中的 聚合物(A-1)未使用二胺化合物(b1-1)时,液晶配向剂所形成的液晶配向膜及液晶显示元件有 电场记忆效应与耐环境性不佳的问题。The diamine compound (b1-1) has been described in the above <Diamine compound>, and will not be repeated here. When the polymer (A-1) in the liquid crystal alignment agent does not use the diamine compound (b1-1), the liquid crystal alignment film and the liquid crystal display element formed by the liquid crystal alignment agent have the problems of electric field memory effect and poor environmental resistance .
基于二胺化合物(b1)的使用量为100摩尔份,由式(I)表示的二胺化合物(b1-1)的使用量 可为50摩尔份至100摩尔份,较佳为55摩尔份至100摩尔份,更佳为65摩尔份至100摩 尔份。The diamine compound (b1-1) represented by the formula (I) may be used in an amount of 50 to 100 parts by mole, preferably 55 to 100 parts by mole, based on 100 parts by mole of the diamine compound (b1). 100 mol parts, more preferably 65 mol parts to 100 mol parts.
二胺化合物(b1-2)Diamine compound (b1-2)
二胺化合物(b1-2)是由式(II)表示的二胺化合物。The diamine compound (b1-2) is a diamine compound represented by formula (II).
式(II)中,R15及R17各自独立表示醚基、硫醚基、硫酯基或酯基。具体而言,R15及R17各自独立表示-O-、-S-、 In formula (II), R 15 and R 17 each independently represent an ether group, a thioether group, a thioester group, or an ester group. Specifically, R 15 and R 17 each independently represent -O-, -S-,
式(II)中,R16表示碳数为2至10的亚烷基;较佳为表示碳数为2至4的亚烷基。In formula (II), R 16 represents an alkylene group having 2 to 10 carbon atoms; preferably, it represents an alkylene group having 2 to 4 carbon atoms.
式(II)中,R18表示单键、亚甲基或亚乙基;较佳为表示单键或亚甲基。In formula (II), R 18 represents a single bond, a methylene group or an ethylene group; preferably, it represents a single bond or a methylene group.
式(II)中,Y1表示碳数为17至40的具有类固醇骨架的一价有机基团。所述类固醇骨架 与式(I)中的R2表示的类固醇骨架相同,在此不另行赘述。In formula (II), Y 1 represents a monovalent organic group having a carbon number of 17 to 40 having a steroid skeleton. The steroid skeleton is the same as the steroid skeleton represented by R 2 in formula (I), and will not be described in detail here.
二胺化合物(b1-2)的具体例包括由式(II-1)至式(II-29)表示的二胺化合物,较佳为包括由 式(II-10)、式(II-18)、式(II-24)、式(II-22)、式(II-26)表示的二胺化合物中的至少一者。Specific examples of the diamine compound (b1-2) include diamine compounds represented by formula (II-1) to formula (II-29), preferably include formula (II-10), formula (II-18) , at least one of the diamine compounds represented by formula (II-24), formula (II-22), and formula (II-26).
由式(II)表示的二胺化合物(b1-2)可以现有的有机合成方法来合成。举例来说,由式(II-1)、 式(II-2)、式(II-7)或式(II-8)表示的化合物的合成是将无水琥珀酸分别与胆固醇或胆甾烷醇 (cholestanol)进行加成反应后,以例如亚硫酰氯(thionyl chloride)形成酰氯,于基于酰氯 更多当量的碱存在下,将二硝基酚(dinitrophenol)与酰氯反应,其后,使用适当的还原剂 如氯化锡进行还原反应,藉以完成上述合成。The diamine compound (b1-2) represented by the formula (II) can be synthesized by an existing organic synthesis method. For example, compounds represented by formula (II-1), formula (II-2), formula (II-7) or formula (II-8) are synthesized by combining anhydrous succinic acid with cholesterol or cholestane, respectively After addition reaction of cholestanol to form acid chloride with, for example, thionyl chloride, dinitrophenol is reacted with acid chloride in the presence of more equivalents of base based on acid chloride, and thereafter, using appropriate A reducing agent such as tin chloride is used for reduction reaction, so as to complete the above synthesis.
由式(II-3)、式(II-4)、式(II-9)或式(II-10)表示的化合物的合成可以是将无水琥珀酸分别 与胆固醇或胆甾烷醇进行加成反应后,于碳酸钾存在下,将前述加成物与二硝基苯甲酰氯 (dinitrobenzoyl chloride)进行酯化反应,其后,使用适当的还原剂如氯化锡进行还原反应, 藉以完成上述合成。The compound represented by formula (II-3), formula (II-4), formula (II-9) or formula (II-10) can be synthesized by adding anhydrous succinic acid to cholesterol or cholestanol, respectively. After the formation reaction, in the presence of potassium carbonate, the aforementioned adduct is subjected to an esterification reaction with dinitrobenzoyl chloride, and thereafter, a reduction reaction is performed using a suitable reducing agent such as tin chloride, so as to complete the above-mentioned reaction. synthesis.
由式(II-5)或式(II-11)表示的化合物的合成可以是将胆固醇或胆甾烷醇,以甲苯磺酰氯 (tosyl chloride)分别进行甲苯磺酰化,而得到的甲苯磺酰化(tosylation)胆固醇或甲苯磺 酰化胆甾烷醇,接续于碱存在下将丁二醇和过量的二硝基苯甲酰基氯反应而得到的二硝基 苯甲酰基丁二醇单酯,与前述甲苯磺酰化胆甾烷醇,再于适当有机溶剂中加热形成醚基, 其后,使用适当的还原剂如氯化锡进行还原反应,藉以完成上述合成。The compound represented by the formula (II-5) or the formula (II-11) can be synthesized by tosylation of cholesterol or cholestanol with tosyl chloride, respectively, to obtain a tosyl chloride. Tosylation (tosylation) cholesterol or tosylation of cholestanol, followed by dinitrobenzoyl butanediol monoester obtained by reacting butanediol and excess dinitrobenzoyl chloride in the presence of a base, with The aforementioned tosylation of cholestanol is heated in a suitable organic solvent to form an ether group, and then a suitable reducing agent such as tin chloride is used to carry out a reduction reaction, thereby completing the above synthesis.
由式(II-6)或式(II-12)表示的化合物的合成可以是将无水琥珀酸分别与胆固醇或胆甾烷 醇进行加成反应后,将前述加成物的羰基以氢化铝锂还原为亚甲基,于如第三丁醇钾的碱 存在下,将前述还原物与2,4-二硝基氯苯(2,4-dinitrochlorobenzene)进行酯化反应,其后, 使用适当的还原剂如氯化锡进行还原反应;或于如第三丁醇钾的碱存在下,将2,4-二硝基氯 苯与过量的丁二醇反应而得的1-(4-羟基丁氧基)-2,4-二硝基苯 (1-(4-hydroxybutoxy)-2,4-dinitrobenzene),与前所述的方法制得的甲苯磺酰化胆固醇或甲苯磺酰化胆甾烷醇,于适当有机溶剂中加热形成醚基,其后,使用适当的还原剂如氯化锡进行还原反应,藉以完成上述合成。The compound represented by the formula (II-6) or the formula (II-12) can be synthesized by adding anhydrous succinic acid to cholesterol or cholestanol, respectively, and then converting the carbonyl group of the adduct to aluminum hydride. Lithium is reduced to a methylene group, and in the presence of a base such as potassium tert-butoxide, the aforementioned reduced product is subjected to an esterification reaction with 2,4-dinitrochlorobenzene (2,4-dinitrochlorobenzene), and thereafter, an appropriate A reducing agent such as tin chloride is used for reduction reaction; or in the presence of a base such as potassium 3-butoxide, the 1-(4-hydroxyl group obtained by reacting 2,4-dinitrochlorobenzene with excess butanediol Butoxy)-2,4-dinitrobenzene (1-(4-hydroxybutoxy)-2,4-dinitrobenzene), tosylated cholesterol or tosylated cholesterol prepared as previously described The alkanol is heated in a suitable organic solvent to form an ether group, and then a reduction reaction is carried out using a suitable reducing agent such as tin chloride to complete the above synthesis.
由式(II-13)表示的化合物的合成可以是于如第三丁醇钾的碱存在下,将2,4-二硝基氯苯 与过量的乙二醇反应而得的1-(4-羟基乙氧基)-2,4-二硝基苯(1-(4-hydroxyethoxy)-2,4-dinitro benzene),与依如前所述的方法制得甲苯磺酰化胆甾烷醇,于适当有机溶剂中加热形成醚基, 其后,使用适当的还原剂如氯化锡进行还原反应,藉以完成上述合成。The compound represented by the formula (II-13) can be synthesized by reacting 2,4-dinitrochlorobenzene with excess ethylene glycol in the presence of a base such as potassium tert-butoxide. -Hydroxyethoxy)-2,4-dinitrobenzene (1-(4-hydroxyethoxy)-2,4-dinitrobenzene), and tosylated cholestanol as previously described , heated in a suitable organic solvent to form an ether group, and then used a suitable reducing agent such as tin chloride to carry out a reduction reaction, thereby completing the above synthesis.
由式(II-14)、式(II-15)或式(II-16)表示的化合物的合成可以是分别使用羊毛甾醇 (lanosterol)、光甾醇(lumisterol)或麦角甾醇(ergosterol)作为起始原料,并依式(II-6) 的合成方法合成。The synthesis of the compound represented by formula (II-14), formula (II-15) or formula (II-16) can be started using lanosterol, lumisterol or ergosterol, respectively raw materials, and synthesized according to the synthetic method of formula (II-6).
由式(II-17)或式(II-18)表示的化合物的合成可以是将胆固醇或胆甾烷醇,以氯化甲磺酰 (methanesulfonyl chloride)分别进行甲磺酰化后,以过量的乙二醇进行取代反应,以合成 一单醚化合物,再于碱存在下,将前述单醚化合物及3,5-二硝基苯甲酰氯(3,5-dinitrobenzoyl chloride)反应合成二硝基化合物后,使用合适的还原剂如碳化钯(palladium carbon)进行 还原反应,藉以完成上述合成。The compound represented by formula (II-17) or formula (II-18) can be synthesized by methanesulfonylation of cholesterol or cholestanol with methanesulfonyl chloride, respectively, and then with excess amount. Ethylene glycol undergoes a substitution reaction to synthesize a monoether compound, and in the presence of a base, the aforementioned monoether compound and 3,5-dinitrobenzoyl chloride are reacted to synthesize a dinitro compound Afterwards, the above synthesis is completed by performing a reduction reaction using a suitable reducing agent such as palladium carbon.
由式(II-19)或式(II-20)表示的化合物的合成可以是以氢化钾分别使胆甾烷醇或胆固醇形 成醇盐(alkoxide),再与过量的二溴丙烷形成醚基以获得中间体,接续于碳酸钾存在下, 将此中间体与3,5-二硝基苯甲酸(3,5-dinitrobenzoic acid)反应合成二硝基化合物后,使用 合适的还原剂如碳化钯进行还原反应,藉以完成上述合成。The compound represented by formula (II-19) or formula (II-20) can be synthesized by using potassium hydride to form alkoxide with cholesterol or cholesterol, respectively, and then form an ether group with excess dibromopropane to form an alkoxide. The intermediate is obtained, followed by the presence of potassium carbonate, this intermediate is reacted with 3,5-dinitrobenzoic acid (3,5-dinitrobenzoic acid) to synthesize a dinitro compound, and a suitable reducing agent such as palladium carbide is used to carry out reduction reaction to complete the above synthesis.
由式(II-21)或式(II-22)表示的化合物的合成可以是将无水琥珀酸分别与胆固醇或胆甾烷 醇进行加成反应后,于N,N-二环己基碳二亚胺(N,N-dicyclohexylcarbodiimide)存在下,将 此加成物与3,5-(N,N-二烯丙基)氨基苯酚(3,5-(N,N-diallyl)aminophenol)反应,后以1,3- 二甲基巴比妥酸(1,3-dimethylbarbituricacid)及四三苯基膦钯(tetrakistriphenyl phosphinepalladium)除去烯丙基而制得。The compound represented by the formula (II-21) or the formula (II-22) can be synthesized by adding anhydrous succinic acid to cholesterol or cholestanol, respectively, and then adding N,N-dicyclohexylcarbon two. In the presence of imine (N,N-dicyclohexylcarbodiimide), this adduct is reacted with 3,5-(N,N-diallyl)aminophenol (3,5-(N,N-diallyl)aminophenol), It is obtained by removing allyl groups with 1,3-dimethylbarbituric acid and tetrakistriphenyl phosphinepalladium.
由式(II-23)或式(II-24)表示的化合物的合成可以是将无水琥珀酸分别与胆固醇或胆甾烷 醇进行加成反应后,使用硼烷-四氢呋喃错合物(Borane-oxolane complex)将羰基还原成醇 藉以作为中间体;于碱存在下,将前述中间体与3,5-二硝基苯甲酰氯反应合成二硝基化合物 后,使用合适的还原剂如碳化钯进行还原反应,藉以完成上述合成。The compound represented by formula (II-23) or formula (II-24) can be synthesized by adding anhydrous succinic acid to cholesterol or cholestanol, respectively, and then using borane-tetrahydrofuran complex (Borane tetrahydrofuran complex). -oxolane complex) to reduce the carbonyl group to alcohol as an intermediate; in the presence of a base, the aforementioned intermediate is reacted with 3,5-dinitrobenzoyl chloride to synthesize a dinitro compound, and a suitable reducing agent such as palladium carbide is used. A reduction reaction is carried out to complete the above synthesis.
由式(II-25)或式(II-26)表示的化合物的合成可以是将无水戊二酸取代琥珀酸分别与胆固 醇或胆甾烷醇进行加成反应后,并依式(II-4)或式(II-10)的合成方法合成。The compound represented by formula (II-25) or formula (II-26) can be synthesized by adding anhydrous glutaric acid substituted succinic acid to cholesterol or cholestanol, respectively, and according to formula (II- 4) or the synthesis method of formula (II-10).
由式(II-27)、式(II-28)或式(II-29)表示的化合物的合成可以是使用合适的氢化催化剂氢 化羊毛甾醇、光甾醇或麦角甾醇后,作为起始原料,并依式(II-14)、式(II-15)或式(II-16)的 合成方法合成。The compound represented by formula (II-27), formula (II-28) or formula (II-29) can be synthesized by hydrogenating lanosterol, photosterol or ergosterol using a suitable hydrogenation catalyst as a starting material, and It is synthesized according to the synthesis method of formula (II-14), formula (II-15) or formula (II-16).
当液晶配向剂中的聚合物(A-1)中的二胺化合物(b1)包括二胺化合物(b1-2)时,可使液晶 配向剂所形成的液晶配向膜及液晶显示元件具有较佳的电场记忆效应。When the diamine compound (b1) in the polymer (A-1) in the liquid crystal alignment agent includes the diamine compound (b1-2), the liquid crystal alignment film and the liquid crystal display element formed by the liquid crystal alignment agent can have better performance The electric field memory effect.
基于二胺化合物(b1)的使用量为100摩尔份,由式(II)表示的二胺化合物(b1-2)的使用量 可为5摩尔份至30摩尔份,较佳为7摩尔份至27摩尔份,更佳为10摩尔份至25摩尔份。The diamine compound (b1-2) represented by the formula (II) may be used in an amount of 5 to 30 parts by mole, preferably 7 to 7 parts by mole, based on 100 parts by mole of the diamine compound (b1) used. 27 mol parts, more preferably 10 mol parts to 25 mol parts.
二胺化合物(b1-3)Diamine compound (b1-3)
二胺化合物(b1-3)为由式(III)表示的二胺化合物(b1-3)。The diamine compound (b1-3) is the diamine compound (b1-3) represented by the formula (III).
式(III)中,Y2各自独立表示-O-、-NH-、 -CH2O-、Y3各自独立表示单键、碳数为1 至20的二价脂肪族烃基、二价脂环族烃基或二价芳香族烃基;Y4各自独立表示单键、 -O-、-NH-、 其中m表示1至5的整数;Y5各自独立 表示含氮的芳香族杂环基;k表示1至4的整数。In formula (III), Y 2 each independently represents -O-, -NH-, -CH 2 O-, Y 3 each independently represents a single bond, a divalent aliphatic hydrocarbon group with a carbon number of 1 to 20, a divalent alicyclic hydrocarbon group or a divalent aromatic hydrocarbon group; Y 4 each independently represents a single bond, -O-, -NH-, wherein m represents an integer from 1 to 5; Y 5 each independently represents a nitrogen-containing aromatic heterocyclic group; and k represents an integer from 1 to 4.
详细而言,式(III)中的2个氨基(-NH2)的键结位置没有特别的限定。具体可举出相对 于侧链的结合基(Y2),苯环上的2个氨基分别为2,3位置、2,4位置、2,5位置、2,6位置、3,4位置或3,5位置等。就合成聚酰胺酸时的反应性的观点来看,所述2个氨基的键结位置较佳为2,4位置、2,5位置或3,5位置。而就考虑合成二胺化合物时的容易性而言,所述2 个氨基的键结位置更佳为2,4位置或2,5位置。Specifically, the bonding position of the two amino groups (—NH 2 ) in the formula (III) is not particularly limited. Specifically, with respect to the binding group (Y 2 ) of the side chain, the two amino groups on the benzene ring are respectively 2,3 position, 2,4 position, 2,5 position, 2,6 position, 3,4 position or 3,5 positions etc. From the viewpoint of reactivity at the time of synthesizing a polyamic acid, the bonding positions of the two amino groups are preferably 2,4 positions, 2,5 positions, or 3,5 positions. On the other hand, the bonding position of the two amino groups is more preferably the 2,4 position or the 2,5 position in consideration of the easiness of synthesizing the diamine compound.
式(III)中,Y2各自独立表示-O-、-NH-、 -CH2O-、就合成二胺化合物时的容 易性而言,Y2较佳为各自独立表示-O-、-NH-、 -CH2O-、 In formula (III), Y 2 each independently represents -O-, -NH-, -CH 2 O-, In terms of easiness in synthesizing the diamine compound, Y 2 preferably independently represents -O-, -NH-, -CH 2 O-,
式(III)中,Y3各自独立表示单键、碳数为1至20的二价脂肪族烃基、二价脂环族烃基 或二价芳香族烃基。碳数为1至20的二价脂肪族烃基可为直链状或分支状、亦可具有不饱 和键,且较佳为碳数为1至10的二价脂肪族烃基。二价脂环族烃基中的脂环的具体例包括 环丙烷环、环丁烷环、环戊烷环、环己烷环、环庚烷环、环辛烷环、环壬烷环、环癸烷环、环十一烷环、环十二烷环、环十三烷环、环十四烷环、环十五烷环、环十六烷环、环十七 烷环、环十八烷环、环十九烷环、环二十烷环、三环二十烷环(tricycloicosane ring)、三环二十二烷环(tricyclodocosane ring)、双环庚烷环(bicycloheptane ring)、十氢萘环(decahydronaphthalene ring)、降冰片烯环(norbornene ring)或金刚烷环(adamantanering) 等。In formula (III), Y 3 each independently represents a single bond, a divalent aliphatic hydrocarbon group having 1 to 20 carbon atoms, a divalent alicyclic hydrocarbon group or a divalent aromatic hydrocarbon group. The divalent aliphatic hydrocarbon group having 1 to 20 carbon atoms may be linear or branched, or may have an unsaturated bond, and is preferably a divalent aliphatic hydrocarbon group having 1 to 10 carbon atoms. Specific examples of the alicyclic ring in the divalent alicyclic hydrocarbon group include a cyclopropane ring, a cyclobutane ring, a cyclopentane ring, a cyclohexane ring, a cycloheptane ring, a cyclooctane ring, a cyclononane ring, and a cyclodecane ring Alkane ring, cycloundecane ring, cyclododecane ring, cyclotridecane ring, cyclotetradecane ring, cyclopentadecane ring, cyclohexadecane ring, cycloheptadecane ring, cyclooctadecane ring , cyclononadecane ring, cycloeicosane ring, tricycloicosane ring, tricyclodocosane ring, bicycloheptane ring, decahydronaphthalene ring ( decahydronaphthalene ring), norbornene ring (norbornene ring) or adamantane ring (adamantanering) and the like.
二价芳香族烃基中的芳香环的具体例包括苯环、萘环、四氢萘环、薁环(azulenering)、 茚环(indene ring)、芴环(fluorene ring)、蒽环、菲环或萉环(phenalene ring)等。Specific examples of the aromatic ring in the divalent aromatic hydrocarbon group include a benzene ring, a naphthalene ring, a tetrahydronaphthalene ring, an azuene ring, an indene ring, a fluorene ring, an anthracene ring, a phenanthrene ring, or a Sepia ring (phenalene ring) and so on.
具体而言,式(III)中,Y3较佳为各自独立表示单键、亚甲基、碳数为2至10的直链或 分支的亚烷基、碳数为2至10的直链或分支的亚烯基、碳数为2至10的直链或分支的亚炔基、二价脂环族烃基或二价芳香族烃基,其中二价脂环族烃基中的脂环为环丙烷环、环丁烷环、环戊烷环、环己烷环、环庚烷环、降冰片烯环或金刚烷环,二价芳香族烃基中的 芳香环为苯环、萘环、四氢萘环、芴环或蒽环。Y3更佳为各自独立表示单键、亚甲基、碳 数为2至10的直链或分支的亚烷基、碳数为2至10的直链或分支的亚烯基、二价脂环族 烃基或二价芳香族烃基,其中二价脂环族烃基中的脂环为环己烷环、降冰片烯环或金刚烷 环,二价芳香族烃基中的芳香环为苯环、萘环、芴环或蒽环。Y3再更佳为各自独立表示单 键、亚甲基、碳数为2至10的直链或分支的亚烷基、亚环己基、亚苯基或亚萘基。Y3特佳 为各自独立表示单键、亚甲基、碳数为2至5的直链或分支的亚烷基或亚苯基。Specifically, in formula (III), Y 3 preferably each independently represents a single bond, a methylene group, a linear or branched alkylene group having 2 to 10 carbon atoms, and a linear chain having 2 to 10 carbon atoms. Or branched alkenylene group, straight-chain or branched alkynylene group with carbon number of 2 to 10, divalent alicyclic hydrocarbon group or divalent aromatic hydrocarbon group, wherein the alicyclic in the divalent alicyclic hydrocarbon group is cyclopropane ring, cyclobutane ring, cyclopentane ring, cyclohexane ring, cycloheptane ring, norbornene ring or adamantane ring, the aromatic ring in the divalent aromatic hydrocarbon group is benzene ring, naphthalene ring, tetrahydronaphthalene ring, fluorene ring or anthracene ring. More preferably, Y 3 each independently represents a single bond, a methylene group, a linear or branched alkylene group having 2 to 10 carbon atoms, a linear or branched alkenylene group having 2 to 10 carbon atoms, a divalent lipid Cyclic hydrocarbon group or divalent aromatic hydrocarbon group, wherein the alicyclic ring in the divalent alicyclic hydrocarbon group is cyclohexane ring, norbornene ring or adamantane ring, and the aromatic ring in the divalent aromatic hydrocarbon group is benzene ring, naphthalene ring ring, fluorene ring or anthracene ring. More preferably, Y 3 each independently represents a single bond, a methylene group, a straight-chain or branched alkylene group having 2 to 10 carbon atoms, a cyclohexylene group, a phenylene group, or a naphthylene group. It is particularly preferable that Y 3 each independently represents a single bond, a methylene group, a linear or branched alkylene group having 2 to 5 carbon atoms, or a phenylene group.
式(III)中,Y4各自独立表示单键、-O-、-NH-、 In formula (III), Y 4 each independently represents a single bond, -O-, -NH-,
其中m表示1至5的整数。Y4较佳为各自独立表示单键、-O-、 其中m表示1至5的整数。wherein m represents an integer from 1 to 5. Y 4 preferably each independently represents a single bond, -O-, wherein m represents an integer from 1 to 5.
式(III)中,Y5各自独立表示含氮的芳香族杂环基。具体来说,含氮的芳香族杂环基为含 有选自由式(III-A)、式(III-B)以及式(III-C)所组成的族群中的至少一种结构的含氮的芳香族 杂环基。In formula (III), Y 5 each independently represents a nitrogen-containing aromatic heterocyclic group. Specifically, the nitrogen-containing aromatic heterocyclic group is a nitrogen-containing heterocyclic group containing at least one structure selected from the group consisting of formula (III-A), formula (III-B) and formula (III-C). Aromatic heterocyclic group.
式(III-C)中,R19表示碳数为1至5的直链或分支的烷基。In formula (III-C), R 19 represents a linear or branched alkyl group having 1 to 5 carbon atoms.
Y5中的含氮的芳香族杂环的具体例包括吡咯环(pyrrole ring)、咪唑环(imidazole ring)、 恶唑环(oxazole ring)、噻唑环(thiazole ring)、吡唑环(pyrazolering)、吡啶环(pyridine ring)、 嘧啶环(pyrimidine ring)、喹啉环(quinoline ring)、吡唑啉环(pyrazoline ring)、异喹啉环 (isoquinoline ring)、咔唑环(carbazolering)、嘌呤环(purine ring)、噻二唑环(thiadiazole ring)、哒嗪环(pyridazine ring)、吡唑啉环(pyrazoline ring)、三嗪环(triazine ring)、吡唑 啉烷环(pyrazolidinering)、三唑环(triazole ring)、吡嗪环(pyrazine ring)、苯并咪唑环 (benzimidazolering)、二氮菲环(phenanthroline ring)、吲哚环(indole ring)、喹恶啉环 (quinoxalinering)、苯并噻唑环(benzothiazole ring)、酚噻嗪(phenothiazine ring)、恶二 唑环(oxadiazole ring)或吖啶环(acridine ring)。具体而言,Y5较佳为各自独立表示吡咯基、咪唑基、吡唑基、吡啶基、嘧啶基、哒嗪基、三嗪基、三唑基、吡嗪基或苯并咪唑基。 Y5更佳为各自独立表示吡咯基、咪唑基、吡唑基、吡啶基或嘧啶基。Specific examples of the nitrogen-containing aromatic heterocycle in Y 5 include a pyrrole ring, an imidazole ring, an oxazole ring, a thiazole ring, and a pyrazole ring. , pyridine ring, pyrimidine ring, quinoline ring, pyrazoline ring, isoquinoline ring, carbazole ring, purine ring purine ring, thiadiazole ring, pyridazine ring, pyrazoline ring, triazine ring, pyrazolidine ring, triazole Triazole ring, pyrazine ring, benzimidazole ring, phenanthroline ring, indole ring, quinoxalinering, benzothiazole benzothiazole ring, phenothiazine ring, oxadiazole ring or acridine ring. Specifically, Y 5 preferably each independently represents a pyrrolyl group, an imidazolyl group, a pyrazolyl group, a pyridyl group, a pyrimidinyl group, a pyridazinyl group, a triazinyl group, a triazolyl group, a pyrazinyl group, or a benzimidazolyl group. More preferably, Y 5 each independently represents a pyrrolyl group, an imidazolyl group, a pyrazolyl group, a pyridyl group or a pyrimidinyl group.
又,Y4较佳为键结于不与Y5所含的式(III-A)、式(III-B)以及式(III-C)邻接的取代基。In addition, Y 4 is preferably a substituent not adjacent to formula (III-A), formula (III-B), and formula (III-C) contained in Y 5 .
式(III)中,k表示1至4的整数。又,由与四羧酸二酐化合物的反应性的观点来看,k较佳为表示1至3的整数。另外,当k表示2至4的整数时,多个“-Y2-Y3-Y4-Y5”中的多个 Y2、Y3、Y4、Y5中的每一个可表示相同或不同的基团。In formula (III), k represents an integer of 1 to 4. Moreover, k is preferably an integer representing 1 to 3 from the viewpoint of reactivity with the tetracarboxylic dianhydride compound. In addition, when k represents an integer of 2 to 4, each of the plurality of Y 2 , Y 3 , Y 4 , and Y 5 in the plurality of "-Y 2 -Y 3 -Y 4 -Y 5 " may represent the same or different groups.
式(III)中,Y2、Y3、Y4、Y5及k的较佳组合为:Y2为-O-、-NH-、 -CH2O-或Y3为亚甲基、碳数为2至10的直 链或分支的亚烷基、碳数为2至10的直链或分支的亚烯基、二价脂环族烃基或二价芳香族 烃基,其中二价脂环族烃基中的脂环为环丙烷环、环丁烷环、环戊烷环、环己烷环、环庚 烷环、降冰片烯环或金刚烷环,二价芳香族烃基中的芳香环为苯环、萘环、四氢萘环、芴 环或蒽环;Y4为单键、-O-、-NH-、 (m为1至5的整数);Y5中的含氮的芳香族杂环为吡咯环、 咪唑环、恶唑环、噻唑环、吡唑环、吡啶环、嘧啶环、喹啉环、吡唑啉环、异喹啉环、咔 唑环、嘌呤环、噻二唑环、哒嗪环、吡唑啉环、三嗪环、吡唑啉烷环、三唑环、吡嗪环、 苯并咪唑环、二氮菲环、吲哚环、喹恶啉环、苯并噻唑环、酚噻嗪环、恶二唑环或吖啶环; 并且k为1或2。In formula (III), the preferred combination of Y 2 , Y 3 , Y 4 , Y 5 and k is: Y 2 is -O-, -NH-, -CH 2 O- or Y 3 is a methylene group, a straight-chain or branched alkylene group having a carbon number of 2 to 10, a straight-chain or branched alkenylene group having a carbon number of 2 to 10, a divalent alicyclic hydrocarbon group or a divalent aromatic group Hydrocarbon group, wherein the alicyclic ring in the divalent alicyclic hydrocarbon group is a cyclopropane ring, cyclobutane ring, cyclopentane ring, cyclohexane ring, cycloheptane ring, norbornene ring or adamantane ring, divalent aromatic The aromatic ring in the hydrocarbon group is a benzene ring, a naphthalene ring, a tetrahydronaphthalene ring, a fluorene ring or an anthracene ring; Y 4 is a single bond, -O-, -NH-, (m is an integer of 1 to 5); the nitrogen-containing aromatic heterocyclic ring in Y 5 is a pyrrole ring, an imidazole ring, an oxazole ring, a thiazole ring, a pyrazole ring, a pyridine ring, a pyrimidine ring, a quinoline ring, a pyridine ring oxazoline ring, isoquinoline ring, carbazole ring, purine ring, thiadiazole ring, pyridazine ring, pyrazoline ring, triazine ring, pyrazolinane ring, triazole ring, pyrazine ring, benzo an imidazole ring, a phenanthrene ring, an indole ring, a quinoxaline ring, a benzothiazole ring, a phenothiazine ring, an oxadiazole ring, or an acridine ring; and k is 1 or 2.
式(III)中,Y2、Y3、Y4、Y5及k的更佳组合为:Y2为-O-、-NH-、 -CH2O-或Y3为亚甲基、碳数为2至10的直链或分支的亚 烷基、碳数为2至10的直链或分支的亚烯基、二价脂环族烃基或二价芳香族烃基,其中二 价脂环族烃基中的脂环为环己烷环、降冰片烯环或金刚烷环,二价芳香族烃基中的芳香环 为苯环、萘环、芴环或蒽环;Y4为单键、-O-、-NH-、 (m为1至5的整数);Y5为吡咯基、咪唑基、 吡唑基、吡啶基、嘧啶基、吡唑啉基、咔唑基、哒嗪基、吡唑啉基、三嗪基、吡唑啉烷基、 三唑基、吡嗪基或苯并咪唑基;并且k为1或2。In formula (III), a more preferable combination of Y 2 , Y 3 , Y 4 , Y 5 and k is: Y 2 is -O-, -NH-, -CH 2 O- or Y 3 is a methylene group, a straight-chain or branched alkylene group having a carbon number of 2 to 10, a straight-chain or branched alkenylene group having a carbon number of 2 to 10, a divalent alicyclic hydrocarbon group or a divalent aromatic group Hydrocarbon group, wherein the alicyclic ring in the divalent alicyclic hydrocarbon group is a cyclohexane ring, a norbornene ring or an adamantane ring, and the aromatic ring in the divalent aromatic hydrocarbon group is a benzene ring, a naphthalene ring, a fluorene ring or an anthracene ring; Y 4 is a single bond, -O-, -NH-, (m is an integer from 1 to 5); Y 5 is pyrrolyl, imidazolyl, pyrazolyl, pyridyl, pyrimidinyl, pyrazolinyl, carbazolyl, pyridazinyl, pyrazolinyl, triazinyl , pyrazolinyl, triazolyl, pyrazinyl, or benzimidazolyl; and k is 1 or 2.
式(III)中,Y2、Y3、Y4、Y5及k的再更佳组合为:Y2为-O-、-NH-、 或-CH2O-;Y3为亚甲基、碳数为2至5的直链或分支 的亚烷基或亚苯基;Y4为单键、-O-、 (m为1至5的整数);Y5为吡咯基、咪唑基、吡唑基、吡啶基或嘧啶 基;并且k为1、2或3。In formula (III), a more preferable combination of Y 2 , Y 3 , Y 4 , Y 5 and k is: Y 2 is -O-, -NH-, or -CH 2 O-; Y 3 is a methylene group, a straight-chain or branched alkylene group with a carbon number of 2 to 5 or a phenylene group; Y 4 is a single bond, -O-, (m is an integer from 1 to 5); Y 5 is pyrrolyl, imidazolyl, pyrazolyl, pyridyl or pyrimidinyl; and k is 1, 2 or 3.
二胺化合物(b1-3)的具体例包括表I至表VIII所述的Y2、Y3、Y4、Y5及k的组合的二胺化合物。Specific examples of the diamine compound (b1-3) include diamine compounds of combinations of Y 2 , Y 3 , Y 4 , Y 5 and k described in Tables I to VIII.
表ITable I
表IITable II
表IIITable III
表IVTable IV
表VTable V
表VITable VI
表VIITable VII
表VIIITable VIII
制造本发明的二胺化合物(b1-3)的方法没有特别的限制,例如是可以下述方法来制造: 先合成由式(III-D)表示的二硝基化合物,接着,在触媒、溶剂以及氢化物的存在下将硝基还 原成氨基。The method for producing the diamine compound (b1-3) of the present invention is not particularly limited. For example, it can be produced by the following method. and the reduction of the nitro group to the amino group in the presence of a hydride.
式(III-D)中,Y2、Y3、Y4、Y5及k分别与式(III)中的Y2、Y3、Y4、Y5及k同义,在此 不另行赘述。In formula (III-D), Y 2 , Y 3 , Y 4 , Y 5 and k are respectively synonymous with Y 2 , Y 3 , Y 4 , Y 5 and k in formula (III), and will not be repeated here. .
触媒的具体例没有特别的限制但可包括钯-碳、二氧化铂、雷氏镍(raneynickel)、铂黑、 铑-氧化铝、硫化铂碳、或上述触媒的组合。溶剂的具体例没有特别的限制但可包括乙酸乙 酯、甲苯、四氢呋喃、二恶烷、醇类、或上述溶剂的组合。氢化物的具体例没有特别的限 制但可包括氢气、肼(hydrazine)、氯化氢(hydrogen chloride)或上述化合物的组合。Specific examples of the catalyst are not particularly limited but may include palladium-carbon, platinum dioxide, Raneynickel, platinum black, rhodium-alumina, platinum sulfide carbon, or a combination of the above catalysts. Specific examples of the solvent are not particularly limited but may include ethyl acetate, toluene, tetrahydrofuran, dioxane, alcohols, or a combination of the above solvents. Specific examples of the hydride are not particularly limited but may include hydrogen, hydrazine, hydrogen chloride, or a combination of the above compounds.
由式(III-D)表示的二硝基化合物是经Y4而使Y3与Y5键结;接着Y3经Y2而与含有二硝基的苯环键结的方法来合成;或者使含有二硝基的苯环经Y2而与Y3键结,接着,Y3经 Y4而与Y5键结的方法来合成。The dinitro compound represented by the formula (III-D) is synthesized by a method in which Y 3 is bonded to Y 5 via Y 4 ; then Y 3 is bonded to a benzene ring containing a dinitro group via Y 2 ; or It is synthesized by a method in which a dinitro group-containing benzene ring is bonded to Y 3 via Y 2 , and then Y 3 is bonded to Y 5 via Y 4 .
Y2为-O-、-NH-、-CH2O-、等结合基,这些结合基可通过现有的有机合成方法来形成。Y 2 is -O-, -NH-, -CH 2 O-, and other binding groups, which can be formed by existing organic synthesis methods.
举例来说,在Y2为-O-或-CH2O-的情况下,由式(III-D)表示的二硝基化合物 可通过使含有二硝基的卤素衍生物与含有Y3、Y4及Y5的羟基衍生物于碱存在下进行反应 而得;或者通过使含有二硝基的羟基衍生物与含有Y3、Y4及Y5的卤素取代衍生物于碱存 在下进行反应而得。For example, in the case where Y 2 is -O- or -CH 2 O-, the dinitro compound represented by formula (III-D) can be obtained by combining a halogen derivative containing a dinitro group with a compound containing Y 3 , The hydroxy derivatives of Y 4 and Y 5 are obtained by reacting in the presence of a base; or by reacting a hydroxy derivative containing a dinitro group with a halogen-substituted derivative containing Y 3 , Y 4 and Y 5 in the presence of a base And get.
在Y2为-NH-的情况下,由式(III-D)表示的二硝基化合物可通过使含有二硝基的卤 素衍生物与含有Y3、Y4及Y5的氨基取代衍生物于碱存在下进行反应而得。In the case where Y 2 is -NH-, the dinitro compound represented by the formula (III-D) can be obtained by substituting a halogen derivative containing a dinitro group with an amino-substituted derivative containing Y 3 , Y 4 and Y 5 It is obtained by reacting in the presence of a base.
在Y2为的情况下,由式(III-D)表示的二硝基化合物可通过使含有二硝基的 羟基衍生物与含有Y3、Y4及Y5的酰氯(acid chloride)化合物于碱存在下进行反应而得。at Y 2 for In the case of , the dinitro compound represented by the formula (III-D) can be carried out by making a hydroxy derivative containing a dinitro group and an acid chloride compound containing Y 3 , Y 4 and Y 5 in the presence of a base response.
在Y2为的情况下,由式(III-D)表示的二硝基化合物可通过使含有二硝基的 酰氯化合物与含有Y3、Y4及Y5的经氨基取代的化合物于碱存在下进行反应而得。at Y 2 for In this case, the dinitro compound represented by the formula (III-D) can be obtained by reacting a dinitro-containing acid chloride compound with an amino-substituted compound containing Y 3 , Y 4 and Y 5 in the presence of a base. have to.
在Y2为的情况下,由式(III-D)表示的二硝基化合物可通过使经氨基取代的 化合物与含有Y3、Y4及Y5的含有二硝基的酰氯化合物于碱存在下进行反应而得。at Y 2 for In this case, the dinitro compound represented by the formula (III-D) can be obtained by reacting an amino-substituted compound with a dinitro-containing acid chloride compound containing Y 3 , Y 4 and Y 5 in the presence of a base. have to.
含有二硝基的卤素衍生物及含有二硝基的衍生物的具体例包括3,5-二硝基氯苯(3,5-dinitrochlorobenzene)、2,4-二硝基氯苯(2,4-dinitrochlorobenzene)、2,4-二硝基氟苯 (2,4-dinitro fluorobenzene)、3,5-二硝基苯甲酰氯(3,5-dinitro benzoylchloride)、3,5-二硝基 苯甲酸(3,5-dinitrobenzoic acid)、2,4-二硝基苯甲酰氯(2,4-dinitrobenzoyl chloride)、2,4-二 硝基苯甲酸(2,4-dinitrobenzoic acid)、3,5-二硝基氯化苄(3,5-dinitro benzyl chloride)、2,4- 二硝基氯化苄(2,4-dinitrobenzylchloride)、3,5-二硝基苯甲醇(3,5-dinitrobenzyl alcohol)、 2,4-二硝基苯甲醇(2,4-dinitrobenzyl alcohol)、2,4-二硝基苯胺(2,4-dinitroaniline)、3,5-二 硝基苯胺(3,5-dinitroaniline)、2,6-二硝基苯胺(2,6-dinitroaniline)、2,4-二硝基酚 (2,4-dinitrophenol)、2,5-二硝基酚(2,5-dinitrophenol)、2,6-二硝基酚(2,6-dinitrophenol) 或2,4-二硝基苯乙酸(2,4-dinitrophenylacetic acid)。含有二硝基的卤素衍生物及含有二硝基 的衍生物,若考虑到原料的取得性、反应性的观点时,可以单独使用一种或者组合多种来 使用。Specific examples of dinitro-containing halogen derivatives and dinitro-containing derivatives include 3,5-dinitrochlorobenzene (3,5-dinitrochlorobenzene), 2,4-dinitrochlorobenzene (2,4-dinitrochlorobenzene) -dinitrochlorobenzene), 2,4-dinitro fluorobenzene, 3,5-dinitro benzoylchloride, 3,5-dinitrobenzoic acid (3,5-dinitrobenzoic acid), 2,4-dinitrobenzoyl chloride, 2,4-dinitrobenzoic acid, 3,5- Dinitrobenzyl chloride (3,5-dinitro benzyl chloride), 2,4-dinitrobenzyl chloride (2,4-dinitrobenzylchloride), 3,5-dinitrobenzyl alcohol (3,5-dinitrobenzyl alcohol) ), 2,4-dinitrobenzyl alcohol (2,4-dinitrobenzyl alcohol), 2,4-dinitroaniline (2,4-dinitroaniline), 3,5-dinitroaniline (3,5-dinitroaniline) ), 2,6-dinitroaniline (2,6-dinitroaniline), 2,4-dinitrophenol (2,4-dinitrophenol), 2,5-dinitrophenol (2,5-dinitrophenol), 2,6-dinitrophenol or 2,4-dinitrophenylacetic acid. The dinitro group-containing halogen derivatives and the dinitro group-containing derivatives may be used alone or in combination of two or more from the viewpoints of availability of raw materials and reactivity.
二胺化合物(b1-3)的具体例较佳为包括由式(III-1)至式(III-6)表示的二胺化合物中的至 少一者。Specific examples of the diamine compound (b1-3) preferably include at least one of the diamine compounds represented by formula (III-1) to formula (III-6).
当液晶配向剂中的聚合物(A-1)中的二胺化合物(b1)包括二胺化合物(b1-3)时,可使液晶 配向剂所形成的液晶配向膜及液晶显示元件具有较佳的耐环境性。When the diamine compound (b1) in the polymer (A-1) in the liquid crystal alignment agent includes the diamine compound (b1-3), the liquid crystal alignment film and the liquid crystal display element formed by the liquid crystal alignment agent can have better performance environmental resistance.
基于二胺化合物(b1)的使用量为100摩尔份,由式(III)表示的二胺化合物(b1-3)的使用量 可为1摩尔份至20摩尔份,较佳为3摩尔份至18摩尔份,更佳为5摩尔份至15摩尔份。The diamine compound (b1-3) represented by formula (III) may be used in an amount of 1 to 20 parts by mole, preferably 3 to 3 parts by mole, based on 100 parts by mole of the diamine compound (b1) used. 18 mole parts, more preferably 5 mole parts to 15 mole parts.
其他二胺化合物(b1-4)Other diamine compounds (b1-4)
其他二胺化合物(b1-4)的具体例包括1,2-二氨基乙烷、1,3-二氨基丙烷、1,4-二氨基丁烷、 1,5-二氨基戊烷、1,6-二氨基己烷、1,7-二氨基庚烷、1,8-二氨基辛烷、1,9-二氨基壬烷、1,10- 二氨基癸烷、4,4’-二氨基庚烷、1,3-二氨基-2,2-二甲基丙烷、1,6-二氨基-2,5-二甲基己烷、1,7- 二氨基-2,5-二甲基庚烷、1,7-二氨基-4,4-二甲基庚烷、1,7-二氨基-3-甲基庚烷、1,9-二氨基-5- 甲基壬烷、2,11-二氨基十二烷、1,12-二氨基十八烷、1,2-双(3-氨基丙氧基)乙烷、4,4’-二氨 基二环己基甲烷、4,4’-二氨基-3,3’-二甲基二环己基胺、1,3-二氨基环己烷、1,4-二氨基环己 烷(1,4-diaminocyclohexane)、异佛尔酮二胺、四氢二环戊二烯二胺、三环[6.2.1.02,7]-十一碳 烯二甲基二胺、4,4’-亚甲基双(环己基胺)(4,4’-methylenebis(cyclohexylamine))、4,4’-二氨基 二苯基甲烷、4,4’-二氨基二苯基乙烷、4,4’-二氨基二苯基砜、4,4’-二氨基苯甲酰苯胺、4,4’- 二氨基二苯基醚、3,4’-二氨基二苯基醚、1,5-二氨基萘、5-氨基-1-(4’-氨基苯基)-1,3,3-三甲 基氢茚、6-氨基-1-(4’-氨基苯基)-1,3,3-三甲基氢茚、六氢-4,7-甲桥亚氢茚基二亚甲基二胺、 3,3’-二氨基二苯甲酮、3,4’-二氨基二苯甲酮、4,4’-二氨基二苯甲酮、2,2-双[4-(4-氨基苯氧基) 苯基]丙烷、2,2-双[4-(4-氨基苯氧基)苯基]六氟丙烷、2,2-双(4-氨基苯基)六氟丙烷、2,2-双[4-(4- 氨基苯氧基)苯基]砜、1,4-双(4-氨基苯氧基)苯、1,3-双(4-氨基苯氧基)苯、1,3-双(3-氨基苯氧 基)苯、9,9-双(4-氨基苯基)-10-氢蒽、9,10-双(4-氨基苯基)蒽 (9,10-bis(4-aminophenyl)anthracene)、2,7-二氨基芴、9,9-双(4-氨基苯基)芴、4,4’-亚甲基-双(2-氯苯胺)、4,4’-(对-亚苯基异亚丙基)双苯胺、4,4’-(间-亚苯基异亚丙基)双苯胺、2,2’-双 [4-(4-氨基-2-三氟甲基苯氧基)苯基]六氟丙烷、4,4’-双[(4-氨基-2-三氟甲基)苯氧基]-八氟联苯、 5-[4-(4-正戊烷基环己基)环己基]苯基亚甲基-1,3-二氨基苯 (5-[4-(4-n-pentylcyclohexyl)cyclohexyl]phenyl methylene-1,3-diaminobenzene)、1,1-双[4-(4- 氨基苯氧基)苯基]-4-(4-乙基苯基)环己烷(1,1-bis[4-(4-aminophenoxy)phenyl]-4- (4-ethylphenyl)cyclohexane)或由式(2-1)至式(2-25)表示的二胺化合物等其他二胺化合物 (b1-4)。然而,本发明不限于此,其他二胺化合物(b1-4)可还包括其他合适的二胺化合物。Specific examples of other diamine compounds (b1-4) include 1,2-diaminoethane, 1,3-diaminopropane, 1,4-diaminobutane, 1,5-diaminopentane, 1,5-diaminopentane, 6-Diaminohexane, 1,7-diaminoheptane, 1,8-diaminooctane, 1,9-diaminononane, 1,10-diaminodecane, 4,4'-diamino Heptane, 1,3-diamino-2,2-dimethylpropane, 1,6-diamino-2,5-dimethylhexane, 1,7-diamino-2,5-dimethyl Heptane, 1,7-diamino-4,4-dimethylheptane, 1,7-diamino-3-methylheptane, 1,9-diamino-5-methylnonane, 2, 11-diaminododecane, 1,12-diaminooctadecane, 1,2-bis(3-aminopropoxy)ethane, 4,4'-diaminodicyclohexylmethane, 4,4'-Diamino-3,3'-dimethyldicyclohexylamine, 1,3-diaminocyclohexane, 1,4-diaminocyclohexane (1,4-diaminocyclohexane), isophoronediamine , tetrahydrodicyclopentadiene diamine, tricyclo[6.2.1.0 2,7 ]-undecenedimethyldiamine, 4,4'-methylenebis(cyclohexylamine)(4,4 '-methylenebis(cyclohexylamine)), 4,4'-diaminodiphenylmethane, 4,4'-diaminodiphenylethane, 4,4'-diaminodiphenylsulfone, 4,4'- Diaminobenzanilide, 4,4'-diaminodiphenyl ether, 3,4'-diaminodiphenyl ether, 1,5-diaminonaphthalene, 5-amino-1-(4'-amino Phenyl)-1,3,3-trimethylhydroindene, 6-amino-1-(4'-aminophenyl)-1,3,3-trimethylhydroindene, hexahydro-4,7- Tolylidene indenyl dimethylenediamine, 3,3'-diaminobenzophenone, 3,4'-diaminobenzophenone, 4,4'-diaminobenzophenone, 2 ,2-bis[4-(4-aminophenoxy)phenyl]propane, 2,2-bis[4-(4-aminophenoxy)phenyl]hexafluoropropane, 2,2-bis(4 -Aminophenyl)hexafluoropropane, 2,2-bis[4-(4-aminophenoxy)phenyl]sulfone, 1,4-bis(4-aminophenoxy)benzene, 1,3-bis (4-Aminophenoxy)benzene, 1,3-bis(3-aminophenoxy)benzene, 9,9-bis(4-aminophenyl)-10-hydroanthracene, 9,10-bis(4 -Aminophenyl)anthracene (9,10-bis(4-aminophenyl)anthracene), 2,7-diaminofluorene, 9,9-bis(4-aminophenyl)fluorene, 4,4'-methylene -Bis(2-chloroaniline), 4,4'-(p-phenylene isopropylidene) bisaniline, 4,4'-(m-phenylene isopropylidene) bisaniline, 2,2 '-bis[4-(4-amino-2-trifluoromethylphenoxy)phenyl]hexafluoropropane, 4,4'-bis[(4-amino-2-trifluoromethyl) ) phenoxy]-octafluorobiphenyl, 5-[4-(4-n-pentylcyclohexyl)cyclohexyl]phenylmethylene-1,3-diaminobenzene (5-[4-(4 -n-pentylcyclohexyl)cyclohexyl]phenyl methylene-1,3-diaminobenzene), 1,1-bis[4-(4-aminophenoxy)phenyl]-4-(4-ethylphenyl)cyclohexane (1,1-bis[4-(4-aminophenoxy)phenyl]-4-(4-ethylphenyl)cyclohexane) or other diamines such as diamine compounds represented by formulas (2-1) to (2-25) Compound (b1-4). However, the present invention is not limited thereto, and other diamine compounds (b1-4) may further include other suitable diamine compounds.
由式(2-1)至式(2-25)表示的其他二胺化合物如下所示。Other diamine compounds represented by formula (2-1) to formula (2-25) are shown below.
式(2-1)中,B1表示-O-、 B2表示含甾基团、三氟甲基、氟基、碳数为2至30的烷基或衍生自吡啶、嘧啶、 三嗪、哌啶及哌嗪等含氮原子环状结构的一价基团。In formula (2-1), B 1 represents -O-, B 2 represents a steroid group, a trifluoromethyl group, a fluoro group, an alkyl group with a carbon number of 2 to 30, or a monovalent cyclic structure derived from a nitrogen atom-containing ring structure such as pyridine, pyrimidine, triazine, piperidine and piperazine group.
由式(2-1)表示的其他二胺化合物的具体例包括2,4-二氨基苯基甲酸乙酯 (2,4-diaminophenyl ethyl formate)、3,5-二氨基苯基甲酸乙酯(3,5-diaminophenyl ethylformate)、2,4-二氨基苯基甲酸丙酯(2,4-diaminophenyl propyl formate)、3,5-二氨基苯基甲 酸丙酯(3,5-diaminophenyl propyl formate)、1-十二烷氧基-2,4-二氨基苯 (1-dodecoxy-2,4-diaminobenzene)、1-十六烷氧基-2,4-二氨基苯 (1-hexadecoxy-2,4-diaminobenzene)、1-十八烷氧基-2,4-二氨基苯 (1-octadecoxy-2,4-diaminobenzene)或由式(2-1-1)至式(2-1-4)表示的其他二胺化合物。Specific examples of other diamine compounds represented by formula (2-1) include 2,4-diaminophenyl ethyl formate, 3,5-diaminophenyl ethyl formate ( 3,5-diaminophenyl ethylformate), 2,4-diaminophenyl propyl formate, 3,5-diaminophenyl propyl formate, 1-Dodecoxy-2,4-diaminobenzene (1-dodecoxy-2,4-diaminobenzene), 1-hexadecoxy-2,4-diaminobenzene (1-hexadecoxy-2,4 -diaminobenzene), 1-octadecoxy-2,4-diaminobenzene (1-octadecoxy-2,4-diaminobenzene), or represented by formula (2-1-1) to formula (2-1-4) of other diamine compounds.
式(2-2)中,B3表示-O-、 B4及B5表示亚脂肪族环、亚芳香族环或亚杂环基团;B6表示碳数为3至18的烷 基、碳数为3至18的烷氧基、碳数为1至5的氟烷基、碳数为1至5的氟烷氧基、氰基或 卤素原子。In formula (2-2), B 3 represents -O-, B 4 and B 5 represent an aliphatic, aromatic, or heterocyclic group; B 6 represents an alkyl group having 3 to 18 carbon atoms, an alkoxy group having 3 to 18 carbon atoms, and a carbon number of 1 A fluoroalkyl group to 5, a fluoroalkoxy group having a carbon number of 1 to 5, a cyano group or a halogen atom.
由式(2-2)表示的其他二胺化合物的具体例包括由式(2-2-1)至式(2-2-13)表示的二胺化合 物。Specific examples of other diamine compounds represented by formula (2-2) include diamine compounds represented by formula (2-2-1) to formula (2-2-13).
式(2-2-10)至式(2-2-13)中,q表示3至12的整数。In formula (2-2-10) to formula (2-2-13), q represents an integer of 3 to 12.
式(2-3)中,B7表示氢、碳数为1至5的酰基、碳数为1至5的烷基、碳数为1至5的 烷氧基或卤素;s表示1至3的整数。当s表示2或3的整数时,多个B7可为相同或不同。In formula (2-3), B 7 represents hydrogen, an acyl group having 1 to 5 carbon atoms, an alkyl group having 1 to 5 carbon atoms, an alkoxy group having 1 to 5 carbon atoms or a halogen; s represents 1 to 3 the integer. When s represents an integer of 2 or 3, a plurality of B 7 may be the same or different.
由式(2-3)表示的二胺化合物的具体例包括(1)当s为1时:对-二氨基苯、间-二氨基苯、 邻-二氨基苯或2,5-二胺甲苯等;(2)当s为2时:4,4’-二氨基联苯、2,2’-二甲基-4,4’-二氨基 联苯(2,2’-dimethyl-4,4’-diamino diphenyl)、3,3’-二甲基-4,4’-二氨基联苯、3,3’-二甲氧基-4,4’- 二氨基联苯、2,2’-二氯-4,4’-二氨基联苯、3,3’-二氯-4,4’-二氨基联苯、2,2’,5,5’-四氯-4,4’-二 氨基联苯、2,2’-二氯-4,4’-二氨基-5,5’-二甲氧基联苯或4,4’-二氨基-2,2’-双(三氟甲基)联苯等; (3)当s为3时:1,4-双(4’-氨基苯基)苯或其组合。由式(2-3)表示的二胺化合物的具体例较佳 为包括对-二氨基苯、2,2’-二甲基-4,4’-二氨基联苯或其组合。Specific examples of the diamine compound represented by formula (2-3) include (1) when s is 1: p-diaminobenzene, m-diaminobenzene, o-diaminobenzene, or 2,5-diaminetoluene etc.; (2) When s is 2: 4,4'-diaminobiphenyl, 2,2'-dimethyl-4,4'-diaminobiphenyl (2,2'-dimethyl-4,4 '-diamino diphenyl), 3,3'-dimethyl-4,4'-diaminobiphenyl, 3,3'-dimethoxy-4,4'-diaminobiphenyl, 2,2'- Dichloro-4,4'-diaminobiphenyl, 3,3'-dichloro-4,4'-diaminobiphenyl, 2,2',5,5'-tetrachloro-4,4'-diphenyl Aminobiphenyl, 2,2'-dichloro-4,4'-diamino-5,5'-dimethoxybiphenyl or 4,4'-diamino-2,2'-bis(trifluoromethyl) (3) When s is 3: 1,4-bis(4'-aminophenyl)benzene or a combination thereof. Specific examples of the diamine compound represented by the formula (2-3) preferably include p-diaminobenzene, 2,2'-dimethyl-4,4'-diaminobiphenyl, or a combination thereof.
式(2-4)中,t表示2至12的整数。In formula (2-4), t represents an integer of 2 to 12.
式(2-5)中,v表示1至5的整数。In formula (2-5), v represents an integer of 1 to 5.
由式(2-5)表示的二胺化合物的具体例包括4,4’-二氨基二苯基硫醚。Specific examples of the diamine compound represented by formula (2-5) include 4,4'-diaminodiphenyl sulfide.
式(2-6)中,B8及B10各自独立表示二价有机基团,B9表示衍生自吡啶、嘧啶、三嗪、哌啶及哌嗪等含氮原子环状结构的二价基团。In formula (2-6), B 8 and B 10 each independently represent a divalent organic group, and B 9 represents a divalent group derived from a nitrogen atom-containing cyclic structure such as pyridine, pyrimidine, triazine, piperidine, and piperazine group.
式(2-7)中,B11、B12、B13及B14各自独立表示碳数为1至12的烃基;w表示1至3的 整数;z表示1至20的整数。In formula (2-7), B 11 , B 12 , B 13 and B 14 each independently represent a hydrocarbon group having 1 to 12 carbon atoms; w represents an integer of 1 to 3; and z represents an integer of 1 to 20.
式(2-8)Formula (2-8)
式(2-8)中,B15表示-O-或亚环己基;B16表示亚甲基;B17表示亚苯基或亚环己基;B18表示氢或庚烷基。In formula (2-8), B 15 represents -O- or cyclohexylene; B 16 represents methylene; B 17 represents phenylene or cyclohexylene; B 18 represents hydrogen or heptyl.
由式(2-8)表示的二胺化合物的具体例包括由式(2-8-1)至式(2-8-2)表示的二胺化合物。Specific examples of the diamine compound represented by formula (2-8) include diamine compounds represented by formula (2-8-1) to formula (2-8-2).
由式(2-9)至式(2-25)表示的其他二胺化合物如下所示。Other diamine compounds represented by formula (2-9) to formula (2-25) are shown below.
式(2-17)至式(2-25)中,B19表示碳数为1至10的烷基或碳数为1至10的烷氧基;B20表示氢、碳数为1至10的烷基或碳数为1至10的烷氧基。In formula (2-17) to formula (2-25), B 19 represents an alkyl group having a carbon number of 1 to 10 or an alkoxy group having a carbon number of 1 to 10; B 20 represents hydrogen and a carbon number of 1 to 10 or an alkoxy group with a carbon number of 1 to 10.
其他二胺化合物(b1-4)的具体例还可包括3,3’-二氨基查耳酮(3,3’-diaminochalcone)、 4,4’-二氨基查耳酮(4,4’-diaminochalcone)、3,4’-二氨基查耳酮(3,4’-diaminochalcone)或 3,4-二氨基查耳酮(3,4-diaminochalcone)等具有查耳酮(chalcone)结构的二胺化合物;3,3’- 二氨基均二苯乙烯(3,3’-diaminostilbene)、4,4’-二氨基均二苯乙烯(4,4’-diaminostilbene)、 4,4’-二氨基均二苯乙烯-2,2’-磺酸(4,4’-diaminostilbene-2,2’-sulfonic acid)或4,4’-双(4-氨基 -1-萘基偶氮)-2,2’-均二苯乙烯磺酸(4,4’-bis(4-amino-1-naphthylazo)-2,2’-stilbene sulfonic acid) 等具有均二苯乙烯(stilbene)结构的二胺化合物;1,2-二氨基蒽醌(1,2-diaminoanthraquinone)、 1,4-二氨基蒽醌(1,4-diamino anthraquinone)、1,5-二氨基蒽醌(1,5-diamino anthraquinone) 或1,4-二氨基蒽醌-2,3-二氰基-9,10-蒽醌(1,4-diaminoanthraquinone-2,3-dicyano-9,10-anthraquinone)等具有蒽醌(anthraquinone)结构的二胺化合 物;或者3,6-二氨基咔唑等具有咔唑(carbazole)结构的二胺化合物。Specific examples of other diamine compounds (b1-4) may also include 3,3'-diaminochalcone, 4,4'-diaminochalcone (4,4'- diaminochalcone), 3,4'-diaminochalcone (3,4'-diaminochalcone) or 3,4-diaminochalcone (3,4-diaminochalcone) and other diamines with chalcone structure Compounds; 3,3'-diaminostilbene, 4,4'-diaminostilbene, 4,4'-diaminostilbene 4,4'-diaminostilbene-2,2'-sulfonic acid or 4,4'-bis(4-amino-1-naphthylazo)-2,2 '-Stilbene sulfonic acid (4,4'-bis(4-amino-1-naphthylazo)-2,2'-stilbene sulfonic acid) and other diamine compounds with stilbene structure; 1 , 1,2-diaminoanthraquinone, 1,4-diamino anthraquinone, 1,5-diamino anthraquinone, or 1 ,4-diaminoanthraquinone-2,3-dicyano-9,10-anthraquinone (1,4-diaminoanthraquinone-2,3-dicyano-9,10-anthraquinone) etc. with anthraquinone structure A diamine compound; or a diamine compound having a carbazole structure such as 3,6-diaminocarbazole.
其他二胺化合物(b1-4)的具体例较佳为包括1,2-二氨基乙烷、4,4’-二氨基二环己基甲烷、 4,4’-二氨基二苯基甲烷、4,4’-二氨基二苯基醚、5-[4-(4-正戊烷基环己基)环己基]苯基亚甲基 -1,3-二氨基苯、1,1-双[4-(4-氨基苯氧基)苯基]-4-(4-乙基苯基)环己烷、2,4-二氨基苯基甲酸乙 酯、2,2’-二甲基-4,4’-二氨基联苯、4,4’-亚甲基双(环己基胺)、1,4-二氨基环己烷、由式(2-1-1) 表示的二胺化合物、由式(2-1-2)表示的二胺化合物、由式(2-2-1)表示的二胺化合物、由式 (2-2-11)表示的二胺化合物、对-二氨基苯、间-二氨基苯、邻-二氨基苯、由式(2-8-1)表示的 二胺化合物、3,3’-二氨基查耳酮或4,4’-二氨基均二苯乙烯等。Specific examples of other diamine compounds (b1-4) preferably include 1,2-diaminoethane, 4,4'-diaminodicyclohexylmethane, 4,4'-diaminodiphenylmethane, 4,4'-diaminodiphenylmethane ,4'-Diaminodiphenyl ether, 5-[4-(4-n-pentylcyclohexyl)cyclohexyl]phenylmethylene-1,3-diaminobenzene, 1,1-bis[4 -(4-Aminophenoxy)phenyl]-4-(4-ethylphenyl)cyclohexane, ethyl 2,4-diaminophenylcarboxylate, 2,2'-dimethyl-4, 4'-diaminobiphenyl, 4,4'-methylenebis(cyclohexylamine), 1,4-diaminocyclohexane, diamine compound represented by formula (2-1-1), formula The diamine compound represented by (2-1-2), the diamine compound represented by the formula (2-2-1), the diamine compound represented by the formula (2-2-11), p-diaminobenzene, m -Diaminobenzene, o-diaminobenzene, a diamine compound represented by formula (2-8-1), 3,3'-diaminochalcone or 4,4'-diaminostilbene, and the like.
其他二胺化合物(b1-4)的具体例更佳为包括对-二氨基苯、2,2’-二甲基-4,4’-二氨基联苯、 4,4’-亚甲基双(环己基胺)、1,4-二氨基环己烷、3,3’-二氨基查耳酮或其组合。Specific examples of other diamine compounds (b1-4) more preferably include p-diaminobenzene, 2,2'-dimethyl-4,4'-diaminobiphenyl, 4,4'-methylenebis (cyclohexylamine), 1,4-diaminocyclohexane, 3,3'-diaminochalcone, or a combination thereof.
基于二胺化合物(b1)的使用量为100摩尔份,其他二胺化合物(b1-4)的使用量可为0摩 尔份至70摩尔份,较佳为0摩尔份至60摩尔份,更佳为0摩尔份至50摩尔份。Based on 100 mole parts of the diamine compound (b1), the other diamine compounds (b1-4) may be used in an amount of 0 to 70 mole parts, preferably 0 to 60 mole parts, more preferably 0 to 50 mole parts.
制备聚合物(A-1)的方法Process for producing polymer (A-1)
制备聚酰胺酸聚合物的方法Method for preparing polyamic acid polymer
制备聚酰胺酸聚合物的方法为先将第一混合物溶解于溶剂中,其中第一混合物包括四 羧酸二酐化合物(a1)与二胺化合物(b1),并于0℃至100℃的温度下进行聚缩合反应。反应1 小时至24小时后,以蒸发器对上述反应溶液进行减压蒸馏,即可得到聚酰胺酸聚合物。或 者,将上述的反应溶液倒入大量的贫溶剂中,以得到析出物。接着,以减压干燥的方式干 燥析出物,即可得到聚酰胺酸聚合物。基于四羧酸二酐化合物(a1)的使用量为100摩尔份, 二胺化合物(b1)的使用量可为20摩尔份至200摩尔份,较佳为30摩尔份至120摩尔份。The method for preparing a polyamic acid polymer is to first dissolve the first mixture in a solvent, wherein the first mixture includes a tetracarboxylic dianhydride compound (a1) and a diamine compound (b1), and dissolve the mixture at a temperature of 0°C to 100°C. The polycondensation reaction was carried out under the following conditions. After reacting for 1 to 24 hours, the above-mentioned reaction solution is distilled under reduced pressure with an evaporator to obtain a polyamic acid polymer. Alternatively, the above-mentioned reaction solution is poured into a large amount of poor solvent to obtain a precipitate. Next, the precipitate is dried under reduced pressure to obtain a polyamic acid polymer. The diamine compound (b1) may be used in an amount of 20 to 200 parts by mole, preferably 30 to 120 parts by mole, based on 100 parts by mole of the tetracarboxylic dianhydride compound (a1).
用于聚缩合反应中的溶剂可与下述液晶配向剂中的溶剂相同或不同,且用于聚缩合反 应中的溶剂并无特别的限制,只要是可溶解反应物与生成物即可。溶剂的具体例包括(1)非 质子系极性溶剂,例如:N-甲基-2-吡咯烷酮(N-methyl-2-pyrrolidone,NMP)、N,N-二甲基 乙酰胺、N,N-二甲基甲酰胺、二甲基亚砜、γ-丁内酯、四甲基尿素或六甲基磷酸三胺等非质 子系极性溶剂;(2)酚系溶剂,例如:间-甲酚、二甲苯酚、酚或卤化酚类等酚系溶剂;或上 述溶剂的组合。然而,本发明不限于此,溶剂可还包括其他合适的溶剂。基于第一混合物 的总使用量为100重量份,用于聚缩合反应中的溶剂的使用量可为200重量份至2000重量 份,较佳为300重量份至1800重量份。The solvent used in the polycondensation reaction may be the same as or different from the solvent in the following liquid crystal aligning agent, and the solvent used in the polycondensation reaction is not particularly limited, as long as it can dissolve the reactant and the product. Specific examples of the solvent include (1) aprotic polar solvents such as N-methyl-2-pyrrolidone (NMP), N,N-dimethylacetamide, N,N - aprotic polar solvents such as dimethylformamide, dimethyl sulfoxide, γ-butyrolactone, tetramethyl urea or hexamethyl phosphate triamine; (2) phenolic solvents, such as m-methyl phosphate Phenol-based solvents such as phenol, xylenol, phenol, or halogenated phenols; or a combination of the above solvents. However, the present invention is not limited thereto, and the solvent may also include other suitable solvents. The solvent used in the polycondensation reaction may be used in an amount of 200 to 2000 parts by weight, preferably 300 to 1800 parts by weight, based on 100 parts by weight of the first mixture.
于聚缩合反应中,溶剂可并用适量的贫溶剂,其中贫溶剂不会造成聚酰胺酸聚合物析 出。贫溶剂的具体例包括(1)醇类,例如:甲醇、乙醇、异丙醇、环己醇、乙二醇、丙二醇、1,4-丁二醇或三乙二醇等醇类;(2)酮类,例如:丙酮、甲基乙基酮、甲基异丁基酮、环己酮等酮类;(3)酯类,例如:醋酸甲酯、醋酸乙酯、醋酸丁酯、草酸二乙酯、丙二酸二乙酯或 乙二醇乙基醚醋酸酯等酯类;(4)醚类,例如:二乙基醚、乙二醇甲基醚、乙二醇乙基醚、 乙二醇正丙基醚、乙二醇异丙基醚、乙二醇正丁基醚、乙二醇二甲基醚或二乙二醇二甲基 醚等醚类;(5)卤化烃类,例如:二氯甲烷、1,2-二氯乙烷、1,4-二氯丁烷、三氯乙烷、氯苯 或邻-二氯苯等卤化烃类;(6)烃类,例如:四氢呋喃、己烷、庚烷、辛烷、苯、甲苯或二甲 苯等烃类或上述贫溶剂的组合。然而,本发明不限于此,贫溶剂可还包括其他合适的溶剂。 基于第一混合物的总使用量为100重量份,贫溶剂的使用量可为0重量份至60重量份,较 佳为0重量份至50重量份。In the polycondensation reaction, the solvent can be used in combination with an appropriate amount of poor solvent, wherein the poor solvent will not cause the precipitation of polyamic acid polymer. Specific examples of the poor solvent include (1) alcohols such as methanol, ethanol, isopropanol, cyclohexanol, ethylene glycol, propylene glycol, 1,4-butanediol, or triethylene glycol; (2) ) ketones, such as: acetone, methyl ethyl ketone, methyl isobutyl ketone, cyclohexanone and other ketones; (3) esters, such as: methyl acetate, ethyl acetate, butyl acetate, oxalic acid Esters such as ethyl ester, diethyl malonate or ethylene glycol ethyl ether acetate; (4) ethers, such as: diethyl ether, ethylene glycol methyl ether, ethylene glycol ethyl ether, ethylene glycol Ethers such as glycol n-propyl ether, ethylene glycol isopropyl ether, ethylene glycol n-butyl ether, ethylene glycol dimethyl ether or diethylene glycol dimethyl ether; (5) Halogenated hydrocarbons, such as: Halogenated hydrocarbons such as dichloromethane, 1,2-dichloroethane, 1,4-dichlorobutane, trichloroethane, chlorobenzene or o-dichlorobenzene; (6) Hydrocarbons, such as tetrahydrofuran, Hydrocarbons such as hexane, heptane, octane, benzene, toluene or xylene, or a combination of the above poor solvents. However, the present invention is not limited thereto, and the lean solvent may further include other suitable solvents. The use amount of the lean solvent may be 0 to 60 parts by weight, preferably 0 to 50 parts by weight, based on 100 parts by weight of the total used amount of the first mixture.
聚酰亚胺聚合物Polyimide polymer
制备聚酰亚胺聚合物的方法为先将第一混合物溶解于溶剂中,其中第一混合物包括四 羧酸二酐化合物(a1)与二胺化合物(b1),并进行聚缩合反应,以形成聚酰胺酸聚合物。接着, 在脱水剂及触媒的存在下,进一步加热,并进行脱水闭环反应,使得聚酰胺酸聚合物中的 酰胺酸官能基经由脱水闭环反应转变成酰亚胺官能基(即酰亚胺化),而得到聚酰亚胺聚合 物。The method for preparing a polyimide polymer is to first dissolve a first mixture in a solvent, wherein the first mixture includes a tetracarboxylic dianhydride compound (a1) and a diamine compound (b1), and perform a polycondensation reaction to form Polyamic acid polymer. Next, in the presence of a dehydrating agent and a catalyst, further heating is performed, and a dehydration ring closure reaction is performed, so that the amic acid functional group in the polyamic acid polymer is converted into an imide functional group (ie, imidization) through the dehydration ring closure reaction. , to obtain a polyimide polymer.
用于聚缩合反应及脱水闭环反应中的溶剂可与下述液晶配向剂中的溶剂相同,故在此 不另赘述。基于聚酰胺酸聚合物的使用量为100重量份,用于脱水闭环反应中的溶剂的使 用量可为200重量份至2000重量份,较佳为300重量份至1800重量份。The solvent used in the polycondensation reaction and the dehydration ring-closure reaction can be the same as the solvent in the following liquid crystal alignment agent, so it will not be repeated here. The amount of the solvent used in the dehydration ring-closure reaction can be 200 to 2000 parts by weight, preferably 300 to 1800 parts by weight, based on 100 parts by weight of the polyamic acid polymer.
为获得较佳的聚酰胺酸聚合物的酰亚胺化程度,脱水闭环反应的操作温度较佳为40℃ 至200℃,更佳为40℃至150℃。若脱水闭环反应的操作温度低于40℃时,酰亚胺化的反 应不完全,而降低聚酰胺酸聚合物的酰亚胺化程度。然而,若脱水闭环反应的操作温度高 于200℃时,所得的聚酰亚胺聚合物的重量平均分子量偏低。In order to obtain a better degree of imidization of the polyamic acid polymer, the operating temperature of the dehydration ring-closure reaction is preferably 40°C to 200°C, more preferably 40°C to 150°C. If the operating temperature of the dehydration ring-closure reaction is lower than 40°C, the imidization reaction is incomplete, and the degree of imidization of the polyamic acid polymer is reduced. However, if the operating temperature of the dehydration ring-closure reaction is higher than 200°C, the weight-average molecular weight of the obtained polyimide polymer is relatively low.
聚合物(A-1)的酰亚胺化率范围通常为30%以下,较佳为20%以下,更佳为10%以下。The range of the imidization rate of the polymer (A-1) is usually 30% or less, preferably 20% or less, and more preferably 10% or less.
用于脱水闭环反应中的脱水剂可选自于酸酐类化合物,其中酸酐类化合物的具体例包 括醋酸酐、丙酸酐、三氟醋酸酐或其组合。基于聚酰胺酸聚合物为1摩尔份,脱水剂的使 用量可为0.01摩尔份至20摩尔份。用于脱水闭环反应中的触媒的具体例包括(1)吡啶类化合 物,例如:吡啶、三甲基吡啶或二甲基吡啶等吡啶类化合物;(2)三级胺类化合物,例如: 三乙基胺等三级胺类化合物;或其上述化合物的组合。基于脱水剂的使用量为1摩尔份, 触媒的使用量可为0.5摩尔份至10摩尔份。The dehydrating agent used in the dehydration ring-closure reaction can be selected from acid anhydride compounds, wherein specific examples of the acid anhydride compounds include acetic anhydride, propionic anhydride, trifluoroacetic anhydride or a combination thereof. The dehydrating agent may be used in an amount of 0.01 to 20 parts by mole based on 1 part by mole of the polyamic acid polymer. Specific examples of catalysts used in the dehydration ring-closure reaction include (1) pyridine-based compounds, such as pyridine-based compounds such as pyridine, collidine, or lutidine; (2) tertiary amine-based compounds, such as: triethyl tertiary amine compounds such as base amine; or a combination of the above compounds. The catalyst may be used in an amount of 0.5 to 10 parts by mole based on 1 part by mole of the dehydrating agent.
聚酰亚胺系嵌段共聚合物Polyimide based block copolymer
聚酰亚胺系嵌段共聚合物包括聚酰胺酸嵌段共聚合物、聚酰亚胺嵌段共聚合物、聚酰 胺酸-聚酰亚胺嵌段共聚合物或上述共聚合物的组合。Polyimide-based block copolymers include polyamic acid block copolymers, polyimide block copolymers, polyamic acid-polyimide block copolymers, or a combination of the above copolymers .
制备聚酰亚胺系嵌段共聚合物的方法较佳为先将起始物溶解于溶剂中,并进行聚缩合 反应,其中起始物包括上述的至少一种聚酰胺酸聚合物和/或上述的至少一种聚酰亚胺聚合 物,且可进一步地包括四羧酸二酐化合物(a1)及二胺化合物(b1)。The method for preparing the polyimide-based block copolymer is preferably to first dissolve the starting material in a solvent and carry out a polycondensation reaction, wherein the starting material includes the above-mentioned at least one polyamic acid polymer and/or The above-mentioned at least one polyimide polymer may further include a tetracarboxylic dianhydride compound (a1) and a diamine compound (b1).
起始物包括上述制备聚酰胺酸聚合物中所使用的四羧酸二酐化合物(a1)与二胺化合物 (b1),且用于聚缩合反应中的溶剂可与下述液晶配向剂中的溶剂相同,在此不另赘述。The starting material includes the tetracarboxylic dianhydride compound (a1) and the diamine compound (b1) used in the above-mentioned preparation of the polyamic acid polymer, and the solvent used in the polycondensation reaction can be used with the following liquid crystal aligning agent. The solvent is the same and will not be repeated here.
基于起始物的使用量为100重量份,用于聚缩合反应中的溶剂的使用量可为200重量 份至2000重量份,较佳为300重量份至1800重量份。聚缩合反应的操作温度较佳为0℃至200℃,更佳为0℃至100℃。The solvent used in the polycondensation reaction may be used in an amount of 200 to 2000 parts by weight, preferably 300 to 1800 parts by weight, based on 100 parts by weight of the starting material. The operating temperature of the polycondensation reaction is preferably 0°C to 200°C, more preferably 0°C to 100°C.
起始物的具体例包括(1)二种末端基相异且结构相异的聚酰胺酸聚合物;(2)二种末端基 相异且结构相异的聚酰亚胺聚合物;(3)末端基相异且结构相异的聚酰胺酸聚合物及聚酰亚 胺聚合物;(4)聚酰胺酸聚合物、四羧酸二酐化合物及二胺化合物,其中四羧酸二酐化合物 及二胺化合物的中的至少一种与形成聚酰胺酸聚合物所使用的四羧酸二酐化合物及二胺化 合物的结构相异;(5)聚酰亚胺聚合物、四羧酸二酐化合物及二胺化合物,其中四羧酸二酐 化合物及二胺化合物中的至少一种与形成聚酰亚胺聚合物所使用的四羧酸二酐化合物及二 胺化合物的结构相异;(6)聚酰胺酸聚合物、聚酰亚胺聚合物、四羧酸二酐化合物及二胺化 合物,其中四羧酸二酐化合物及二胺化合物中的至少一种与形成聚酰胺酸聚合物或聚酰亚 胺聚合物所使用的四羧酸二酐化合物及二胺化合物的结构相异;(7)二种结构相异的聚酰胺 酸聚合物、四羧酸二酐化合物及二胺化合物;(8)二种结构相异的聚酰亚胺聚合物、四羧酸 二酐化合物及二胺化合物;(9)二种末端基为酸酐基且结构相异的聚酰胺酸聚合物以及二胺 化合物;(10)二种末端基为氨基且结构相异的聚酰胺酸聚合物以及四羧酸二酐化合物;(11) 二种末端基为酸酐基且结构相异的聚酰亚胺聚合物以及二胺化合物;或(12)二种末端基为氨 基且结构相异的聚酰亚胺聚合物以及四羧酸二酐化合物。Specific examples of the starting materials include (1) two kinds of polyamic acid polymers with different end groups and different structures; (2) two kinds of polyimide polymers with different end groups and different structures; (3) ) Polyamic acid polymers and polyimide polymers with different terminal groups and different structures; (4) Polyamic acid polymers, tetracarboxylic dianhydride compounds and diamine compounds, among which tetracarboxylic dianhydride compounds and at least one of the diamine compounds are different in structure from the tetracarboxylic dianhydride compound and the diamine compound used to form the polyamic acid polymer; (5) polyimide polymer, tetracarboxylic dianhydride A compound and a diamine compound, wherein at least one of the tetracarboxylic dianhydride compound and the diamine compound has a different structure from the tetracarboxylic dianhydride compound and the diamine compound used to form the polyimide polymer; (6 ) polyamic acid polymer, polyimide polymer, tetracarboxylic dianhydride compound and diamine compound, wherein at least one of the tetracarboxylic dianhydride compound and the diamine compound forms a polyamic acid polymer or polyamide The tetracarboxylic dianhydride compounds and diamine compounds used in the imide polymer have different structures; (7) two kinds of polyamic acid polymers, tetracarboxylic dianhydride compounds and diamine compounds with different structures; ( 8) Two kinds of polyimide polymers, tetracarboxylic dianhydride compounds and diamine compounds with different structures; (9) Two kinds of polyamic acid polymers and diamine compounds with different end groups as acid anhydride groups and different structures (10) Two kinds of polyamic acid polymers and tetracarboxylic dianhydride compounds whose end groups are amino groups and different structures; (11) Two kinds of polyimide polymers whose end groups are acid anhydride groups and different structures and A diamine compound; or (12) two types of polyimide polymers having amino groups at their end groups and different structures, and a tetracarboxylic dianhydride compound.
在不影响本发明的功效范围内,聚酰胺酸聚合物、聚酰亚胺聚合物以及聚酰亚胺系嵌 段共聚合物较佳可以是先进行分子量调节后的末端修饰型聚合物。通过使用末端修饰型的 聚合物,可改善液晶配向剂的涂布性能。制备末端修饰型聚合物的方式可通过在聚酰胺酸 聚合物进行聚缩合反应的同时,加入单官能性化合物来制得。单官能性化合物的具体例包 括(1)一元酸酐,例如:马来酸酐、邻苯二甲酸酐、衣康酸酐、正癸基琥珀酸酐、正十二烷 基琥珀酸酐、正十四烷基琥珀酸酐或正十六烷基琥珀酸酐等一元酸酐;(2)单胺化合物,例 如:苯胺、环己胺、正丁胺、正戊胺、正己胺、正庚胺、正辛胺、正壬胺、正癸胺、正十 一烷胺、正十二烷胺、正十三烷胺、正十四烷胺、正十五烷胺、正十六烷胺、正十七烷胺、 正十八烷胺或正二十烷胺等单胺化合物;(3)单异氰酸酯化合物,例如:异氰酸苯酯或异氰 酸萘基酯等单异氰酸酯化合物;或上述单官能性化合物的组合。然而,本发明不限于此, 单官能性化合物可还包括其他合适的单官能性化合物。The polyamic acid polymer, the polyimide polymer, and the polyimide-based block copolymer may preferably be terminal-modified polymers whose molecular weight is first adjusted within the scope of not affecting the efficacy of the present invention. By using terminal-modified polymers, the coating properties of the liquid crystal aligning agent can be improved. The method for preparing the terminal-modified polymer can be prepared by adding a monofunctional compound at the same time as the polycondensation reaction of the polyamic acid polymer. Specific examples of the monofunctional compound include (1) monobasic acid anhydrides such as maleic anhydride, phthalic anhydride, itaconic anhydride, n-decylsuccinic anhydride, n-dodecylsuccinic anhydride, n-tetradecylsuccinic anhydride Monobasic acid anhydrides such as acid anhydride or n-hexadecyl succinic anhydride; (2) Monoamine compounds, such as: aniline, cyclohexylamine, n-butylamine, n-pentylamine, n-hexylamine, n-heptylamine, n-octylamine, n-nonylamine , n-decylamine, n-undecylamine, n-dodecylamine, n-tridecylamine, n-tetradecylamine, n-pentadecylamine, n-hexadecylamine, n-heptadecylamine, n-octadecylamine Monoamine compounds such as alkylamine or n-eicosylamine; (3) monoisocyanate compounds, for example: monoisocyanate compounds such as phenyl isocyanate or naphthyl isocyanate; or a combination of the above-mentioned monofunctional compounds. However, the present invention is not limited thereto, and the monofunctional compound may further include other suitable monofunctional compounds.
在液晶配向剂中,基于聚合物(A-1)与后述聚合物(A-2)的总使用量为100重量份,聚合 物(A-1)的使用量可为30重量份至95重量份,较佳为40重量份至90重量份,更佳为50重 量份至90重量份。当液晶配向剂中的聚合物(A-1)的使用量落在上述范围内时,可使液晶配 向剂所形成的液晶配向膜及液晶显示元件具有较佳的电场记忆效应。In the liquid crystal aligning agent, based on the total usage amount of the polymer (A-1) and the polymer (A-2) described later being 100 parts by weight, the usage amount of the polymer (A-1) may be 30 parts by weight to 95 parts by weight The weight part is preferably 40 to 90 parts by weight, more preferably 50 to 90 parts by weight. When the amount of the polymer (A-1) in the liquid crystal alignment agent falls within the above range, the liquid crystal alignment film and the liquid crystal display element formed by the liquid crystal alignment agent can have a better electric field memory effect.
聚合物(A-2)Polymer (A-2)
液晶配向剂亦可还包括除了聚合物(A-1)以外的聚合物(A-2)。聚合物(A-2)是由包含四羧 酸二酐化合物(a2)及二胺化合物(b2)的第二混合物进行反应而制得。The liquid crystal aligning agent may further include a polymer (A-2) other than the polymer (A-1). The polymer (A-2) is obtained by reacting the second mixture containing the tetracarboxylic dianhydride compound (a2) and the diamine compound (b2).
四羧酸二酐化合物(a2)没有特别的限制,可以是与上述聚合物(A-1)中的四羧酸二酐化合 物(a1)相同或不同的化合物。The tetracarboxylic dianhydride compound (a2) is not particularly limited, and may be the same or different compound as the tetracarboxylic dianhydride compound (a1) in the above-mentioned polymer (A-1).
二胺化合物(b2)没有特别的限制,可以是与上述聚合物(A-1)中的二胺化合物(b1-2)、二 胺化合物(b1-3)或二胺化合物(b1-4)相同或不同的化合物。The diamine compound (b2) is not particularly limited, and may be the same as the diamine compound (b1-2), the diamine compound (b1-3) or the diamine compound (b1-4) in the above-mentioned polymer (A-1). the same or different compounds.
制备聚合物(A-2)的方法没有特别的限制,例如可与制备聚合物(A-1)的方法相同,故在 此不另行赘述。The method for preparing the polymer (A-2) is not particularly limited, for example, it can be the same as the method for preparing the polymer (A-1), so it will not be repeated here.
在液晶配向剂中,基于聚合物(A-1)与聚合物(A-2)的总使用量为100重量份,聚合物(A-1) 的使用量可为5重量份至70重量份,较佳为10重量份至60重量份,更佳为10重量份至 50重量份。In the liquid crystal alignment agent, based on the total usage amount of polymer (A-1) and polymer (A-2) being 100 parts by weight, the usage amount of polymer (A-1) may be 5 parts by weight to 70 parts by weight , preferably 10 to 60 parts by weight, more preferably 10 to 50 parts by weight.
溶剂(B)Solvent (B)
溶剂(B)的具体例包括N-甲基-2-吡咯烷酮、γ-丁内酯、γ-丁内酰胺、4-羟基-4-甲基-2-戊 酮、乙二醇单甲基醚、乳酸丁酯、乙酸丁酯、甲氧基丙酸甲酯、乙氧基丙酸乙酯、乙二醇 甲基醚、乙二醇乙基醚、乙二醇正丙基醚、乙二醇异丙基醚、乙二醇正丁基醚(Ethylene glycol n-butyl ether)、乙二醇二甲基醚、乙二醇乙基醚乙酸酯、二甘醇二甲基醚、二甘醇二乙基醚、 二甘醇单甲基醚、二甘醇单乙基醚、二甘醇单甲基醚乙酸酯、乙二醇正丁基醚二甘醇单乙 基醚乙酸酯、N,N-二甲基甲酰胺、N,N-二甲基乙酰胺(N,N-dimethyl acetamide),或上述溶 剂的任意组合。溶剂(B)较佳为N-甲基-2-吡咯烷酮、乙二醇正丁基醚、N,N-二甲基乙酰胺, 或上述溶剂的组合。然而,本发明不限于此,溶剂(B)可还包括其他合适的溶剂。溶剂(B) 可以单独使用一种或者组合多种来使用。Specific examples of the solvent (B) include N-methyl-2-pyrrolidone, γ-butyrolactone, γ-butyrolactam, 4-hydroxy-4-methyl-2-pentanone, ethylene glycol monomethyl ether , butyl lactate, butyl acetate, methyl methoxypropionate, ethyl ethoxypropionate, ethylene glycol methyl ether, ethylene glycol ethyl ether, ethylene glycol n-propyl ether, ethylene glycol isopropyl ether Propyl ether, Ethylene glycol n-butyl ether, Ethylene glycol dimethyl ether, Ethylene glycol ethyl ether acetate, Diethylene glycol dimethyl ether, Diethylene glycol diethyl ether base ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monomethyl ether acetate, ethylene glycol n-butyl ether diethylene glycol monoethyl ether acetate, N,N - Dimethylformamide, N,N-dimethylacetamide, or any combination of the above solvents. The solvent (B) is preferably N-methyl-2-pyrrolidone, ethylene glycol n-butyl ether, N,N-dimethylacetamide, or a combination of the above solvents. However, the present invention is not limited thereto, and the solvent (B) may further include other suitable solvents. The solvent (B) may be used alone or in combination.
当液晶配向剂包括聚合物(A-1)以及溶剂(B)时,基于聚合物(A-1)的使用量为100重量份, 溶剂(B)的使用量可为1000重量份至3500重量份,较佳为1000重量份至3200重量份,更 佳为1000重量份至3000重量份。When the liquid crystal alignment agent includes the polymer (A-1) and the solvent (B), based on the polymer (A-1) used in an amount of 100 parts by weight, the solvent (B) can be used in an amount of 1000 to 3500 parts by weight parts, preferably 1000 to 3200 parts by weight, more preferably 1000 to 3000 parts by weight.
当液晶配向剂包括聚合物(A-1)、聚合物(A-2)以及溶剂(B)时,基于聚合物(A-1)与聚合 物(A-2)的总使用量为100重量份,溶剂(B)的使用量可为1000重量份至3500重量份,较佳 为1000重量份至3200重量份,更佳为1000重量份至3000重量份。When the liquid crystal alignment agent includes the polymer (A-1), the polymer (A-2) and the solvent (B), the total usage amount based on the polymer (A-1) and the polymer (A-2) is 100 weight The solvent (B) can be used in an amount of 1000 to 3500 parts by weight, preferably 1000 to 3200 parts by weight, more preferably 1000 to 3000 parts by weight.
添加剂(C)Additives (C)
在不影响本发明的功效范围内,液晶配向剂还可选择性地添加添加剂(C)。添加剂(C) 可为环氧化合物、具有官能性基团的硅烷化合物或其组合。添加剂(C)的作用是用来提高液 晶配向膜与基板表面的附着性。添加剂(C)可以单独使用一种或者组合多种来使用。Within the scope of not affecting the efficacy of the present invention, the liquid crystal alignment agent can also optionally add additives (C). The additive (C) may be an epoxy compound, a silane compound having a functional group, or a combination thereof. The role of the additive (C) is to improve the adhesion of the liquid crystal alignment film to the surface of the substrate. The additive (C) may be used alone or in combination of two or more.
环氧化合物的具体例包括乙二醇二环氧丙基醚、聚乙二醇二环氧丙基醚、丙二醇二环 氧丙基醚、三丙二醇二环氧丙基醚、聚丙二醇二环氧丙基醚、新戊二醇二环氧丙基醚、1,6- 己二醇二环氧丙基醚、丙三醇二环氧丙基醚、2,2-二溴新戊二醇二环氧丙基醚、1,3,5,6-四环 氧丙基-2,4-己二醇、N,N,N’,N’-四环氧丙基-间-二甲苯二胺、1,3-双(N,N-二环氧丙基氨基甲 基)环己烷、N,N,N’,N’-四环氧丙基-4,4’-二氨基二苯基甲烷、N,N-二环氧丙基-对-环氧丙氧基 苯胺、3-(N-烯丙基-N-环氧丙基)氨基丙基三甲氧基硅烷或3-(N,N-二环氧丙基)氨基丙基三甲 氧基硅烷或其组合。然而,本发明不限于此,环氧化合物可还包括其他合适的环氧化合物。Specific examples of the epoxy compound include ethylene glycol diglycidyl ether, polyethylene glycol diglycidyl ether, propylene glycol diglycidyl ether, tripropylene glycol diglycidyl ether, polypropylene glycol diepoxy propyl ether, neopentyl glycol diglycidyl ether, 1,6-hexanediol diglycidyl ether, glycerol diglycidyl ether, 2,2-dibromoneopentyl glycol diglycidyl ether glycidyl ether, 1,3,5,6-tetraglycidyl-2,4-hexanediol, N,N,N',N'-tetraglycidyl-m-xylenediamine , 1,3-bis(N,N-diglycidylaminomethyl)cyclohexane, N,N,N',N'-tetraglycidyl-4,4'-diaminodiphenyl Methane, N,N-diglycidyl-p-glycidoxyaniline, 3-(N-allyl-N-glycidyl)aminopropyltrimethoxysilane or 3-(N, N-diglycidyl)aminopropyltrimethoxysilane or a combination thereof. However, the present invention is not limited thereto, and the epoxy compound may further include other suitable epoxy compounds.
基于聚合物(A-1)的使用量为100重量份,环氧化合物的使用量一般为40重量份以下, 较佳为0.1重量份至30重量份。The use amount of the epoxy compound is generally 40 parts by weight or less, preferably 0.1 parts by weight to 30 parts by weight, based on 100 parts by weight of the polymer (A-1).
具有官能性基团的硅烷化合物的具体例包括3-氨基丙基三甲氧基硅烷、3-氨基丙基三乙 氧基硅烷、2-氨基丙基三甲氧基硅烷、2-氨基丙基三乙氧基硅烷、N-(2-氨基乙基)-3-氨基丙 基三甲氧基硅烷、N-(2-氨基乙基)-3-氨基丙基甲基二甲氧基硅烷、3-脲基丙基三甲氧基硅烷 (3-ureidopropyltrimethoxysilane)、3-脲基丙基三乙氧基硅烷、N-乙氧基羰基-3-氨基丙基三 甲氧基硅烷、N-乙氧基羰基-3-氨基丙基三乙氧基硅烷、N-三乙氧基硅烷基丙基三亚乙三胺、 N-三甲氧基硅烷基丙基三亚乙三胺、10-三甲氧基硅烷基-1,4,7-三吖癸烷、10-三乙氧基硅烷 基-1,4,7-三吖癸烷、9-三甲氧基硅烷基-3,6-二吖壬基醋酸酯、9-三乙氧基硅烷基-3,6-二吖壬 基醋酸酯、N-苯甲基-3-氨基丙基三甲氧基硅烷、N-苯甲基-3-氨基丙基三乙氧基硅烷、N-苯 基-3-氨基丙基三甲氧基硅烷、N-苯基-3-氨基丙基三乙氧基硅烷、N-双(氧化乙烯)-3-氨基丙 基三甲氧基硅烷、N-双(氧化乙烯)-3-氨基丙基三乙氧基硅烷或其组合。然而,本发明不限于 此,具有官能性基团的硅烷化合物可还包括其他合适的具有官能性基团的硅烷化合物。Specific examples of the silane compound having a functional group include 3-aminopropyltrimethoxysilane, 3-aminopropyltriethoxysilane, 2-aminopropyltrimethoxysilane, 2-aminopropyltriethyl Oxysilane, N-(2-aminoethyl)-3-aminopropyltrimethoxysilane, N-(2-aminoethyl)-3-aminopropylmethyldimethoxysilane, 3-urea 3-ureidopropyltrimethoxysilane, 3-ureidopropyltriethoxysilane, N-ethoxycarbonyl-3-aminopropyltrimethoxysilane, N-ethoxycarbonyl-3 -Aminopropyltriethoxysilane, N-triethoxysilylpropyltriethylenetriamine, N-trimethoxysilylpropyltriethylenetriamine, 10-trimethoxysilyl-1,4 ,7-triazadecane, 10-triethoxysilyl-1,4,7-triazdecane, 9-trimethoxysilyl-3,6-diaznonyl acetate, 9-triazide Ethoxysilyl-3,6-diaznonyl acetate, N-benzyl-3-aminopropyltrimethoxysilane, N-benzyl-3-aminopropyltriethoxysilane, N-phenyl-3-aminopropyltrimethoxysilane, N-phenyl-3-aminopropyltriethoxysilane, N-bis(ethylene oxide)-3-aminopropyltrimethoxysilane, N- -Bis(ethylene oxide)-3-aminopropyltriethoxysilane or a combination thereof. However, the present invention is not limited thereto, and the silane compound having a functional group may further include other suitable silane compounds having a functional group.
基于聚合物(A-1)的使用量为100重量份,硅烷化合物的使用量一般为10重量份以下, 较佳为0.5重量份至10重量份。The used amount of the silane compound is generally 10 parts by weight or less, preferably 0.5 to 10 parts by weight, based on 100 parts by weight of the polymer (A-1).
<液晶配向剂的制备方法><Preparation method of liquid crystal alignment agent>
本发明的液晶配向剂的制备方法并无特别的限制,其可采用一般的混合方法来制备。 例如:将聚合物(A-1)或者聚合物(A-1)与聚合物(A-2)的混合物于温度为0℃至200℃的条件 下加入溶剂(B),并可选择性地添加添加剂(C);再以搅拌装置持续搅拌至溶解即可。将聚合 物加入溶剂(B)中的温度较佳为20℃至60℃。The preparation method of the liquid crystal alignment agent of the present invention is not particularly limited, and it can be prepared by a general mixing method. For example: the polymer (A-1) or the mixture of the polymer (A-1) and the polymer (A-2) is added to the solvent (B) at a temperature of 0°C to 200°C, and optionally Add the additive (C); then continue stirring with a stirring device until dissolved. The temperature at which the polymer is added to the solvent (B) is preferably 20°C to 60°C.
于25℃时,本发明的液晶配向剂的粘度通常为15cps至35cps,较佳为17cps至33cps, 更佳为20cps至30cps。At 25° C., the viscosity of the liquid crystal alignment agent of the present invention is usually 15cps to 35cps, preferably 17cps to 33cps, more preferably 20cps to 30cps.
<液晶配向膜的制备方法><Preparation method of liquid crystal alignment film>
本发明的液晶配向剂,可以通过光配向法形成液晶配向膜。The liquid crystal alignment agent of the present invention can form a liquid crystal alignment film by a photo-alignment method.
形成液晶配向膜的方法例如是将液晶配向剂涂附在基板上形成涂膜,并从相对于涂膜 面倾斜的方向上对所述涂膜照射偏振或非偏振的紫外线;或者从相对于涂膜面垂直的方向 上对所述涂膜照射偏振紫外线,藉此对涂膜赋予液晶配向能的方法。The method of forming a liquid crystal alignment film is, for example, applying a liquid crystal alignment agent to a substrate to form a coating film, and irradiating the coating film with polarized or unpolarized ultraviolet rays from a direction inclined relative to the surface of the coating film; or A method of imparting liquid crystal alignment energy to the coating film by irradiating the coating film with polarized ultraviolet rays in a direction perpendicular to the film surface.
首先,通过例如辊涂法、旋涂法、印刷法或喷墨法(ink-jet)等适当的涂布方法,将本 发明的液晶配向剂涂布在设置了图案状透明导电膜的基板的透明导电膜一侧。涂布后,对 所述涂布面进行预烤处理(pre-bake treatment),接着进行后烤处理(post-baketreatment), 藉此形成涂膜。上述的预烤处理目的在于使预涂层中的有机溶剂挥发。预烤处理的条件例 如为在40℃至120℃的温度下进行0.1至5分钟。后烤处理的温度可为120℃至300℃,较 佳为150℃至250℃。后烤处理的时间可为5至200分钟,更佳为10至100分钟。后烤后 的涂膜膜厚较佳为0.001μm至1μm,更佳为0.005μm至0.5μm。First, the liquid crystal aligning agent of the present invention is coated on the substrate provided with the patterned transparent conductive film by an appropriate coating method such as roll coating, spin coating, printing, or ink-jet. Transparent conductive film side. After coating, the coated surface is subjected to a pre-bake treatment, followed by a post-bake treatment, thereby forming a coating film. The purpose of the above-mentioned pre-baking treatment is to volatilize the organic solvent in the pre-coating layer. The conditions for the prebaking treatment are, for example, 0.1 to 5 minutes at a temperature of 40°C to 120°C. The temperature of the post-baking treatment may be 120°C to 300°C, preferably 150°C to 250°C. The post-baking treatment time may be 5 to 200 minutes, more preferably 10 to 100 minutes. The film thickness of the coating film after post-baking is preferably 0.001 µm to 1 µm, more preferably 0.005 µm to 0.5 µm.
基板可以使用例如由浮法玻璃(float glass)、钠钙玻璃等玻璃;聚对苯二甲酸乙二醇酯、 聚对苯二甲酸丁二醇酯、聚醚砜或聚碳酸酯等塑胶等所形成的透明基板等。The substrate can be made of glass such as float glass, soda lime glass, etc.; plastics such as polyethylene terephthalate, polybutylene terephthalate, polyethersulfone, or polycarbonate. formed transparent substrates, etc.
透明导电膜可以使用由SnO2所形成的奈塞(NESA)膜或由In2O3-SnO2所形成的氧化铟锡(Indium Tin Oxide,ITO)膜等。为了形成这些透明导电膜图案可以采用光蚀刻技术(photo-etching)、在形成透明导电膜时使用光罩(mask)的方法等。As the transparent conductive film, a NESA (NESA) film formed of SnO 2 , an indium tin oxide (ITO) film formed of In 2 O 3 -SnO 2 , or the like can be used. In order to form these transparent conductive film patterns, a photo-etching technique, a method of using a mask when forming the transparent conductive film, or the like can be used.
在涂布液晶配向剂时,为了使基板或透明导电膜与涂膜的密着性更加良好,可以在基 板和透明导电膜上预先涂布官能性硅烷化合物、钛酸酯化合物(titanate)等。When coating the liquid crystal aligning agent, in order to improve the adhesion between the substrate or the transparent conductive film and the coating film, functional silane compounds, titanate compounds, etc. may be pre-coated on the substrate and the transparent conductive film.
接着,通过对涂膜照射偏振或非偏振的紫外线而赋予液晶配向能力,而由前述涂膜形 成液晶配向膜。此处,放射线可以使用例如包括150至800nm波长光的紫外线和可见光, 并较佳包括300至400nm波长光的紫外线。在所用的放射线为偏振光(直线偏振光或部分偏 振光)时,可以从相对于涂膜面垂直的方向上进行照射,而为了赋予预倾角,也可以从倾斜 方向进行照射。另一方面,在照射非偏振的放射线时,必须从相对于涂膜面倾斜的方向上 进行照射。Next, a liquid crystal alignment film is formed from the coating film by irradiating the coating film with polarized or unpolarized ultraviolet rays to impart alignment capability to the liquid crystal. Here, as the radiation, for example, ultraviolet rays and visible light including light having a wavelength of 150 to 800 nm, and preferably ultraviolet rays including light having a wavelength of 300 to 400 nm can be used. When the radiation used is polarized light (linearly polarized light or partially polarized light), it may be irradiated from a direction perpendicular to the coating film surface, or may be irradiated from an oblique direction in order to impart a pretilt angle. On the other hand, when irradiating non-polarized radiation, it is necessary to irradiate from a direction inclined with respect to the surface of the coating film.
照射放射线的光源可以使用例如低压水银灯、高压水银灯、氘灯、金属卤化物灯、氩 气共振灯、氙灯或准分子雷射器等。前述较佳波长区域的紫外线,可以通过将前述光源与 例如滤光片、衍射光栅等并用的方法等而得到。As a light source for irradiating radiation, for example, a low-pressure mercury lamp, a high-pressure mercury lamp, a deuterium lamp, a metal halide lamp, an argon resonance lamp, a xenon lamp, or an excimer laser can be used. The ultraviolet rays in the above-mentioned preferable wavelength region can be obtained by a method of using the above-mentioned light source in combination with, for example, a filter, a diffraction grating, or the like.
放射线的照射量较佳为1J/m2以上且小于10000J/m2,更佳为10J/m2至3000J/m2。另外,在通过光配向法对由以往已知的液晶配向剂所形成的涂膜赋予液晶配向能力时,需要10000J/m2以上的放射线照射量。然而,如果使用本发明的液晶配向剂,则即使光配向法时的放射线照射量为3000J/m2以下,进一步为1000J/m2以下,再进一步为300J/m2以下,也 可以赋予良好的液晶配向能力,从而有助于降低液晶显示元件的制造成本。The irradiation dose of radiation is preferably 1 J/m 2 or more and less than 10000 J/m 2 , more preferably 10 J/m 2 to 3000 J/m 2 . In addition, in order to impart liquid crystal alignment ability to a coating film formed of a conventionally known liquid crystal aligning agent by a photo-alignment method, a radiation exposure amount of 10000 J/m 2 or more is required. However, when the liquid crystal aligning agent of the present invention is used, even if the radiation exposure amount in the photo-alignment method is 3000 J/m 2 or less, further 1000 J/m 2 or less, and further 300 J/m 2 or less, a good Liquid crystal alignment ability, thereby helping to reduce the manufacturing cost of liquid crystal display elements.
<液晶显示元件的制造方法><Manufacturing method of liquid crystal display element>
本发明的液晶显示元件包括由上述液晶配向剂所形成的液晶配向膜。本发明的液晶显 示元件可以如下述方法制造。The liquid crystal display element of the present invention includes a liquid crystal alignment film formed of the above-mentioned liquid crystal alignment agent. The liquid crystal display element of the present invention can be produced as follows.
准备两块如上所述形成了液晶配向膜的基板,并在这两块基板间配置液晶,制造液晶 胞。为了制造液晶胞(cell),可以列举例如以下两种方法。Two substrates on which the liquid crystal alignment films were formed as described above were prepared, and liquid crystal was arranged between the two substrates to manufacture a liquid crystal cell. In order to manufacture a liquid crystal cell (cell), the following two methods are mentioned, for example.
第一种方法:首先,将两块基板隔着间隙(胞间隙)相对配置,使各自的液晶配向膜相对向;使用密封剂将两块基板的周边部位贴合在一起;向由基板表面和密封剂所划分的胞间隙内注入填充液晶;并且封闭注入孔,如此可以制造液晶胞。The first method: first, arrange the two substrates with a gap (cell gap) facing each other, so that the respective liquid crystal alignment films face each other; use a sealant to attach the peripheral parts of the two substrates together; The liquid crystal is injected into the interstitial space divided by the sealant; and the injection hole is closed, so that the liquid crystal cell can be manufactured.
第二种方法:被称作为滴注(One Drop Fill,ODF)方式的方法。首先,在形成液晶配 向膜的两块基板中的一块基板上的规定部位,涂布例如紫外线固化性密封材料;在液晶配 向膜面上滴下液晶;然后,贴合另一块基板,使液晶配向膜相对向;接着,对基板整面照射紫外线,使密封剂固化,藉此可以制造液晶胞。The second method: a method called the One Drop Fill (ODF) method. First, apply, for example, a UV-curable sealing material to a predetermined position on one of the two substrates forming the liquid crystal alignment film; drop liquid crystal on the surface of the liquid crystal alignment film; then, attach the other substrate to make the liquid crystal alignment film Opposite to each other; then, the entire surface of the substrate is irradiated with ultraviolet rays to cure the sealant, whereby a liquid crystal cell can be produced.
在采用上述任一方法的情况下,都希望接着将液晶胞加热至所用液晶呈各向同性相的 温度后,缓慢冷却至室温,藉此除去填充液晶时的流动配向。In the case of using any of the above methods, it is desirable to subsequently heat the liquid crystal cell to a temperature at which the liquid crystal to be used exhibits an isotropic phase, and then slowly cool to room temperature, thereby removing the flow alignment when the liquid crystal is filled.
然后,通过在液晶胞的外侧表面上贴合偏振片,由此可以得到本发明的液晶显示元件。 此处,当液晶配向膜为水平配向性时,通过调整形成了液晶配向膜的两片基板中照射的直 线偏振光放射线的偏振方向所成角度以及各个基板与偏振板的角度,可以得到具有TN型或 STN型液晶胞的液晶显示元件。另一方面,当液晶配向膜为垂直配向性时,通过构成液晶 胞,使形成了液晶配向膜的两片基板的配向容易轴(easy-to-align axis)的方向平行,并将 偏振板与该液晶胞粘合在一起,使其偏振方向与配向容易轴成45°角,可以形成具有垂直配 向型液晶胞的液晶显示元件。Then, the liquid crystal display element of this invention can be obtained by bonding a polarizing plate to the outer surface of a liquid crystal cell. Here, when the liquid crystal alignment film is horizontally aligned, by adjusting the angle formed by the polarization directions of the linearly polarized radiation irradiated on the two substrates on which the liquid crystal alignment film is formed, and the angle between each substrate and the polarizing plate, a TN can be obtained. type or STN type liquid crystal display element. On the other hand, when the liquid crystal alignment film is vertically aligned, the liquid crystal cells are formed so that the directions of the easy-to-align axes of the two substrates on which the liquid crystal alignment film is formed are parallel, and the polarizing plate is aligned with the The liquid crystal cells are bonded together so that the polarization direction is at an angle of 45° with the alignment easy axis, and a liquid crystal display element having a vertical alignment type liquid crystal cell can be formed.
密封剂的具体例包括含有作为间隔物的氧化铝球或固化剂的环氧树脂等。Specific examples of the sealant include an epoxy resin containing alumina balls as spacers or a curing agent, and the like.
液晶的具体例包括向列型液晶或碟状型液晶等。Specific examples of liquid crystals include nematic liquid crystals, discotic liquid crystals, and the like.
在TN型或STN型液晶胞情况下,具有正介电异方向性的向列型液晶的具体例较佳为 包括联苯类液晶(biphenyl-based liquid crystals)、苯基环己烷类液晶(phenylcyclohexane-based liquid crystal)、酯类液晶、三联苯类液晶(terphenyl liquidcrystal)、联苯 基环己烷类液晶(biphenyl cyclohexane-based liquid crystals)、嘧啶类液晶(pyrimidine-based liquid crystals)、二恶烷类液晶(dioxane-based liquidcrystals)、双环辛烷类液晶 (bicyclooctane-based liquid crystals)、立方烷类液晶(cubane-based liquid crystals)等。此外, 在前述液晶中还可以进一步添加例如氯化胆甾醇(cholesteryl chloride)、胆甾醇壬酸酯 (cholesteryl nonabenzoate)、胆甾醇碳酸酯(cholesteryl carbonate)等胆甾型液晶(cholesteric liquid crystal);以商品名“C-15”、“CB-15”(默克公司制造)进行销售的手性剂;对癸氧基 苯亚甲基-对氨基-2-甲基丁基肉桂酸酯(p-decyloxybenzylidene-p-amino-2-methyl butyl cinnamate)等强介电性液晶(ferroelectric liquid crystal)等添加剂进行使用。In the case of TN-type or STN-type liquid crystal cells, specific examples of nematic liquid crystals with positive dielectric anisotropy preferably include biphenyl-based liquid crystals, phenylcyclohexane-based liquid crystals ( phenylcyclohexane-based liquid crystal), ester liquid crystal, terphenyl liquid crystal, biphenyl cyclohexane-based liquid crystal, pyrimidine-based liquid crystals, dioxin Dioxane-based liquid crystals, bicyclooctane-based liquid crystals, cubane-based liquid crystals, etc. In addition, cholesteric liquid crystals such as cholesteryl chloride, cholesteryl nonabenzoate, and cholesteryl carbonate may be further added to the aforementioned liquid crystals; Chiral agents sold under the trade names "C-15" and "CB-15" (manufactured by Merck); p-decyloxybenzylidene-p-amino-2-methylbutyl cinnamate (p- decyloxybenzylidene-p-amino-2-methyl butyl cinnamate) and other additives such as ferroelectric liquid crystal are used.
另一方面,在垂直配向型液晶胞情况下,具有负介电异方向性的向列型液晶的具体例 较佳为包括二氰基苯类液晶(dicyanobenzene-based liquid crystal)、哒嗪类液晶(pyridazine-based liquid crystals)、希夫碱类液晶(Schiff base-based liquidcrystal)、氧化偶 氮类液晶(azoxy-based liquid crystals)、联苯类液晶(biphenyl-based liquid crystals)、苯基环 己烷类液晶(phenyl cyclohexane-based liquidcrystals)或其组合。On the other hand, in the case of vertically aligned liquid crystal cells, specific examples of nematic liquid crystals with negative dielectric anisotropy preferably include dicyanobenzene-based liquid crystals, pyridazine liquid crystals (pyridazine-based liquid crystals), Schiff base-based liquid crystal, azoxy-based liquid crystals, biphenyl-based liquid crystals, phenylcyclohexane Phenyl cyclohexane-based liquidcrystals or combinations thereof.
液晶胞外侧使用的偏振板可以列举用乙酸纤维素(cellulose acetate)保护膜夹住使聚乙 烯醇(polyvinyl alcohol)拉亚配向的同时吸收碘所得的称作为“H膜”的偏振膜而形成的偏振 板或者H膜自身所形成的偏振板。The polarizing plate used on the outside of the liquid crystal cell includes a polarizing film called "H film" obtained by sandwiching a cellulose acetate protective film and absorbing iodine while aligning polyvinyl alcohol in Raya. The polarizing plate or the polarizing plate formed by the H film itself.
如此制造的本发明的液晶显示元件,其显示性能优良,并且即使长时间使用,显示性 能也不会变差。The thus-produced liquid crystal display element of the present invention is excellent in display performance and does not deteriorate in display performance even when used for a long time.
图1是根据本发明一实施例的液晶显示元件的侧视图。液晶显示元件100包括第一单 元110、第二单元120及液晶单元130,其中第二单元120与第一单元110分离配置,且液晶单元130设置在第一单元110与第二单元120之间。FIG. 1 is a side view of a liquid crystal display element according to an embodiment of the present invention. The liquid
第一单元110包括第一基板112、第一导电膜114及第一液晶配向膜116,其中第一导 电膜114位于第一基板112与第一液晶配向膜116之间。另外,第一单元110中的第一液晶配向膜116位于第一单元110的靠近液晶单元130的一侧。The first unit 110 includes a
第二单元120包括第二基板122、第二导电膜124及第二液晶配向膜126,其中第二导 电膜124位于第二基板122与第二液晶配向膜126之间。另外,第二单元120中的第二液晶配向膜126位于第二液晶配向膜126的靠近液晶单元130的一侧。换言之,液晶单元130 位于第一液晶配向膜116与第二液晶配向膜126之间。The second unit 120 includes a
第一基板112与第二基板122是选自于透明材料等材料,其中透明材料包括用于液晶 显示装置的无碱玻璃、钠钙玻璃、硬质玻璃(派勒斯玻璃)、石英玻璃、聚乙烯对苯二甲酸酯、聚丁烯对苯二甲酸酯、聚醚砜或聚碳酸酯等。然而,本发明不以此为限,第一基板112 与第二基板122的材料也可选自其他合适的材料。The
第一导电膜114与第二导电膜124的材质是选自于氧化锡(SnO2)或氧化铟-氧化锡(In2O3-SnO2)等材质。然而,本发明不以此为限,第一导电膜114与第二导电膜124的材 质也可选自其他合适的材质。The materials of the first conductive film 114 and the second conductive film 124 are selected from materials such as tin oxide (SnO 2 ) or indium oxide-tin oxide (In 2 O 3 -SnO 2 ). However, the present invention is not limited to this, and the materials of the first conductive film 114 and the second conductive film 124 can also be selected from other suitable materials.
第一液晶配向膜116及第二液晶配向膜126各自为上述的液晶配向膜,其作用在于使 液晶单元130形成预倾角。此外,当施予第一导电膜114与第二导电膜124电压时,第一导电膜114与第二导电膜124之间可产生电场。此电场可驱动液晶单元130,进而使液晶单元130中的液晶分子的排列发生改变。Each of the first liquid
二胺化合物(b1-1)的制备例Preparation example of diamine compound (b1-1)
以下说明二胺化合物(b1-1)的制备例1至制备例6。Preparation Examples 1 to 6 of the diamine compound (b1-1) will be described below.
制备例1Preparation Example 1
由式(I-1)表示的化合物(以下称为“二胺化合物(b1-1-1)”)按照下述合成路线1合成。The compound represented by the formula (I-1) (hereinafter referred to as "diamine compound (b1-1-1)") was synthesized according to the following synthesis route 1.
[合成路线1][Synthetic route 1]
将105克对苯二酚、135克碳酸钾(K2CO3)与700毫升乙腈(ACN)置入容量为3升 的四口烧瓶内,搅拌并升温至80℃。再于四口烧瓶滴入100克甲磺酸4,4,4-三氟丁酯 (4,4,4-trifluorobutyl methanesulfonate)与500毫升乙腈的混合溶液。滴完后,于80℃下持 温4小时。接着,加入190克的25wt%的氢氧化钠水溶液,并于80℃下回流30分钟。接 着,加入415毫升的水,并于80℃下持温1小时。于反应结束后进行过滤,收集过滤后的 滤液并抽干,再接续以管柱层析分离而获得约65克的R1OH固体。105 g of hydroquinone, 135 g of potassium carbonate (K 2 CO 3 ) and 700 ml of acetonitrile (ACN) were placed in a 3-liter four-necked flask, stirred and heated to 80°C. Then, a mixed solution of 100 g of 4,4,4-trifluorobutyl methanesulfonate (4,4,4-trifluorobutyl methanesulfonate) and 500 ml of acetonitrile was dropped into the four-necked flask. After dropping, the temperature was maintained at 80°C for 4 hours. Next, 190 g of a 25 wt % sodium hydroxide aqueous solution was added, and the mixture was refluxed at 80° C. for 30 minutes. Next, 415 ml of water were added and the temperature was maintained at 80°C for 1 hour. Filtration was performed after the reaction was completed, and the filtered filtrate was collected and drained, followed by separation by column chromatography to obtain about 65 g of R1OH solid.
接着,将120克R1OH固体、95克4-甲酰基肉桂酸、12克4-二甲氨基吡啶 (4-dimethylaminopyridine,DMAP)与1080毫升二氯甲烷(CH2Cl2)置入容量为2升的四 口烧瓶内并进行搅拌。于搅拌的过程中加入125克1-(3-二甲基氨基丙基)-3-乙基碳二亚胺盐 酸(1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide Hydrochloride,EDC.HCl),并于加入后 升温至40℃,于40℃下回流反应6小时。反应结束后,以540毫升的水萃取2次,收集有机层并以无水硫酸镁除水后过滤抽干。抽干后获得的固体,再以300克异丙醇加热溶解, 并于冷却后静置结晶,过滤收集结晶并抽干而获得约130克的R3A固体。Next, 120 g of R1OH solid, 95 g of 4-formylcinnamic acid, 12 g of 4-dimethylaminopyridine (DMAP) and 1080 ml of dichloromethane (CH 2 Cl 2 ) were placed in a volume of 2 liters in the four-necked flask and stirred. 125 g of 1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide Hydrochloride (EDC.HCl) was added during stirring, and After the addition, the temperature was raised to 40°C, and the reaction was refluxed at 40°C for 6 hours. After the reaction, extracted twice with 540 ml of water, collected the organic layer, removed water with anhydrous magnesium sulfate, filtered and drained. The solid obtained after draining was heated and dissolved with 300 g of isopropanol, and allowed to stand for crystallization after cooling. The crystallization was collected by filtration and dried to obtain about 130 g of R3A solid.
然后,将64克R3A固体与560毫升的二甲基甲酰胺(DMF)置入容量为3升的三颈 烧瓶内并搅拌溶解,再加入150克过硫酸氢钾(Potassium peroxymonosulfate,Oxone),并 于室温下反应3小时。反应完成后,将溶液抽干,再以1300毫升的水清洗固体3次。其后, 再用1300毫升甲醇清洗1次。收集清洗后的固体并真空干燥而获得约55克的R3B固体。Then, 64 grams of R3A solid and 560 milliliters of dimethylformamide (DMF) were placed in a three-necked flask with a capacity of 3 liters and stirred to dissolve, and then 150 grams of potassium hydrogen persulfate (Potassium peroxymonosulfate, Oxone) was added, and React at room temperature for 3 hours. After the reaction was completed, the solution was sucked dry, and the solid was washed three times with 1300 mL of water. After that, it was washed once with 1300 ml of methanol. The washed solids were collected and dried in vacuo to obtain about 55 grams of R3B solids.
接着,将67克R3B固体、60克2-(N,N-二第三丁氧羰基-2,4-二氨基苯基)-1-乙醇(2-(N,N-di-Boc-2,4-diaminophenyl)-1-ethanol,t-Boc DPE)与2克4-二甲氨基吡啶与340 毫升二氯甲烷置入容量为5升的四口烧瓶内并搅拌。于搅拌的过程中加入40克1-(3-二甲基 氨基丙基)-3-乙基碳二亚胺盐酸(EDC.HCl),并于加入后升温至40℃,于40℃下回流反 应6小时。反应完成后,以2500毫升的水萃取2次,收集有机层并以无水硫酸镁除水后过滤抽干。抽干后获得的固体,再以370克异丙醇加热溶解,并于冷却后静置结晶,过滤收 集结晶并抽干而获得约100克的R4B固体。Next, 67 grams of R3B solid, 60 grams of 2-(N,N-di-tert-butoxycarbonyl-2,4-diaminophenyl)-1-ethanol (2-(N,N-di-Boc-2 , 4-diaminophenyl)-1-ethanol, t-Boc DPE), 2 g of 4-dimethylaminopyridine and 340 ml of dichloromethane were placed in a four-necked flask with a capacity of 5 liters and stirred. 40 g of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloric acid (EDC.HCl) was added during stirring, and the temperature was raised to 40°C after the addition, and refluxed at 40°C The reaction was carried out for 6 hours. After the reaction was completed, the mixture was extracted twice with 2500 ml of water, the organic layer was collected, and the water was removed with anhydrous magnesium sulfate, followed by filtration and suction. The solid obtained after draining was heated and dissolved with 370 grams of isopropanol, and was allowed to stand for crystallization after cooling, and the crystallization was collected by filtration and drained to obtain about 100 grams of R4B solid.
然后,将100克R4B固体与1400毫升二氯甲烷置入容量为5升的四口烧瓶内并搅拌。于搅拌的过程中加入135克三氟甲磺酸锡(II)(Tin(II)trifluoromethanesulfonate,Sn(OTf)2), 并于加入后在氮气中升温至40℃并回流反应1.5小时。反应结束后,将1600毫升乙酸乙酯 倒入烧瓶内并搅拌。接着,再将970毫升的2.5M氢氧化钠水溶液倒入烧瓶内并搅拌30分 钟。接着,将溶液倒入2升的分液瓶中,静置并收集上层有机层。随后,以970毫升的2.5M 氢氧化钠水溶液萃取4次,再以970毫升的水萃取10次。将萃取后的有机层以无水硫酸镁 除水后过滤抽干,再以200克甲醇清洗后,过滤并抽干以收集固体。该固体随后再以300克乙腈加热溶解,并于冷却后静置结晶,过滤收集结晶并抽干而获得约48克的RPADA固 体(即,由式(I-1)表示的二胺化合物b1-1-1)。Then, 100 g of R4B solid and 1400 ml of dichloromethane were placed in a four-necked flask with a capacity of 5 liters and stirred. During the stirring process, 135 g of tin(II) trifluoromethanesulfonate (Tin(II) trifluoromethanesulfonate, Sn(OTf) 2 ) was added, and after the addition, the temperature was raised to 40° C. under nitrogen and the reaction was refluxed for 1.5 hours. After the reaction was completed, 1600 mL of ethyl acetate was poured into the flask and stirred. Next, 970 ml of 2.5M aqueous sodium hydroxide solution was poured into the flask and stirred for 30 minutes. Next, the solution was poured into a 2-liter separatory flask, left to stand and the upper organic layer was collected. Subsequently, it was extracted 4 times with 970 ml of 2.5M aqueous sodium hydroxide solution and 10 times with 970 ml of water. The extracted organic layer was dewatered with anhydrous magnesium sulfate, filtered and drained, washed with 200 g of methanol, filtered and drained to collect solids. The solid was then dissolved by heating with 300 g of acetonitrile, and allowed to crystallize after cooling. The crystals were collected by filtration and drained to obtain about 48 g of RPADA solid (ie, the diamine compound b1-represented by the formula (I-1). 1-1).
制备例2Preparation Example 2
由式(I-2)表示的化合物(以下称为“二胺化合物(b1-1-2)”)按照下述合成路线2合成。The compound represented by the formula (I-2) (hereinafter referred to as "diamine compound (b1-1-2)") was synthesized according to the following synthesis route 2.
[合成路线2][Synthetic route 2]
将65克4-甲酰基肉桂酸、100克的4-(4-庚基环己基)苯酚(4-(4-heptylcyclohexyl)phenol, 7CPO)与4.5克4-二甲氨基吡啶置入容量为2升的四口烧瓶内。再于四口烧瓶内加入730 毫升二氯甲烷,并于搅拌过程中再加入84克1-(3-二甲基氨基丙基)-3-乙基碳二亚胺盐酸 (EDC.HCl)。其后,于40℃下反应6小时。反应结束后,加水进行萃取,收集有机层并 以无水硫酸镁除水后过滤抽干。抽干后获得的固体,再以异丙醇加热清洗,其后再过滤并 收集固体,而获得约130克的R3CHO固体。Put 65 grams of 4-formylcinnamic acid, 100 grams of 4-(4-heptylcyclohexyl)phenol (4-(4-heptylcyclohexyl)phenol, 7CPO) and 4.5 grams of 4-dimethylaminopyridine into a volume of 2 liter four-necked flask. Then, 730 ml of dichloromethane was added into the four-necked flask, and 84 g of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloric acid (EDC.HCl) was added during the stirring process. Then, it was made to react at 40 degreeC for 6 hours. After the reaction was completed, water was added for extraction, the organic layer was collected, and the water was removed with anhydrous magnesium sulfate, followed by filtration and draining. The solid obtained after draining was heated and washed with isopropanol, after which the solid was filtered and collected to obtain about 130 g of R3CHO as a solid.
接着,将80克R3CHO固体与620毫升二甲基甲酰胺置入容量为1升的三颈烧瓶内并搅拌。于R3CHO固体溶解后,加入170克过硫酸氢钾(Oxone),并在室温下反应3小时。 反应完成后,将溶剂抽干以获得固体,并将该固体以纯水及甲醇清洗。于清洗后,进行真 空干燥而获得约75克的R3COOH固体。Next, 80 g of R3CHO solid and 620 ml of dimethylformamide were placed in a 1-liter three-necked flask and stirred. After the R3CHO solid was dissolved, 170 g of potassium hydrogen persulfate (Oxone) was added and reacted at room temperature for 3 hours. After the reaction was completed, the solvent was sucked dry to obtain a solid, and the solid was washed with pure water and methanol. After washing, vacuum drying was performed to obtain about 75 grams of R3COOH solid.
然后,将46.7克R3COOH固体与250毫升甲苯置入0.5升容量的三颈烧瓶内并搅拌溶解,接着,加入0.09克二甲基甲酰胺(DMF),并升温至75℃。随后,慢慢滴入13.6克氯 化亚砜(thionyl chloride,SOCl2),并在滴完后升温至80℃,反应5分钟。接着,将温度降 至40℃。将26.5克2,4-二硝基苯基乙醇(2,4-dinitrophenyl-ethanol)与0.6克4-二甲氨基吡 啶,以12.4克吡啶(Pyridine)溶解,并滴入上述的三颈烧瓶内,持续搅拌12小时。其后, 升温至60℃,并加入20毫升甲醇,接续持温在45℃并维持1小时。最后将溶剂抽干,再 以甲醇清洗藉以获得约57克的析出的R3DiNO-L固体。Then, 46.7 g of R3COOH solid and 250 ml of toluene were placed in a 0.5-liter three-necked flask and stirred to dissolve. Then, 0.09 g of dimethylformamide (DMF) was added, and the temperature was raised to 75°C. Subsequently, 13.6 g of thionyl chloride (SOCl 2 ) was slowly added dropwise, and the temperature was raised to 80° C. after the drop was completed, and the reaction was carried out for 5 minutes. Next, the temperature was lowered to 40°C. 26.5 g of 2,4-dinitrophenyl-ethanol (2,4-dinitrophenyl-ethanol) and 0.6 g of 4-dimethylaminopyridine were dissolved in 12.4 g of pyridine (Pyridine) and dropped into the above three-necked flask. , continue stirring for 12 hours. Thereafter, the temperature was raised to 60°C, and 20 mL of methanol was added, followed by maintaining the temperature at 45°C for 1 hour. Finally, the solvent was drained and washed with methanol to obtain about 57 g of solid R3DiNO-L precipitated.
接着,将48.4克R3DiNO-L固体与440毫升苯甲醚置入容量为3升的四口烧瓶内搅拌。 另外,准备186毫升纯水、7.7克Pt/C置入容量为2升的烧杯内搅拌,随后再加入0.13克偏钒酸铵(NH4VO3)与0.7克次磷酸(H3PO2)水溶液(50wt%),制备成混合液。将上述混 合液倒入四口烧瓶内,并升温至65℃。随后,滴入30克联胺(NH2NH2),全数滴入后,升 温至80℃并反应4小时。随后,过滤溶液,并将滤液以乙酸乙酯及水萃取后抽干以获得固 体。接着,将固体以乙酸乙酯加热清洗,其后再过滤并收集固体,而获得约30克的RPADA3 固体(即,由式(I-2)表示的二胺化合物b1-1-2)。Next, 48.4 g of R3DiNO-L solid and 440 ml of anisole were placed in a four-necked flask with a capacity of 3 liters and stirred. In addition, prepare 186 ml of pure water and 7.7 g of Pt/C into a beaker with a capacity of 2 liters and stir, then add 0.13 g of ammonium metavanadate (NH 4 VO 3 ) and 0.7 g of hypophosphorous acid (H 3 PO 2 ) An aqueous solution (50 wt%) was prepared as a mixed solution. The above mixture was poured into a four-necked flask, and the temperature was raised to 65°C. Subsequently, 30 g of hydrazine (NH 2 NH 2 ) was added dropwise, and after all the dropwise addition, the temperature was raised to 80° C. and the reaction was performed for 4 hours. Subsequently, the solution was filtered, and the filtrate was extracted with ethyl acetate and water and then sucked dry to obtain a solid. Next, the solid was heated and washed with ethyl acetate, after which the solid was filtered and collected to obtain about 30 g of RPADA3 solid (ie, the diamine compound b1-1-2 represented by the formula (I-2)).
制备例3Preparation Example 3
由式(I-3)表示的化合物(以下称为“二胺化合物(b1-1-3)”)按照下述合成路线3合成。The compound represented by the formula (I-3) (hereinafter referred to as "diamine compound (b1-1-3)") was synthesized according to the following synthesis route 3.
[合成路线3][Synthetic route 3]
将140克四氢吡喃氧基苯酚(Tetrahydropyranyloxy Phenol)、180克4-(4,4,4-三氟丁氧 基)苯甲酸(4-(4,4,4-trifluorobutoxy)benzoic acid)与8.8克4-二甲氨基吡啶置入容量为3升 的四口烧瓶内。再于四口烧瓶内加入1600克二氯甲烷,并于搅拌过程中再加入150克1-(3- 二甲基氨基丙基)-3-乙基碳二亚胺盐酸(EDC.HCl)。加完后,于室温下反应8小时。反应 结束后,加水进行萃取,收集有机层并以无水硫酸镁除水后过滤抽干。抽干后获得的固体, 再以异丙醇清洗并加热。于清洗后,过滤收集固体并进行真空干燥,而获得约270克的R5THP 固体。Combine 140 g of Tetrahydropyranyloxy Phenol, 180 g of 4-(4,4,4-trifluorobutoxy)benzoic acid with 8.8 grams of 4-dimethylaminopyridine were placed in a four-necked flask with a capacity of 3 liters. Then, 1600 g of dichloromethane was added into the four-necked flask, and 150 g of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloric acid (EDC.HCl) was added during the stirring process. After the addition, the reaction was carried out at room temperature for 8 hours. After the reaction was completed, water was added for extraction, the organic layer was collected, and the water was removed with anhydrous magnesium sulfate, followed by filtration and suction. The solid obtained after draining was washed with isopropanol and heated. After washing, the solid was collected by filtration and vacuum dried to obtain about 270 grams of R5THP as a solid.
接着,将270克R5THP固体、65毫升甲醇与1200毫升二氯甲烷置入容量为2升的四口烧瓶内并进行搅拌。于搅拌的过程中,滴入170克的12wt%的对甲苯磺酸醋酸溶液。加 入后,于室温下反应2小时。反应结束后,加水进行萃取,萃取后抽干溶剂,获得约210 克的R5OH固体。Next, 270 g of R5THP solid, 65 ml of methanol and 1200 ml of dichloromethane were placed in a four-necked flask with a capacity of 2 liters and stirred. During the stirring process, 170 g of a 12 wt% p-toluenesulfonic acid acetic acid solution was added dropwise. After the addition, the reaction was carried out at room temperature for 2 hours. After the reaction was completed, water was added for extraction, and after extraction, the solvent was drained to obtain about 210 g of R5OH solid.
然后,将70克R5OH固体、36克4-甲酰基肉桂酸与2.5克4-二甲氨基吡啶置入容量为1升的四口烧瓶内,再加入550克二氯甲烷并进行搅拌。随后,再于搅拌的过程中滴入47.3克1-(3-二甲基氨基丙基)-3-乙基碳二亚胺盐酸(EDC.HCl)。加完后,于40℃下反应8小 时。反应结束后,加水进行萃取,收集有机层并以无水硫酸镁除水后过滤抽干。抽干后获 得的固体,再以异丙醇清洗并加热。于清洗后,过滤收集固体并进行真空干燥,而获得约 87克的R5BCHO固体。Then, 70 grams of R5OH solid, 36 grams of 4-formylcinnamic acid and 2.5 grams of 4-dimethylaminopyridine were placed in a four-necked flask with a capacity of 1 liter, and 550 grams of dichloromethane was added and stirred. Subsequently, 47.3 g of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloric acid (EDC.HCl) was added dropwise during stirring. After the addition, the reaction was carried out at 40°C for 8 hours. After the reaction was completed, water was added for extraction, the organic layer was collected and removed with anhydrous magnesium sulfate, filtered and drained. The solid obtained after draining was washed with isopropanol and heated. After washing, the solid was collected by filtration and vacuum dried to obtain about 87 grams of R5BCHO as a solid.
接着,将87克R5BCHO固体与583毫升二甲基甲酰胺,置入1升容量的三颈瓶内并 搅拌溶解。再加入160克的过硫酸氢钾(Oxone),并于室温下反应3小时。反应完成后, 将溶液抽干,再以1600毫升的水清洗固体3次。其后,再用800毫升甲醇清洗1次。收集 清洗后的固体并真空干燥而获得约44克的R5BCOOH固体。Next, put 87 grams of R5BCHO solid and 583 milliliters of dimethylformamide into a 1-liter three-necked flask and stir to dissolve. 160 g of potassium hydrogen persulfate (Oxone) was added, and the reaction was carried out at room temperature for 3 hours. After the reaction was completed, the solution was sucked dry, and the solid was washed three times with 1600 mL of water. After that, it was washed once with 800 ml of methanol. The washed solids were collected and dried in vacuo to yield about 44 grams of R5BCOOH solids.
然后,将44克R5BCOOH固体、30克2-(N,N-二第三丁氧羰基-2,4-二氨基苯基)-1-乙醇 (t-Boc DPE)、2克4-二甲氨基吡啶与850毫升二氯甲烷置入容量为1升的四口烧瓶内并进 行搅拌。于搅拌的过程中加入20克1-(3-二甲基氨基丙基)-3-乙基碳二亚胺盐酸(EDC.HCl), 并于室温下回流反应6小时。反应结束后,以350毫升的水萃取,收集有机层并以无水硫 酸镁除水后过滤抽干。抽干后获得的固体,再以异丙醇加热溶解,并于冷却后静置结晶, 过滤收集结晶并抽干,而获得约70克的R5BBoc固体。Then, 44 grams of R5BCOOH solid, 30 grams of 2-(N,N-di-tert-butoxycarbonyl-2,4-diaminophenyl)-1-ethanol (t-Boc DPE), 2 grams of 4-dimethyl Aminopyridine and 850 ml of dichloromethane were placed in a four-necked flask with a capacity of 1 liter and stirred. During stirring, 20 g of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloric acid (EDC.HCl) was added, and the reaction was carried out under reflux for 6 hours at room temperature. After the completion of the reaction, extract with 350 ml of water, collect the organic layer, remove water with anhydrous magnesium sulfate, filter and drain. The solid obtained after being sucked dry was dissolved by heating with isopropanol, and allowed to stand for crystallization after cooling, and the crystallization was collected by filtration and sucked dry to obtain about 70 grams of R5BBoc solid.
接着,将50克R5BBoc固体与1200毫升二氯甲烷置入容量为5升的四口烧瓶内并进行搅拌。于搅拌的过程中加入62克三氟甲磺酸锡(II)(Sn(OTf)2)。加入后,于氮气中升温至40℃并回流反应1.5小时。反应完成后,将2000毫升乙酸乙酯倒入烧瓶内并进行搅拌。 接着,再将450毫升的2.5M氢氧化钠水溶液倒入烧瓶内,并搅拌30分钟。接着,将溶液 倒入2升的分液瓶中,静置并收集上层有机层。随后,以450毫升的2.5M氢氧化钠水溶液 萃取4次,再以200毫升的水萃取4次。将萃取后的有机层以无水硫酸镁除水后过滤抽干, 再以甲醇清洗后,过滤并抽干收集固体。该固体随后再以乙腈加热溶解,并于冷却后静置 结晶,过滤收集结晶并抽干而获得约28克的RPADA5B固体(即,由式(I-3)表示的二胺化 合物b1-1-3)。Next, 50 g of R5BBoc solid and 1200 ml of dichloromethane were placed in a four-necked flask with a capacity of 5 liters and stirred. 62 grams of tin(II) triflate (Sn(OTf) 2 ) was added during stirring. After the addition, the temperature was raised to 40°C under nitrogen and the reaction was refluxed for 1.5 hours. After the reaction was completed, 2000 ml of ethyl acetate was poured into the flask and stirred. Next, 450 ml of 2.5M aqueous sodium hydroxide solution was poured into the flask, and stirred for 30 minutes. Next, the solution was poured into a 2-liter separatory flask, left to stand and the upper organic layer was collected. Subsequently, it was extracted 4 times with 450 ml of 2.5M aqueous sodium hydroxide solution and 4 times with 200 ml of water. The extracted organic layer was dewatered with anhydrous magnesium sulfate, filtered and drained, washed with methanol, filtered and drained to collect solids. The solid was then dissolved by heating with acetonitrile, and allowed to crystallize after cooling. The crystals were collected by filtration and drained to obtain about 28 g of RPADA5B solid (ie, the diamine compound b1-1- represented by the formula (I-3)) 3).
制备例4Preparation Example 4
由式(I-6)表示的化合物(以下称为“二胺化合物(b1-1-4)”)按照下述合成路线4合成。The compound represented by the formula (I-6) (hereinafter referred to as "diamine compound (b1-1-4)") was synthesized according to the following synthesis route 4.
[合成路线4][Synthetic route 4]
将285克4-羟基桂皮酸(4-hydroxycinnamic acid)、293克二氢吡喃(3,4-Dihydro-2H-pyran, DHP)与1800毫升二氯甲烷置入容量为3升的四口烧瓶内并搅拌均匀,并于搅拌的过程中 再滴入20.6克三氟乙酸(2,2,2-Trifluoroacetic acid,TFA)。其后,于40℃下反应6小时。 反应结束后,以抽气过滤收集固体。将收集到的固体再以1300克甲醇于50℃下洗涤,接续 再干燥固体而获得约345克的R4-COOH固体。Put 285 g of 4-hydroxycinnamic acid (4-hydroxycinnamic acid), 293 g of dihydropyran (3,4-Dihydro-2H-pyran, DHP) and 1800 ml of dichloromethane into a four-necked flask with a capacity of 3 liters The mixture was stirred evenly, and 20.6 g of trifluoroacetic acid (2,2,2-Trifluoroacetic acid, TFA) was added dropwise during the stirring. Then, it was made to react at 40 degreeC for 6 hours. After the reaction was completed, the solid was collected by suction filtration. The collected solid was further washed with 1300 g of methanol at 50°C, followed by further drying of the solid to obtain about 345 g of R4-COOH solid.
接着,将124克R4-COOH固体、137克4-(4-庚基环己基)苯酚(7CPO)与6.1克4-二 甲氨基吡啶置入容量为3升的四口烧瓶内。再于四口烧瓶内加入830毫升二氯甲烷,并于 搅拌过程中再加入105克1-(3-二甲基氨基丙基)-3-乙基碳二亚胺盐酸(EDC.HCl)。其后, 于40℃下反应8小时。反应结束后,加水进行萃取,收集有机层并以无水硫酸镁除水后过 滤抽干。抽干后获得的固体,再以异丙醇清洗并加热。于清洗后,过滤收集固体并进行真 空干燥,而获得约210克的R4-7CPO固体。Next, 124 g of R4-COOH solid, 137 g of 4-(4-heptylcyclohexyl)phenol (7CPO) and 6.1 g of 4-dimethylaminopyridine were placed in a 3-liter four-necked flask. Then, 830 ml of dichloromethane was added to the four-necked flask, and 105 g of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloric acid (EDC.HCl) was added during stirring. Then, it was made to react at 40 degreeC for 8 hours. After the reaction was completed, water was added for extraction, and the organic layer was collected and removed by anhydrous magnesium sulfate, filtered and dried. The solid obtained after draining was washed with isopropanol and heated. After washing, the solids were collected by filtration and vacuum dried to obtain about 210 grams of R4-7CPO solids.
然后,将110克R4-7CPO固体与670毫升二氯甲烷加入容量为3升的烧瓶内并搅拌。在搅拌过程中滴入140克的12wt%对甲苯磺酸醋酸溶液。其后,在室温下反应2小时。反 应结束后,加入少许甲醇。随后,再将溶剂抽干,并用二氯甲烷和饱和碳酸氢钠水溶液进 行萃取,最后再用水进行萃取,收集有机层。有机层以无水硫酸镁除水后过滤抽干,而获 得约80克的R4-OH固体。Then, 110 g of R4-7CPO solid and 670 mL of dichloromethane were added to a 3-liter flask and stirred. During the stirring process, 140 g of a 12 wt% p-toluenesulfonic acid acetic acid solution was added dropwise. Thereafter, the reaction was carried out at room temperature for 2 hours. After the reaction was over, a little methanol was added. Then, the solvent was sucked dry, and extracted with dichloromethane and saturated aqueous sodium bicarbonate solution, and finally with water, and the organic layer was collected. The organic layer was dewatered with anhydrous magnesium sulfate, filtered and drained to obtain about 80 g of R4-OH as a solid.
接着,将20.7克2,4-二硝基苯基乙醇和96.5克甲苯置于容量为0.5升的三颈瓶中,再 加入0.1克二甲基甲酰胺,并升温至75℃。随后,慢慢加入12克氯化亚砜,加完后将温度维持在80℃,并持续反应,待溶液呈现黄色澄清后,将温度降至30℃。将46克R4-OH固 体与0.56克4-二甲氨基吡啶溶于22克吡啶中,随后将其滴入三颈瓶中。加完后,于室温下 搅拌12小时后,升温至60℃并加入80克甲醇。接续于45℃下持温1小时后,将溶剂抽干 而获得约44克的R4-DiNO固体。Next, 20.7 g of 2,4-dinitrophenylethanol and 96.5 g of toluene were placed in a 0.5-liter three-necked flask, 0.1 g of dimethylformamide was added, and the temperature was raised to 75°C. Subsequently, 12 grams of thionyl chloride was slowly added. After the addition, the temperature was maintained at 80°C and the reaction was continued. After the solution became yellow and clear, the temperature was lowered to 30°C. 46 g of R4-OH solid and 0.56 g of 4-dimethylaminopyridine were dissolved in 22 g of pyridine, which was then dropped into a three-necked flask. After the addition was complete, after stirring at room temperature for 12 hours, the temperature was raised to 60°C and 80 g of methanol was added. After a subsequent 1 hour hold at 45°C, the solvent was pumped dry to obtain about 44 grams of R4-DiNO as a solid.
然后,将80克R4-DiNO固体、85克还原铁与40克氯化铵(NH4Cl)置于容量为5升 的四口烧瓶中,于烧瓶中加入950克水和1050克乙酸乙酯(EA),搅拌均匀后升温至70℃, 并于70℃下反应2小时。反应结束后,于70℃下经硅藻土过滤,待滤液分层后将水层去除, 收集有机层并以无水硫酸镁除水后过滤抽干,而获得约35克的RPADA4固体(即,由式(I-6) 表示的二胺化合物b1-1-4)。Then, 80 grams of R4-DiNO solid, 85 grams of reduced iron and 40 grams of ammonium chloride (NH 4 Cl) were placed in a four-necked flask with a capacity of 5 liters, and 950 grams of water and 1050 grams of ethyl acetate were added to the flask. (EA), stirred uniformly, heated to 70°C, and reacted at 70°C for 2 hours. After the reaction is completed, filter through diatomaceous earth at 70 ° C, remove the water layer after the filtrate is layered, collect the organic layer and remove water with anhydrous magnesium sulfate, filter and drain, and obtain about 35 grams of RPADA4 solid (i.e. , the diamine compound b1-1-4) represented by the formula (I-6).
制备例5Preparation Example 5
由式(I-7)表示的化合物(以下称为“二胺化合物(b1-1-5)”)按照下述合成路线5合成。The compound represented by the formula (I-7) (hereinafter referred to as "diamine compound (b1-1-5)") was synthesized according to the following synthesis route 5.
[合成路线5][Synthetic route 5]
将65克4-甲酰基肉桂酸、100克4-(4-庚基环己基)苯酚(7CPO)与4.5克4-二甲氨基吡啶置入容量为2升的四口烧瓶内。再于四口烧瓶内加入730毫升二氯甲烷,并于搅拌过 程中再加入84克1-(3-二甲基氨基丙基)-3-乙基碳二亚胺盐酸(EDC.HCl)。其后,于40℃ 下反应6小时。反应结束后,加水进行萃取,收集有机层并以无水硫酸镁除水后过滤抽干。 抽干后获得的固体,再以异丙醇加热清洗。其后,再过滤并收集固体,而获得约130克的 R3CHO固体。65 grams of 4-formylcinnamic acid, 100 grams of 4-(4-heptylcyclohexyl)phenol (7CPO) and 4.5 grams of 4-dimethylaminopyridine were placed in a four-necked flask with a capacity of 2 liters. In the four-necked flask, add 730 milliliters of dichloromethane, and in the stirring process, add 84 grams of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloric acid (EDC.HCl). Then, it was made to react at 40 degreeC for 6 hours. After the reaction was completed, water was added for extraction, the organic layer was collected and removed with anhydrous magnesium sulfate, filtered and drained. The solid obtained after draining was heated and washed with isopropanol. After that, the solid was filtered again and collected to obtain about 130 g of R3CHO as a solid.
接着,将80克R3CHO固体、620毫升二甲基甲酰胺置入容量为1升的三颈烧瓶内并搅拌。于R3CHO固体溶解后,加入170克过硫酸氢钾(Oxone),并在室温下反应3小时。 反应完成后,将溶剂抽干获得固体,并将该固体以纯水及甲醇清洗。于清洗后,过滤收集 固体并进行真空干燥,而获得约75克的R3COOH淡黄色固体。Next, 80 g of R3CHO solid and 620 ml of dimethylformamide were placed in a 1-liter three-necked flask and stirred. After the R3CHO solid was dissolved, 170 g of potassium hydrogen persulfate (Oxone) was added and reacted at room temperature for 3 hours. After completion of the reaction, the solvent was sucked dry to obtain a solid, which was washed with pure water and methanol. After washing, the solid was collected by filtration and dried in vacuo to obtain about 75 g of R3COOH as a pale yellow solid.
然后,将68.5克R3COOH淡黄色固体、28.1克的2,4-二硝基酚、3.73克4-二甲氨基吡啶与1250毫升0.125M的二氯甲烷加入容量为1升的四口烧瓶内并进行搅拌。于搅拌的过 程中加入34.5克1-(3-二甲基氨基丙基)-3-乙基碳二亚胺盐酸(EDC.HCl)。其后,在40℃ 下回流反应6小时。反应结束后,加水进行萃取,收集有机层并以无水硫酸镁除水后过滤 抽干。抽干后获得的固体,再以异丙醇清洗并加热。于清洗后,过滤收集固体并进行真空 干燥,而获得约50克的R3DiNO固体。Then, 68.5 g of R3COOH pale yellow solid, 28.1 g of 2,4-dinitrophenol, 3.73 g of 4-dimethylaminopyridine and 1250 ml of 0.125 M dichloromethane were added to a four-necked flask with a capacity of 1 liter and Stir. During stirring, 34.5 g of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC.HCl) was added. Thereafter, the reaction was refluxed at 40°C for 6 hours. After the reaction was completed, water was added for extraction, the organic layer was collected, and the water was removed with anhydrous magnesium sulfate, then filtered and drained. The solid obtained after draining was washed with isopropanol and heated. After washing, the solid was collected by filtration and vacuum dried to obtain about 50 grams of R3DiNO as a solid.
接着,将28.3克R3DiNO固体与270毫升苯甲醚置入容量为2升的四口烧瓶内搅拌;另外,准备115毫升纯水、6克Pt/C置入容量为2升的烧杯内搅拌,随后再加入0.08克偏 钒酸铵与0.42克次磷酸水溶液(50wt%),制备成混合液。将上述混合液倒入四口烧瓶内, 并升温至65℃。随后,滴入18.4克联胺,全数滴入后,升温至80℃并反应4小时。随后, 过滤溶液,并将滤液以乙酸乙酯及水萃取后抽干以获得固体。接着,将固体以乙酸乙酯加 热清洗,其后再过滤并收集固体,而获得约10克的RPADA3M固体(即,由式(I-7)表示的 二胺化合物b1-1-5)。Then, put 28.3 grams of R3DiNO solid and 270 milliliters of anisole into a four-necked flask with a capacity of 2 liters and stir; in addition, prepare 115 milliliters of pure water and 6 grams of Pt/C and put them into a beaker with a capacity of 2 liters and stir, Subsequently, 0.08 g of ammonium metavanadate and 0.42 g of an aqueous solution of hypophosphorous acid (50 wt %) were added to prepare a mixed solution. The above mixed solution was poured into a four-necked flask, and the temperature was raised to 65°C. Subsequently, 18.4 g of hydrazine was added dropwise, and after all the dropwise addition, the temperature was raised to 80° C. and the reaction was performed for 4 hours. Subsequently, the solution was filtered, and the filtrate was extracted with ethyl acetate and water and then sucked dry to obtain a solid. Next, the solid was heated and washed with ethyl acetate, after which the solid was filtered and collected to obtain about 10 g of RPADA3M solid (i.e., the diamine compound b1-1-5 represented by the formula (I-7)).
制备例6Preparation Example 6
由式(I-9)表示的化合物(以下称为“二胺化合物(b1-1-6)”)按照下述合成路线6合成。The compound represented by the formula (I-9) (hereinafter referred to as "diamine compound (b1-1-6)") was synthesized according to the following synthesis route 6.
[合成路线6][Synthetic route 6]
将45克4-甲酰基肉桂酸、100克的5α-胆甾烷-3β-醇(5α-Cholestan-3β-ol)与3.2克4- 二甲氨基吡啶置入容量为2升的四口烧瓶内。再于四口烧瓶内加入520毫升二氯甲烷,并 于搅拌过程中再加入60克1-(3-二甲基氨基丙基)-3-乙基碳二亚胺盐酸(EDC.HCl)。其后, 于40℃下反应6小时。反应结束后,加水进行萃取,收集有机层并以无水硫酸镁除水后过 滤抽干。抽干后获得的固体,再以异丙醇加热清洗。其后,再过滤并收集固体,而获得约120克的R6CHO固体。Put 45 grams of 4-formylcinnamic acid, 100 grams of 5α-cholestan-3β-ol (5α-Cholestan-3β-ol) and 3.2 grams of 4-dimethylaminopyridine into a four-necked flask with a capacity of 2 liters Inside. Then 520 ml of dichloromethane was added to the four-necked flask, and 60 g of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloric acid (EDC.HCl) was added during stirring. Then, it was made to react at 40 degreeC for 6 hours. After the reaction was completed, water was added for extraction, and the organic layer was collected and removed by anhydrous magnesium sulfate, filtered and dried. The solid obtained after draining was heated and washed with isopropanol. After that, the solid was filtered again and collected to obtain about 120 grams of R6CHO solid.
接着,将80克R6CHO固体、500毫升二甲基甲酰胺置入容量为1升的三颈烧瓶内并搅拌。于R6CHO固体溶解后,加入135克过硫酸氢钾(Oxone),并在室温下反应3小时。 反应完成后,将溶剂抽干获得固体,并将该固体以纯水及甲醇清洗。于清洗后,过滤收集 固体并进行真空干燥,而获得约60克的R6COOH固体。Next, 80 g of R6CHO solid and 500 ml of dimethylformamide were placed in a 1-liter three-necked flask and stirred. After the R6CHO solid was dissolved, 135 g of potassium hydrogen persulfate (Oxone) was added and reacted at room temperature for 3 hours. After completion of the reaction, the solvent was sucked dry to obtain a solid, which was washed with pure water and methanol. After washing, the solid was collected by filtration and vacuum dried to obtain about 60 grams of R6COOH as a solid.
然后,将120克的R6COOH固体与200毫升甲苯置入容量为1升的三颈烧瓶内并搅拌溶解,再加入0.2克二甲基甲酰胺,并升温至75℃。随后,慢慢滴入23克氯化亚砜,并在 滴完后升温至80℃,于80℃下反应5分钟。接着,将温度降至30℃。将40克2,4-二硝基 苯基乙醇、1克4-二甲氨基吡啶,以40克吡啶溶解,并滴入上述的三颈烧瓶内,持续搅拌 12小时。其后,升温至60℃,并加入150毫升甲醇,接续持温在45℃下并维持1小时。最 后,将溶剂抽干,再以甲醇清洗而获得约90克的析出的R6DiNO固体。Then, 120 g of R6COOH solid and 200 ml of toluene were placed in a three-necked flask with a capacity of 1 liter and stirred to dissolve, then 0.2 g of dimethylformamide was added, and the temperature was raised to 75°C. Subsequently, 23 g of thionyl chloride was slowly added dropwise, and the temperature was raised to 80°C after the dropping, and the reaction was carried out at 80°C for 5 minutes. Next, the temperature was lowered to 30°C. 40 g of 2,4-dinitrophenylethanol and 1 g of 4-dimethylaminopyridine were dissolved in 40 g of pyridine, and dropped into the above three-necked flask, and the stirring was continued for 12 hours. Thereafter, the temperature was raised to 60°C, and 150 mL of methanol was added, followed by maintaining the temperature at 45°C for 1 hour. Finally, the solvent was sucked dry and washed with methanol to obtain about 90 grams of precipitated R6DiNO solid.
接着,将50克R6DiNO固体与400毫升苯甲醚置入容量为1升的四口烧瓶内搅拌;另外,准备160毫升纯水、10克Pt/C置入容量为2升的烧杯内搅拌,随后再加入0.12克偏钒 酸铵、0.6克次磷酸水溶液(50wt%),制备成混合液。将上述混合液倒入四口烧瓶内,并升 温至65℃。随后,滴入26克联胺,全数滴入后,升温至80℃并反应4小时。随后,过滤 溶液,并将滤液以乙酸乙酯及水萃取后抽干以获得固体。接着,将固体以乙酸乙酯加热清 洗,其后再过滤并收集固体,而获得约20克的RPADA6固体(即,由式(I-9)表示的二胺化 合物b1-1-6)。Then, put 50 grams of R6DiNO solid and 400 milliliters of anisole into a four-necked flask with a capacity of 1 liter and stir; in addition, prepare 160 milliliters of pure water and 10 grams of Pt/C and put them into a beaker with a capacity of 2 liters and stir, Subsequently, 0.12 g of ammonium metavanadate and 0.6 g of an aqueous solution of hypophosphorous acid (50 wt %) were added to prepare a mixed solution. The above mixture was poured into a four-necked flask, and the temperature was raised to 65°C. Subsequently, 26 g of hydrazine was added dropwise, and after all the dropwise addition, the temperature was raised to 80° C. and the reaction was carried out for 4 hours. Subsequently, the solution was filtered, and the filtrate was extracted with ethyl acetate and water and then sucked dry to obtain a solid. Next, the solid was heated and washed with ethyl acetate, after which the solid was filtered and collected to obtain about 20 g of RPADA6 solid (i.e., the diamine compound b1-1-6 represented by the formula (I-9)).
二胺化合物(b1-2)的制备例Preparation example of diamine compound (b1-2)
二胺化合物(b1-2)的制备例例如可参考中国台湾专利公开号TW201536862A的内容。详 细而言,由式(II-10)表示的化合物(以下称为“二胺化合物(b1-2-1)”)的制备方法可参考前述专 利公开说明书第40页第8行至第41页第21行的内容;由式(II-18)表示的化合物(以下称为 “二胺化合物(b1-2-2)”)的制备方法可参考前述专利公开说明书第41页第22行至第44页第1 行的内容;由式(II-24)表示的化合物(以下称为“二胺化合物(b1-2-3)”)的制备方法可参考前述 专利公开说明书第44页第2行至第45页第25行的内容;由式(II-22)表示的化合物(以下称 为“二胺化合物(b1-2-4)”)的制备方法可参考前述专利公开说明书第45页第26行至第47页 第11行的内容;以及由式(II-26)表示的化合物(以下称为“二胺化合物(b1-2-5)”)的制备方法 可参考前述专利公开说明书第47页第12行至第49页第4行的内容。For the preparation example of the diamine compound (b1-2), reference can be made to the content of Taiwan Patent Publication No. TW201536862A. In detail, for the preparation method of the compound represented by the formula (II-10) (hereinafter referred to as "diamine compound (b1-2-1)"), reference can be made to pages 40, lines 8 to 41 of the aforementioned Patent Publication The content of line 21; for the preparation method of the compound represented by formula (II-18) (hereinafter referred to as "diamine compound (b1-2-2)"), reference may be made to page 41, line 22 to The content of page 44, line 1; for the preparation method of the compound represented by formula (II-24) (hereinafter referred to as "diamine compound (b1-2-3)"), reference may be made to page 44, line 2 of the aforementioned patent publication To the content of page 45, line 25; for the preparation method of the compound represented by formula (II-22) (hereinafter referred to as "diamine compound (b1-2-4)"), please refer to page 45 of the aforementioned patent publication. The contents of line 26 to page 47, line 11; and the preparation method of the compound represented by the formula (II-26) (hereinafter referred to as "diamine compound (b1-2-5)") can be referred to the aforementioned Patent Publication No. Contents from page 47, line 12 to page 49, line 4.
二胺化合物(b1-3)的制备例Preparation example of diamine compound (b1-3)
二胺化合物(b1-3)的制备例例如可参考中国台湾专利公开号TW201546120A的内容。详 细而言,由式(III-1)表示的化合物(以下称为“二胺化合物(b1-3-1)”)的制备方法可参考前述专 利公开说明书段落[0144]~[0146]的内容;由式(III-2)表示的化合物(以下称为“二胺化合物 (b1-3-2)”)的制备方法可参考前述专利公开说明书段落[0147]~[0149]的内容;由式(III-3)表示 的化合物(以下称为“二胺化合物(b1-3-3)”)的制备方法可参考前述专利公开说明书段落 [0150]~[0152]的内容;由式(III-4)表示的化合物(以下称为“二胺化合物(b1-3-4)”)的制备方法 可参考前述专利公开说明书段落[0153]~[0155]的内容;由式(III-5)表示的化合物(以下称为 “二胺化合物(b1-3-5)”)的制备方法可参考前述专利公开说明书段落[0156]~[0158]的内容;以 及由式(III-6)表示的化合物(以下称为“二胺化合物(b1-3-6)”)的制备方法可参考前述专利公开 说明书段落[0159]~[0161]的内容。For the preparation example of the diamine compound (b1-3), reference can be made to the content of Taiwan Patent Publication No. TW201546120A. In detail, for the preparation method of the compound represented by the formula (III-1) (hereinafter referred to as "diamine compound (b1-3-1)"), reference can be made to the contents of paragraphs [0144] to [0146] of the aforementioned Patent Publication For the preparation method of the compound represented by formula (III-2) (hereinafter referred to as "diamine compound (b1-3-2)"), reference can be made to the contents of paragraphs [0147] to [0149] of the aforementioned patent publication; For the preparation method of the compound represented by (III-3) (hereinafter referred to as "diamine compound (b1-3-3)"), reference can be made to the contents of paragraphs [0150] to [0152] of the aforementioned patent publication; For the preparation method of the compound represented by 4) (hereinafter referred to as "diamine compound (b1-3-4)"), reference can be made to the contents of paragraphs [0153] to [0155] of the aforementioned patent publication; it is represented by formula (III-5) For the preparation method of the compound (hereinafter referred to as "diamine compound (b1-3-5)"), reference can be made to the contents of paragraphs [0156] to [0158] of the aforementioned patent publication; and the compound represented by the formula (III-6) For the preparation method of (hereinafter referred to as "diamine compound (b1-3-6)"), reference can be made to the contents of paragraphs [0159] to [0161] of the aforementioned patent publication.
聚合物(A-1)的合成例Synthesis example of polymer (A-1)
以下说明聚合物(A-1)的合成例A-1-1-1至合成例A-1-1-6、合成例A-1-2-1至合成例 A-1-2-6、合成例A-1-3-1至合成例A-1-3-6以及合成例A-1-4-1至合成例A-1-4-6。Synthesis Examples A-1-1-1 to A-1-1-6, Synthesis Examples A-1-2-1 to A-1-2-6, Synthesis Examples A-1-2-6, Synthesis Example A-1-3-1 to Synthesis Example A-1-3-6 and Synthesis Example A-1-4-1 to Synthesis Example A-1-4-6.
合成例A-1-1-1Synthesis Example A-1-1-1
在容积500毫升的四颈锥瓶上设置氮气入口、搅拌器、冷凝管及温度计,并导入氮气。 然后,在四颈锥瓶中加入0.025摩尔(50摩尔%)的制备例1所得的二胺化合物b1-1-1以及0.025摩尔(50摩尔%)的其他二胺化合物(b1-4-1)以及80克的N-甲基-2-吡酪烷酮(简称为NMP),并于室温下搅拌至溶解。接着,加入0.05摩尔(100摩尔%)的2,3,5-三羧基 环戊基醋酸二酐(简称为a1-1)及20克的NMP,并于室温下反应2小时。待反应结束后, 将反应溶液倒入1500毫升水中,以使聚合物析出。然后,过滤所得的聚合物,并重复以甲 醇清洗及过滤三次,置入真空烘箱中,以温度60℃进行干燥后,即可得聚合物A-1-1-1。A nitrogen inlet, a stirrer, a condenser and a thermometer were set on a four-necked conical flask with a volume of 500 ml, and nitrogen was introduced. Then, 0.025 mol (50 mol %) of the diamine compound b1-1-1 obtained in Preparation Example 1 and 0.025 mol (50 mol %) of the other diamine compound (b1-4-1) were added to the four-necked conical flask And 80 grams of N-methyl-2-pyrrolidone (abbreviated as NMP), and stirred at room temperature until dissolved. Next, 0.05 mol (100 mol %) of 2,3,5-tricarboxycyclopentylacetic dianhydride (abbreviated as a1-1) and 20 g of NMP were added and reacted at room temperature for 2 hours. After the reaction was completed, the reaction solution was poured into 1500 ml of water to precipitate the polymer. Then, the obtained polymer was filtered, washed with methanol and filtered three times, placed in a vacuum oven, and dried at a temperature of 60°C to obtain polymer A-1-1-1.
合成例A-1-1-2至合成例A-1-1-6、合成例A-1-2-1至合成例A-1-2-6、合成例A-1-3-1 至合成例A-1-3-6以及合成例A-1-4-1至合成例A-1-4-6Synthesis Example A-1-1-2 to Synthesis Example A-1-1-6, Synthesis Example A-1-2-1 to Synthesis Example A-1-2-6, Synthesis Example A-1-3-1 to Synthesis Example A-1-3-6 and Synthesis Example A-1-4-1 to Synthesis Example A-1-4-6
合成例A-1-1-2至合成例A-1-1-6、合成例A-1-2-1至合成例A-1-2-6、合成例A-1-3-1 至合成例A-1-3-6以及合成例A-1-4-1至合成例A-1-4-6是以与合成例A-1-1-1相同的步骤来 制备,其不同处在于:改变聚合物的原料种类及其使用量(如表1所示)。Synthesis Example A-1-1-2 to Synthesis Example A-1-1-6, Synthesis Example A-1-2-1 to Synthesis Example A-1-2-6, Synthesis Example A-1-3-1 to Synthesis Example A-1-3-6 and Synthesis Example A-1-4-1 to Synthesis Example A-1-4-6 were prepared in the same procedure as Synthesis Example A-1-1-1, except for the difference It lies in: changing the raw material types of polymers and their usage amounts (as shown in Table 1).
聚合物(A-2)的合成例Synthesis example of polymer (A-2)
合成例A-2-1至合成例A-2-6Synthesis Example A-2-1 to Synthesis Example A-2-6
合成例A-2-1至合成例A-2-6是以与合成例A-1-1-1相同的步骤来制备,其不同处在于: 改变聚合物的原料种类及其使用量(如表2所示)。Synthesis Example A-2-1 to Synthesis Example A-2-6 are prepared in the same steps as Synthesis Example A-1-1-1, except that: shown in Table 2).
聚合物(A-1)的比较合成例Comparative Synthesis Example of Polymer (A-1)
比较合成例A’-1-1至比较合成例A’-1-5Comparative Synthesis Example A'-1-1 to Comparative Synthesis Example A'-1-5
比较合成例A’-1-1至比较合成例A’-1-5是以与合成例A-1-1-1相同的步骤来制备,其 不同处在于:改变聚合物的原料种类及其使用量(如表3所示)。Comparative Synthesis Example A'-1-1 to Comparative Synthesis Example A'-1-5 were prepared in the same steps as those of Synthesis Example A-1-1-1, except that the types of raw materials and The amount used (as shown in Table 3).
表1至表3中标号所对应的化合物如下所示。The compounds corresponding to the symbols in Tables 1 to 3 are shown below.
表1Table 1
表1(续)Table 1 (continued)
表1(续)Table 1 (continued)
表1(续)Table 1 (continued)
表2Table 2
表3table 3
液晶配向剂、液晶配向膜以及液晶显示元件的实施例与比较例Examples and Comparative Examples of Liquid Crystal Alignment Agent, Liquid Crystal Alignment Film, and Liquid Crystal Display Element
以下说明液晶配向剂、液晶配向膜以及液晶显示元件的实施例1至实施例36以及比较 例1至比较例8。Examples 1 to 36 and Comparative Examples 1 to 8 of the liquid crystal alignment agent, the liquid crystal alignment film, and the liquid crystal display element will be described below.
实施例1Example 1
a.液晶配向剂a. Liquid crystal alignment agent
将100重量份的聚合物(A-1-1-1)加入1200重量份的N-甲基-2-吡咯烷酮(简称为B-1) 及800重量份的乙二醇正丁基醚(简称为B-2)中,并于室温下搅拌混合至溶解,即可制得 实施例1的液晶配向剂。Add 100 parts by weight of polymer (A-1-1-1) to 1200 parts by weight of N-methyl-2-pyrrolidone (referred to as B-1) and 800 parts by weight of ethylene glycol n-butyl ether (referred to as B-2), and stirring and mixing at room temperature until dissolved, the liquid crystal alignment agent of Example 1 can be obtained.
b.液晶配向膜及液晶显示元件b. Liquid crystal alignment film and liquid crystal display element
将上述液晶配向剂以印刷机(由日本写真印刷株式会社制造,型号为S15-036)分别涂 布于两片具有由ITO(indium-tin-oxide)构成的导电膜的玻璃基板,以形成预涂层。之后, 将玻璃基板放置于加热板上,并以温度为100℃、时间为5分钟的条件进行预烘烤。接着, 在循环烘箱中,以温度为220℃、时间为30分钟的条件进行后烘烤。最后,经过配向处理后,即可获得上面形成了实施例1的液晶配向膜的玻璃基板。The above-mentioned liquid crystal alignment agent was applied to two glass substrates with a conductive film composed of ITO (indium-tin-oxide) by a printer (manufactured by Nippon Photo Printing Co., Ltd., model S15-036), to form a pre-preg. coating. Then, the glass substrate was placed on a hot plate and pre-baked on the conditions of a temperature of 100° C. and a time of 5 minutes. Next, in a circulating oven, post-baking was performed under the conditions of a temperature of 220° C. and a time of 30 minutes. Finally, after the alignment treatment, the glass substrate on which the liquid crystal alignment film of Example 1 is formed can be obtained.
将上述所获得的两片上面形成了液晶配向膜的玻璃基板,其中一片涂以热压胶,另一 片洒上4μm的隔离壁(spacer)。接着,将两片玻璃基板进行贴合,再以热压机施以10kg的压力,在温度为150℃的条件下进行热压贴合。然后,以液晶注入机(岛津制作所制造, 型号为ALIS-100X-CH)进行液晶注入。接着,利用紫外光硬化胶封住液晶注入口,以紫外 光灯照光使紫外光硬化胶硬化,并在烘箱中以温度为60℃、时间为30分钟的条件进行液晶 回火处理(annealing treatment),即可获得实施例1的液晶显示元件。Two of the above-obtained glass substrates with the liquid crystal alignment film formed thereon were coated with thermocompression glue, and the other was sprinkled with a 4 µm spacer. Next, two glass substrates were bonded together, and a pressure of 10 kg was applied with a hot press, and the thermocompression bonding was performed under the condition of a temperature of 150°C. Then, liquid crystal injection was performed using a liquid crystal injector (manufactured by Shimadzu Corporation, model ALIS-100X-CH). Next, the liquid crystal injection port was sealed with a UV light curing glue, and the UV light curing glue was cured by illuminating the UV light, and the liquid crystal annealing treatment was performed in an oven at a temperature of 60° C. and a time of 30 minutes. , the liquid crystal display element of Example 1 can be obtained.
将实施例1的液晶显示元件以后述各评价方式进行评价,其结果如表4所示。Table 4 shows the results of evaluating the liquid crystal display element of Example 1 by the following evaluation methods.
实施例2至实施例36Example 2 to Example 36
实施例2至实施例36的液晶配向剂、液晶配向膜及液晶显示元件是以与实施例1相同 的步骤分别制备,其不同处在于:改变成分的种类及其使用量,如表4所示。将实施例2至36所制得液晶显示元件以后述评价方式进行评价,其结果如表4所示。The liquid crystal alignment agents, liquid crystal alignment films and liquid crystal display elements of Examples 2 to 36 were prepared in the same steps as those of Example 1, except that the types of components and their usage amounts were changed, as shown in Table 4. . The liquid crystal display elements produced in Examples 2 to 36 were evaluated in the following evaluation method, and Table 4 shows the results.
比较例1至比较例8Comparative Example 1 to Comparative Example 8
比较例1至比较例8的液晶配向剂、液晶配向膜及液晶显示元件是以与实施例1相同 的步骤分别制备,不同的地方在于:改变成分的种类及其使用量,如表5所示。对比较例1至比较例8所制得液晶显示元件以后述评价方式进行评价,其结果如表5所示。The liquid crystal alignment agents, liquid crystal alignment films and liquid crystal display elements of Comparative Examples 1 to 8 were prepared in the same steps as in Example 1, except that the types of components and their usage amounts were changed, as shown in Table 5. . The liquid crystal display elements produced in Comparative Examples 1 to 8 were evaluated by the evaluation method described later, and Table 5 shows the results.
表4及表5中标号所对应的化合物如下所示。The compounds corresponding to the symbols in Tables 4 and 5 are shown below.
评价方式Evaluation method
<电场记忆效应><Electric Field Memory Effect>
以“T.J.Scheffer,et.al.,J.Appl.Phys.,vol.19,2013(1980)”记载的方法为准,使用液晶评价装 置(中央精机(CHUO PRECISION INDUSTRIAL CO.,LTD.)制,型号为OMS-CM4RD) 对实施例1至实施例36及比较例1至比较例8的液晶显示元件进行评价。具体而言,利用 He-Ne雷射光的结晶旋转法予以测定预倾角,记录为Pm。接着,通以60Hz、16伏特的交流电,并放置于发光二极体(LED)背光源上,经过36小时后再次测定其预倾角,记录为 Pn。并以下述公式计算预倾角变化。预倾角变化越小,表示液晶显示元件的电场记忆效应越佳。反之,预倾角变化越大,表示液晶显示元件的电场记忆效应越差,甚至可能产生无法 进行光配向的问题。According to the method described in "T J Scheffer, et. al., J. Appl. Phys., vol. 19, 2013 (1980)", a liquid crystal evaluation device (manufactured by Chuo Precision Industry Co., Ltd.) was used. , the model is OMS-CM4RD) The liquid crystal display elements of Examples 1 to 36 and Comparative Examples 1 to 8 were evaluated. Specifically, the pretilt angle was measured by the crystal rotation method of He-Ne laser light, and recorded as P m . Next, the alternating current of 60 Hz and 16 volts was applied, and it was placed on a light emitting diode (LED) backlight, and the pretilt angle was measured again after 36 hours, and recorded as P n . And calculate the pretilt angle change with the following formula. The smaller the change of the pretilt angle, the better the electric field memory effect of the liquid crystal display element. On the contrary, the larger the change of the pretilt angle, the worse the electric field memory effect of the liquid crystal display element, and may even cause the problem that photo-alignment cannot be performed.
预倾角变化=︱Pm-Pn︱Pretilt angle change = ︱P m -P n ︱
预倾角变化的评价基准如下所示:The evaluation criteria for pretilt angle change are as follows:
◎:预倾角变化≦0.3°;◎: Pre-tilt angle change ≦0.3°;
○:0.3°<预倾角变化≦0.6°;○: 0.3°<pre-tilt angle change≦0.6°;
△:0.6°<预倾角变化≦1.0°;△: 0.6°<pre-tilt angle change≦1.0°;
╳:1.0°<预倾角变化,或者无法进行光配向。╳: 1.0°<pre-tilt angle change, or photo-alignment cannot be performed.
<耐环境性><Environmental resistance>
将实施例1至实施例36及比较例1至比较例8的液晶显示元件分别放置于温度为65℃ 且相对湿度为85%的环境中。经120小时后,利用电气测量机台(东阳公司制,型号为Model 6254)分别测量实施例1至实施例36及比较例1至比较例8的液晶显示元件的离子密度。 测试条件是于60℃温度下施加1.7伏特电压、0.01Hz的三角波,于电流-电压之波形中,计 算0伏特至1伏特范围的波峰面积可测得离子密度(pC)。离子密度越低,表示耐环境性越佳。反之,离子密度越高,表示耐环境性越差。The liquid crystal display elements of Examples 1 to 36 and Comparative Examples 1 to 8 were placed in an environment with a temperature of 65° C. and a relative humidity of 85%, respectively. After 120 hours, the ion densities of the liquid crystal display elements of Examples 1 to 36 and Comparative Examples 1 to 8 were measured using an electrical measuring machine (manufactured by Toyo Corporation, model 6254). The test condition is to apply a triangular wave of 1.7 volts and 0.01 Hz at a temperature of 60°C. In the current-voltage waveform, the ion density (pC) can be measured by calculating the peak area in the range of 0 volts to 1 volts. The lower the ion density, the better the environmental resistance. Conversely, the higher the ion density, the worse the environmental resistance.
离子密度的评价基准如下所示:The evaluation criteria for ion density are as follows:
◎:离子密度<20;◎: ion density <20;
○:20≦离子密度<40;○: 20≦Ion density<40;
△:40≦离子密度<50;△: 40≦Ion density<50;
╳:50≦离子密度。╳: 50≦Ion density.
表4Table 4
表4(续)Table 4 (continued)
表4(续)Table 4 (continued)
表5table 5
<评价结果><Evaluation result>
由表4及表5可知,相较于没有使用二胺化合物(b1-1)的液晶配向剂(比较例1至比较例 8),使用二胺化合物(b1-1)的液晶配向剂(实施例1至实施例36)所形成的液晶配向膜及液晶显 示元件具有良好的电场记忆效应与耐环境性。更进一步来说,没有使用二胺化合物(b1-1)的液 晶配向剂(比较例1至比较例8)所形成的液晶配向膜及液晶显示元件有电场记忆效应与耐环境 性不佳的问题。As can be seen from Table 4 and Table 5, compared with the liquid crystal aligning agents without the diamine compound (b1-1) (Comparative Examples 1 to 8), the liquid crystal aligning agents using the diamine compound (b1-1) (Example The liquid crystal alignment films and liquid crystal display elements formed in Examples 1 to 36) have good electric field memory effect and environmental resistance. Furthermore, the liquid crystal alignment film and the liquid crystal display element formed by the liquid crystal alignment agent (Comparative Example 1 to Comparative Example 8) without using the diamine compound (b1-1) have the problems of electric field memory effect and poor environmental resistance. .
当液晶配向剂中的聚合物(A-1)的使用量落在30重量份至95重量份的范围内(实施例7至 实施例12)时,可使液晶配向剂所形成的液晶配向膜及液晶显示元件具有较佳的电场记忆效应。When the use amount of the polymer (A-1) in the liquid crystal alignment agent falls within the range of 30 parts by weight to 95 parts by weight (Examples 7 to 12), the liquid crystal alignment film formed by the liquid crystal alignment agent can be And the liquid crystal display element has better electric field memory effect.
当液晶配向剂中的聚合物(A-1)中的二胺化合物(b1)包括二胺化合物(b1-2)(实施例13至实 施例18、实施例31及实施例32)时,可使液晶配向剂所形成的液晶配向膜及液晶显示元件具 有较佳的电场记忆效应。When the diamine compound (b1) in the polymer (A-1) in the liquid crystal aligning agent includes the diamine compound (b1-2) (Example 13 to Example 18, Example 31 and Example 32), it can be The liquid crystal alignment film and the liquid crystal display element formed by the liquid crystal alignment agent have better electric field memory effect.
当液晶配向剂中的聚合物(A-1)中的二胺化合物(b1)包括二胺化合物(b1-3)(实施例19至实 施例24、实施例33及实施例34)时,可使液晶配向剂所形成的液晶配向膜及液晶显示元件具 有较佳的耐环境性。When the diamine compound (b1) in the polymer (A-1) in the liquid crystal aligning agent includes the diamine compound (b1-3) (Example 19 to Example 24, Example 33 and Example 34), it can be The liquid crystal alignment film and the liquid crystal display element formed by the liquid crystal alignment agent have better environmental resistance.
当液晶配向剂中的聚合物(A-1)中的二胺化合物(b1)包括二胺化合物(b1-2)及二胺化合物 (b1-3)(实施例25至实施例30、实施例35及实施例36)时,可使液晶配向剂所形成的液晶配向 膜及液晶显示元件具有较佳的电场记忆效应及较佳的耐环境性。When the diamine compound (b1) in the polymer (A-1) in the liquid crystal alignment agent includes the diamine compound (b1-2) and the diamine compound (b1-3) (Example 25 to Example 30, Example 35 and 36), the liquid crystal alignment film and the liquid crystal display element formed by the liquid crystal alignment agent can have better electric field memory effect and better environmental resistance.
综上所述,本发明的液晶配向剂中的聚合物是由四羧酸二酐化合物及具有特定结构的二 胺化合物进行反应而制得,故将所述液晶配向剂用于形成液晶配向膜时,使用所述液晶配向 膜的液晶显示元件具有良好的电场记忆效应及耐环境性,因而适用于液晶配向膜以及液晶显 示元件。To sum up, the polymer in the liquid crystal alignment agent of the present invention is prepared by reacting a tetracarboxylic dianhydride compound and a diamine compound with a specific structure, so the liquid crystal alignment agent is used to form a liquid crystal alignment film When the liquid crystal alignment film is used, the liquid crystal display element using the liquid crystal alignment film has good electric field memory effect and environmental resistance, so it is suitable for the liquid crystal alignment film and the liquid crystal display element.
虽然本发明已以实施例揭示如上,然其并非用以限定本发明,任何所属技术领域中技术 人员,在不脱离本发明的精神和范围内,当可作些许的更改与润饰,故本发明的保护范围当 视权利要求所界定的为准。Although the present invention has been disclosed above with examples, it is not intended to limit the present invention. Any person skilled in the art can make some changes and modifications without departing from the spirit and scope of the present invention. Therefore, the present invention The scope of protection shall be subject to what is defined in the claims.
Claims (18)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011282222.9A CN114507149A (en) | 2020-11-16 | 2020-11-16 | Diamine compound, polymer, alignment agent, alignment film, and liquid crystal display element |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011282222.9A CN114507149A (en) | 2020-11-16 | 2020-11-16 | Diamine compound, polymer, alignment agent, alignment film, and liquid crystal display element |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114507149A true CN114507149A (en) | 2022-05-17 |
Family
ID=81547020
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011282222.9A Pending CN114507149A (en) | 2020-11-16 | 2020-11-16 | Diamine compound, polymer, alignment agent, alignment film, and liquid crystal display element |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114507149A (en) |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100047482A1 (en) * | 2008-08-21 | 2010-02-25 | Samsung Electronics Co., Ltd. | Photo-reactive compounds and liquid crystal display device using the same |
WO2011046397A2 (en) * | 2009-10-15 | 2011-04-21 | 주식회사 엘지화학 | Light-sensitive resin composition and a dry film comprising the same |
CN103184054A (en) * | 2011-12-27 | 2013-07-03 | Jsr株式会社 | Liquid crystal alignment agent, liquid crystal alignment film, liquid crystal display element, polymer and compound |
CN104178181A (en) * | 2013-05-22 | 2014-12-03 | 奇美实业股份有限公司 | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element |
CN105273724A (en) * | 2014-06-06 | 2016-01-27 | 奇美实业股份有限公司 | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element |
CN105969404A (en) * | 2015-03-10 | 2016-09-28 | 奇美实业股份有限公司 | Liquid crystal aligning agent, liquid crystal alignment film formed by liquid crystal aligning agent and liquid crystal display element |
TW201730274A (en) * | 2016-02-25 | 2017-09-01 | 奇美實業股份有限公司 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element |
JP2018045180A (en) * | 2016-09-16 | 2018-03-22 | 日産化学工業株式会社 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display |
-
2020
- 2020-11-16 CN CN202011282222.9A patent/CN114507149A/en active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100047482A1 (en) * | 2008-08-21 | 2010-02-25 | Samsung Electronics Co., Ltd. | Photo-reactive compounds and liquid crystal display device using the same |
WO2011046397A2 (en) * | 2009-10-15 | 2011-04-21 | 주식회사 엘지화학 | Light-sensitive resin composition and a dry film comprising the same |
CN103184054A (en) * | 2011-12-27 | 2013-07-03 | Jsr株式会社 | Liquid crystal alignment agent, liquid crystal alignment film, liquid crystal display element, polymer and compound |
CN104178181A (en) * | 2013-05-22 | 2014-12-03 | 奇美实业股份有限公司 | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element |
CN105273724A (en) * | 2014-06-06 | 2016-01-27 | 奇美实业股份有限公司 | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element |
CN105969404A (en) * | 2015-03-10 | 2016-09-28 | 奇美实业股份有限公司 | Liquid crystal aligning agent, liquid crystal alignment film formed by liquid crystal aligning agent and liquid crystal display element |
TW201730274A (en) * | 2016-02-25 | 2017-09-01 | 奇美實業股份有限公司 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element |
JP2018045180A (en) * | 2016-09-16 | 2018-03-22 | 日産化学工業株式会社 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI434111B (en) | Liquid crystal aligning agent and liquid crystal display element | |
TWI468435B (en) | Liquid crystal aligning agent, liquid crystal display element and compound | |
JP5527538B2 (en) | Liquid crystal aligning agent, method for producing liquid crystal aligning film, and liquid crystal display element | |
JP5057056B2 (en) | Liquid crystal aligning agent, method for producing liquid crystal aligning film, polyamic acid, polyimide and diamine compound | |
CN105295958B (en) | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element | |
JP2008299317A (en) | Vertical alignment type liquid crystal aligning agent and liquid crystal display element | |
CN105273724B (en) | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element | |
JP4978433B2 (en) | Liquid crystal aligning agent and liquid crystal display element | |
TWI529242B (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display device | |
JP5019038B2 (en) | Liquid crystal aligning agent, liquid crystal display element, and polymer and raw material diamine for the same | |
CN106398722B (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | |
JP2010102014A (en) | Liquid crystal aligning agent, liquid crystal alignment layer and method for forming the same, and liquid crystal display element | |
CN104946268B (en) | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element | |
TW200819510A (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | |
JP2008225010A (en) | Liquid crystal aligning agent and liquid crystal display element | |
JP4539836B2 (en) | Liquid crystal aligning agent and horizontal electric field type liquid crystal display element | |
TWI480313B (en) | Liquid crystal aligning agent and liquid crystal display element | |
TW200837459A (en) | Liquid crystal alignment agent and liquid crystal display element | |
JP4924832B2 (en) | Liquid crystal aligning agent and liquid crystal display element | |
TW202321426A (en) | Liquid crystal aligning agent, liquid crystal alignment film, method for producing liquid crystal display element, and liquid crystal display element | |
TWI865463B (en) | Diamine compound, polymer, liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display device | |
CN114507149A (en) | Diamine compound, polymer, alignment agent, alignment film, and liquid crystal display element | |
JP4844712B2 (en) | Liquid crystal aligning agent and liquid crystal display element | |
CN118011690A (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display component | |
JP2005255763A (en) | Liquid crystal aligning agent and liquid crystal display element |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220517 |